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ABSTRACT 
In dogs, nutrition has been implicated in the development of numerous chronic 
diseases, including obesity, diabetes and cardiovascular disease. Health claims for dog food 
are not regulated in Canada, thus many claims do not have a scientific basis. The development 
of a pet food with proven health benefits is important to pet owners as well as the pet food 
industry. The purpose of this study was to develop a low glycemic canine diet that will 
provide health benefits for dogs, namely decreased serum insulin and glucose concentrations, 
reduced food intake and weight gain, and improved cardiovascular health. 
To achieve this objective, four studies were performed. These studies examined the 
acute and longer term health effects of feeding unprocessed as well as extruded carbohydrate 
sources as both single ingredients and in complete dog diets. In addition, metabolic and 
cardiovascular health parameters were measured in dogs when they were lean, obese and after 
weight loss. Post-prandial serum glucose and insulin responses were used to determine 
glycemic index of the carbohydrate sources and to evaluate glucose tolerance. Flow-mediated 
dilation, echocardiography and blood pressure were used to assess cardiovascular health. 
Computed tomography was performed to measure body fat amount and distribution. Leptin, 
adiponectin and C-reactive protein were also analyzed. 
The results of these studies found that peas had a lower glycemic index compared to 
barley and rice, but that after extrusion, the glycemic index of the pea diet was not different 
than the rice diet. Post-prandial hyperglycemia in dogs was associated with acute changes in 
endothelial function which may be related to increased methylglyoxal concentrations. 
However, several negative health effects were observed in dogs after only 12 weeks of obesity 
and weight loss reversed some, but not all, of these changes. The pea-based diet reduced post-
prandial insulin response in obese dogs after 12 weeks on the diet even though no changes 
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were observed in body fat amount or distribution. In conclusion, this research supports the 
usefulness of peas as an ingredient in canine diets and provides valuable data for the pet food 
and pulse industries, as well as for veterinarians and pet owners.  
 iv 
ACKNOWLEDGMENTS 
I have many people I would like to thank for their support during my graduate work. 
Thank you first to my supervisor, Dr. Lynn Weber. Your passion for research carried me 
through my graduate program and I am sincerely grateful for all of your encouragement and 
advice. I would also like to thank my advisory committee members, Dr. Murray Drew, Dr. 
Marion Smart, Dr. Susan Whiting, Dr. Phyllis Paterson and Dr. Jaswant Singh. Thank you to 
all of the research assistants and dog volunteers, namely Courtney Kotzer and Petra Jebbink, 
for all of your help. 
I greatly appreciate all of the financial support I received: Natural Sciences and 
Engineering Research Council Doctoral Canada Graduate Scholarship; Department of 
Veterinary Biomedical Sciences Devolved Scholarship; Pfizer Fellowship Award; Pfizer 
Graduate Student Research Award; College of Graduate Studies and Research Travel Award; 
Western College of Veterinary Medicine Travel Award; the Canadian Society of 
Atherosclerosis, Thrombosis and Vascular Biology Travel Award; and the International 
Union of Nutritional Sciences Travel Award. Thank you to the Natural Sciences and 
Engineering Research Council, Saskatchewan Pulse Growers, Western College of Veterinary 
Medicine Vitamin Settlement Grant, and Horizon Pet Nutrition for the financial support for 
my research. 
Thank you very much to my family and friends. I could not have achieved this without 
your love and support. 
 v 
TABLE OF CONTENTS 
page 
 
ABSTRACT ii 
ACKNOWLEDGMENTS iv 
LIST OF TABLES viii 
LIST OF FIGURES ix 
LIST OF ABBREVIATIONS xi 
INTRODUCTION 1 
1.1 Rationale 1 
1.2 Research Design 1 
1.3 Objectives 7 
1.4 Hypotheses 8 
LITERATURE REVIEW 10 
2.1 Obesity and Weight Management 10 
2.1.1 Obesity 10 
2.1.2 Health Effects of Obesity 13 
2.1.3 Glucose Tolerance and Insulin Resistance 14 
2.1.3.1 Assessment of Glucose Tolerance and Insulin Resistance 16 
2.1.3.2 Advanced Glycation End-Products 18 
2.1.3.3 Methylglyoxal 19 
2.1.4 Dietary Treatment of Obesity 19 
2.1.5 Adipokines 20 
2.1.5.1 Leptin 21 
2.1.5.2 Adiponectin 22 
2.1.6 Weight Loss 23 
2.1.7 Dogs as a Model for Humans 24 
2.2 Cardiovascular Disease 25 
2.2.1 Association between Obesity and Cardiovascular Disease 25 
2.2.2 Diet and the Prevention of Cardiovascular Disease 26 
2.2.3 Inflammation and Oxidative Stress 26 
2.2.3.1 C-Reactive Protein 27 
2.2.3.2 Nitrotyrosine 28 
2.2.4 Endothelial Function 29 
2.2.4.1 Flow-Mediated Dilation 30 
2.2.4.2 Relationship between Flow-Mediated Dilation and Cardiac Function 34 
2.2.5 Echocardiography 34 
2.2.6 Blood Pressure 41 
2.2.7 Heart Rate 43 
2.3 Carbohydrates 43 
 vi 
2.3.1 Types of Carbohydrates 43 
2.3.2 Glycemic Index 45 
2.3.2.1 Glycemic Index Methodology 46 
2.3.2.2 Effects of Glycemic Index on Health 49 
2.3.3 Carbohydrate Sources in Dog Food 50 
2.3.3.1 Effects of Processing 52 
2.3.3.2 Starch Digestibility 53 
STUDY 1: POST-PRANDIAL IMPAIRMENT OF FLOW-MEDIATED DILATION 
AND ELEVATED METHYLGLYOXAL AFTER SIMPLE, BUT NOT COMPLEX, 
CARBOHYDRATE CONSUMPTION IN DOGS 55 
3.1 Introduction 56 
3.2 Methods and Materials 57 
3.2.1 Animals and Treatments 57 
3.2.2 Serum Analysis 59 
3.2.3 Ultrasound and Oscillometry 59 
3.2.4 Statistical Analyses 61 
3.3 Results 61 
3.3.1 Serum Glucose and Insulin 61 
3.3.2 Flow-Mediated Dilation 62 
3.3.3 Methylglyoxal and Nitrotyrosine 65 
3.3.4 Hemodynamics 65 
3.4 Discussion 67 
STUDY 2: DIGESTIBILITY AND ACUTE GLYCEMIC, INSULINEMIC AND 
CARDIOVASCULAR EFFECTS OF PEAS AS A CARBOHYDRATE SOURCE IN 
DOG FOOD 71 
4.1 Introduction 72 
4.2 Materials and Methods 73 
4.2.1 Animals 73 
4.2.2 Digestibility and Diet Formulation 73 
4.2.3 Serum Glucose and Insulin Analysis 79 
4.2.4 Ultrasound and Oscillometry 79 
4.2.5 Statistical Analyses 81 
4.3 Results 81 
4.3.1 Digestibility and Diet Formulation 81 
4.3.2 Serum glucose and insulin analysis 83 
4.3.3 Ultrasound and Oscillometry 86 
4.4 Discussion 89 
STUDY 3: SHORT-TERM OBESITY RESULTS IN DETRIMENTAL METABOLIC 
AND CARDIOVASCULAR CHANGES THAT MAY NOT BE REVERSED WITH 
WEIGHT LOSS 93 
5.1 Introduction 94 
5.2 Materials and Methods 95 
5.2.1 Animals 95 
5.2.2 Body Fat Analysis 96 
 vii 
5.2.3 Blood Collection and Analyses 97 
5.2.4 Ultrasound and Oscillometry 98 
5.2.5 Statistical Analyses 99 
5.3 Results 99 
5.4 Discussion 111 
STUDY 4: EFFECT OF A PEA- OR RICE-BASED DIET ON POST-PRANDIAL 
INSULIN RESPONSE, BODY FAT DISTRIBUTION AND CARDIOVASCULAR 
HEALTH IN OBESE DOGS 115 
6.1 Introduction 116 
6.2 Materials and Methods 118 
6.2.1 Study Design 118 
6.2.2 Body Fat Analysis 119 
6.2.3 Blood Collection and Analyses 120 
6.2.4 Ultrasound and Oscillometry 121 
6.2.5 Statistical Analyses 122 
6.3 Results 123 
6.4 Discussion 134 
DISCUSSION 138 
7.1 Conclusions 138 
7.2 Implications for the Pet Food Industry and Veterinary Practice 143 
7.3 Strengths and Limitations 145 
7.4 Future Research 148 
REFERENCES 155 
APPENDIX A:  SUPPLEMENTAL DATA FOR STUDY 1 181 
APPENDIX B: SUPPLEMENTAL DATA FOR STUDY 2 185 
APPENDIX C: SUPPLEMENTAL DATA FOR STUDY 3 188 
APPENDIX D: SUPPLEMENTAL DATA FOR STUDY 4 189 
APPENDIX E: PERMISSIONS 190 
 
 viii  
LIST OF TABLES 
Table page 
 
Table 1.1 Timeline for studies 3 and 4. ............................................................................. 4 
Table 1.2 Testing time points for studies 3 and 4. ............................................................. 5 
Table 2.1 Body condition score system for dogs. .............................................................. 12 
Table 3.1 Glycemic and insulinemic responses to 10 g of available carbohydrate from 
simple (glucose) and complex (rice, barley, corn and peas) sources.................. 64 
Table 4.1 Ingredient composition of pea and rice diets. ..................................................... 77 
Table 4.2 Calculated nutrient analysis of pea and rice diets. .............................................. 78 
Table 4.3 Proximate analysis and total tract apparent digestibility of ingredients and 
diets. ................................................................................................................ 82 
Table 4.4 Glycemic and insulinemic responses to pea and rice diets. ................................ 85 
Table 5.1 Serum glucose and insulin responses to oral glucose tolerance test in dogs that 
were lean, have been obese for 12 or 32 weeks or have undergone weight loss. 103 
Table 5.2 Cardiac and hemodynamic variables when dogs were lean, obese for 12 wk, 
obese for 32 wk or after weight loss. ................................................................ 106 
Table 5.3 Correlations between total, subcutaneous and visceral body fat with metabolic 
and cardiovascular variables using combined data when dogs were obese for 
12 and 32 weeks, and after weight loss. ............................................................ 109 
Table 6.1 Blood chemistry characteristics of adult dogs before and 12 weeks after 
receiving a pea-based or rice-based diet. .......................................................... 126 
Table 6.2 Serum glucose and insulin response to oral glucose tolerance test in dogs 
before and after receiving pea-based or rice-based diet. .................................... 127 
Table 6.3 Cardiovascular parameters in dogs before and after receiving pea-based or 
rice-based diet. ................................................................................................. 128 
Table 6.4 Correlations between total, subcutaneous and visceral body fat with metabolic 
and cardiovascular variables using combined data before and after feeding a 
pea-based or rice-based diet to dogs ................................................................. 132 
Table B.1 Cardiac and hemodynamic variables before and after feeding the pea diet, rice 
diet or glucose.................................................................................................. 187 
 
 ix  
LIST OF FIGURES 
Figure page 
 
Figure 2.1 Right parasternal long-axis echocardiographic views ....................................... 36 
Figure 2.2 Right parasternal short axis echocardiographic views. ..................................... 37 
Figure 2.3 Echocardiographic apical views. ...................................................................... 40 
Figure 3.1 Flow-mediated dilation, methylglyoxal and nitrotyrosine 60 min after feeding 
simple (glucose) or complex (rice, barley, corn, peas) carbohydrate sources. ... 66 
Figure 4.1 Cardiovascular effects of feeding glucose, pea diet or rice diet. ....................... 88 
Figure 5.1 Assessment of abdominal total, visceral and subcutaneous body fat. ................ 102 
Figure 5.2 Cardiovascular changes in dogs with different body conditions. ...................... 105 
Figure 5.3 Plasma adipokine and C-reactive protein concentrations in dogs with different 
body conditions................................................................................................ 108 
Figure 5.4 Association between visceral body fat, metabolic and cardiovascular 
parameters. ...................................................................................................... 110 
Figure 6.1 Body fat distribution before and after consumption of pea-based or rice-based 
diet. ................................................................................................................. 125 
Figure 6.2 Plasma leptin, adiponectin and C-reactive protein concentrations on 
commercial diet, pea-based diet or rice-based diet. ........................................... 131 
Figure 6.3 Effect of body fat distribution on area under the insulin response curve, 
systolic left ventricle free wall thickness, leptin and adiponectin. ..................... 133 
Figure 7.1 Interrelationships between metabolic and cardiovascular health parameters 
affected by hyperglycemia, oxidative stress and obesity. .................................. 142 
Figure A.1 Serum glucose and insulin responses after feeding simple (glucose) or 
complex (rice, barley, corn, peas) carbohydrate sources. .................................. 181 
Figure A.2 Serum glucose and insulin responses after feeding complex carbohydrate 
sources. ............................................................................................................ 182 
Figure A.3 Serum glucose and insulin responses after feeding three dosages of glucose. .. 183 
Figure A.4 Flow-mediated dilation dose response to glucose 60 min after ingestion. ........ 184 
Figure B.1 Serum glucose and insulin responses after feeding glucose, rice kibble or pea 
kibble. .............................................................................................................. 185 
 x  
Figure B.2 Serum glucose and insulin responses after feeding rice or pea kibble. ............. 186 
Figure C.1 Serum glucose and insulin responses to oral glucose tolerance test in dogs 
that were lean, have been obese for 12 or 32 weeks or have undergone weight 
loss. ................................................................................................................. 188 
Figure D.1 Serum glucose and insulin responses to oral glucose tolerance test after 
consuming pea-based or rice-based diet for 12 weeks....................................... 189 
 
 xi  
LIST OF ABBREVIATIONS 
 
AGE      Advanced glycation end product 
AUC      Area under the curve 
CBC      Complete blood count 
CRP      C-reactive protein 
CT       Computed tomography 
DE       Digestible energy 
DEXA      Dual energy x-ray absorptiometry 
DM       Dry matter 
EF       Ejection Fraction 
ELISA      Enzyme-linked immunosorbent assay 
eNOS      Endothelial nitric oxide synthase 
FMD      Flow-mediated dilation 
GE       Gross energy 
HbA1c      Glycated hemoglobin/hemoglobin A1C 
HOMA      Homeostasis model assessment 
IL-6      Interleukin-6 
LSD      Least significant difference 
LVFW      Left ventricle free wall 
LVID      Left ventricular internal dimension 
LVV      Left ventricular volume 
ME       Metabolizable energy 
MG       Methylglyoxal 
 xii  
M-mode      Motion mode 
NFB      Nuclear factor kappa-B 
QUICKI      Quantitative insulin sensitivity check 
ROS      Reactive oxygen species 
SV       Stroke volume 
TNFα      Tumour necrosis factor-α 
TTADC      Total tract apparent digestibility coefficient 
 
 
 1 
CHAPTER 1 
INTRODUCTION 
1.1 Rationale 
Nutrition plays an important role in the maintenance of health and prevention of 
disease. In dogs, nutrition has been implicated in the development of renal disease, obesity, 
rheumatism, dental disease and cardiovascular disease (Bailoni & Cerchiaro, 2005). 
Internationally the pet food industry is estimated to be worth $49 billion USD and increasing 
at about 5% annually (Bond, 2009). Consumers are becoming increasingly aware about the 
health and environmental impact of eating behaviours, both for themselves and their pets. 
Some owners believe that “natural” and “organic” foods provide long-term health benefits 
and sales of pet foods claiming to have health benefits are worth billions of dollars annually 
(Remillard, 2008). There are currently hundreds of dog foods on the market that make a wide 
variety of health claims. Because health claims for dog food are not regulated, many of the 
claims do not have a scientific basis. Thus, the development of a pet food with proven health 
benefits is important to pet owners as well as the pet food industry. 
1.2 Research Design 
The overall goal of this research was to develop a dog food with proven health 
benefits. To achieve this goal, the research described herein was divided into four studies to 
sequentially examine the short and longer term effects of different carbohydrate sources in 
dog food and their effect on various health parameters in dogs. Although each study had a 
different purpose, the overall theme of the studies was to examine the effect of diet treatment 
on metabolic and cardiovascular health. Thus, the primary variables of interest in all of the 
studies were similar and included the post-prandial glycemic and insulinemic responses to 
carbohydrate sources, changes in cardiac structure and function as measured by 
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echocardiography, and endothelial function as measured by flow-mediated dilation. In 
addition, each study examined unique variables that were of interest in the particular study.  
Study 1 examined the acute effects of feeding four unprocessed carbohydrate sources 
that are suitable for use in pet foods (rice, corn, barley and peas). These carbohydrate sources 
were chosen because rice and corn are common pet food ingredients, but have been shown in 
humans to have a high glycemic index. Barley is becoming a more common pet food 
ingredient and was chosen because it typically has a mid-range glycemic index, though this 
can depend on the barley variety. Peas are a somewhat novel pet food ingredient and were 
chosen because in humans they have a low glycemic index. Peas also were chosen because 
they are a local crop, are used as an ingredient in pet foods manufactured by a Saskatchewan 
company (Horizon Pet Nutrition), and the Saskatchewan Pulse Growers are interested in 
promoting peas as a pet food ingredient. This was the first study performed in order to 
determine which of the four carbohydrate sources had the lowest and highest glycemic index 
as well as to examine the acute cardiovascular effects of single feedings of these foods. This 
information was then used to develop low and high glycemic index diets for study 2.  
Study 2 was similar in design to study 1, but examined the acute effects of two 
complete dog diets which each contained only one carbohydrate source. The carbohydrate 
source in the diets was either rice, the highest glycemic index carbohydrate source based on 
the results from study 1, or peas, the lowest glycemic index carbohydrate source. In order to 
formulate the diets so that the macronutrient and energy contents were equivalent, the first 
step in this study was to perform digestibility trials to determine the total tract apparent 
digestibility of the main ingredients that would be used in the diets, namely chicken meal, rice 
and peas. Once the diets were formulated, their acute glycemic and cardiovascular effects 
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were tested using the same procedures as in study 1, and the apparent digestibility of the diets 
also were determined. 
Once the acute effects of the pea and rice diets were tested in study 2, the next step 
was to study the longer term health effects of the diets. This led to the design of studies 3 and 
4, which were performed simultaneously. Since all of the dogs were at ideal body weight (i.e. 
lean) for studies 1 and 2, and we wanted to examine the effects of the pea and rice diets in 
obese dogs, the first step was to allow the dogs to become obese. Allowing the dogs to 
become obese resulted in the creation of study 3, which compared metabolic and 
cardiovascular health parameters in the dogs when they were lean and obese. Once the dogs 
were obese, study 4 was initiated and the dogs were entered into a cross-over study using the 
pea and rice diets. After the cross-over study was complete, the dogs then needed to return to 
their lean body condition. After weight loss, the dogs were tested again. This testing time-
point was part of study 3 and permitted a comparison of the dogs when they were lean, obese, 
and after weight loss. Tables 1.1 and 1.2 show the timelines and testing time points for studies 
3 and 4. 
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Table 1.1 Timeline for studies 3 and 4. 
Period Body Condition Diet 
December 2010-March 
2011 (12 weeks) 
Lean at start of 
period, obese at end 
of period 
Ad libitum feeding of a 
commercial maintenance diet to 
promote weight gain 
March 2011-June 2011 
(12 weeks) 
Obese Randomly selected to receive either 
pea or rice diet 
June 2011-August 2011 
(8 weeks) 
Obese Washout period; dogs received ad 
libitum commercial maintenance 
diet to maintain obesity 
August 2011-November 
2011 (12 weeks) 
Obese Dogs received the pea or rice diet 
which they had not previously 
received 
November 2011-April 
2012 
(21 weeks) 
Obese at start of 
period, lean at end of 
period 
Commercial maintenance diet in 
restricted amounts to promote 
weight loss 
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Table 1.2 Testing time points for studies 3 and 4. 
Time Point Body Condition Diet 
Study 3 
December 2010 Lean Commercial diet fed in restricted 
amounts to maintain ideal body 
weight 
March 2011 Obese Commercial diet fed ad libitum 
August 2011 Obese Commercial diet fed ad libitum 
April 2012 Weight loss 
(lean) 
Commercial diet fed in restricted 
amounts 
Study 4 
March 2011 Obese Commercial diet fed ad libitum 
June 2011 Obese Pea or rice diet fed ad libitum 
August 2011 Obese Commercial diet fed ad libitum 
November 2011 Obese Pea or rice diet fed ad libitum 
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The research for studies 1-4 was all performed in laboratory beagles, instead of pet 
dogs, in order to allow for maximum control over the dogs’ diet and lifestyle. Initially, six 
beagles (3 females and 3 males) were obtained from Covance Research Products Inc. 
(Princeton, NJ, USA). These dogs were used for study 1. Part way through the second study, 
it was decided that a home needed to be found for one of the female dogs because she was 
having idiopathic epileptic seizures with increasing frequency. To replace her and to increase 
the sample size, four beagles (3 females and 1 male) were obtained from University of Guelph 
(Guelph, ON, Canada). For the second study, five of the original dogs (3 males and 2 females) 
plus two of the dogs from Guelph (1 male and 1 female) were used. Subsequently, all nine of 
the dogs (5 females, 4 males) were started on the study protocols for studies 3 and 4. The 
studies were started in December 2010 with study 3 finishing in April 2012 and study 4 
finishing in November 2011. In September 2011, one of the male dogs from Guelph 
spontaneously developed intervertebral disc disease that required steroid treatment and made 
him ineligible to continue in the study. He was adopted and did not complete the testing that 
was performed in November 2011 or April 2012. This resulted in study 3 having a sample 
size of n=8, and study 4 included n=9 dogs that tested the rice diet and n=8 dogs that tested 
the pea diet. 
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1.3 Objectives 
The overall purpose of this research was to develop a low glycemic index canine diet 
with proven health benefits for dogs, namely decreased serum insulin and glucose 
concentrations, reduced food intake and weight gain, and improved cardiovascular health. The 
specific objectives of each study were: 
Study 1 
1. To determine the glycemic, insulinemic and cardiovascular responses as well as serum 
nitrotyrosine and methylglyoxal concentrations in dogs after single feedings of four 
complex carbohydrate sources (peas, corn, barley and rice) and one simple carbohydrate 
source (glucose). 
Study 2 
1. To determine the digestibility of the primary ingredients used to formulate a pea-based 
or rice-based dog diet. 
2. To formulate two extruded dog diets that contain either a low (pea) or high (rice) 
glycemic index carbohydrate source. 
3. To determine the digestibility of a pea-based or rice-based dog diet. 
4. To determine the glycemic, insulinemic and cardiovascular responses in dogs to single 
feedings of the pea and rice diets. 
5. To compare the glycemic index of individual ingredients (peas and rice from study 1) to 
the glycemic index of two extruded dog diets that contain either peas or rice as their sole 
carbohydrate source. 
Study 3 
1. To examine the effects of obesity on metabolic and cardiovascular parameters in dogs. 
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2. To induce weight loss in obese dogs and determine the effects of weight loss on 
metabolic and cardiovascular parameters. 
Study 4 
1. To determine the longer term effects of a pea-based diet versus a rice-based diet on 
body composition, glycemic and insulinemic responses, metabolic and inflammatory 
indicators as well as cardiac and vascular function in obese dogs. 
1.4 Hypotheses 
The overall hypothesis for this research was that low glycemic index carbohydrate 
sources will have metabolic and cardiovascular benefits compared to high glycemic index 
carbohydrate sources in lean and obese dogs. The specific hypotheses of each study were: 
Study 1 
1. Peas will result in the lowest post-prandial glycemic response compared to corn, barley 
and rice. 
2. Carbohydrate sources that result in lower post-prandial glycemic responses will have 
beneficial effects on the cardiovascular system in dogs. 
3. Elevated methylglyoxal levels will cause impaired endothelial function via increased 
oxidative stress after a single feeding of a high glycemic index food. 
Study 2 
1. Compared to a rice-based dog diet, single feedings of a pea-based diet will result in 
lower glycemic and insulinemic responses as well as improved cardiovascular function.  
2. Peas and rice that are extruded in a dog diet will have a higher glycemic index than 
unprocessed peas and rice. 
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Study 3 
1. Obesity in dogs will result in glucose intolerance, insulin resistance, detrimental 
changes in cardiac structure and function, elevated plasma concentrations of leptin and 
C-reactive protein, and reduced plasma adiponectin. 
2. The detrimental changes that occur with obesity dogs will be more closely correlated to 
the amount of visceral, not subcutaneous, fat in dogs. 
3. Weight loss will reverse the detrimental metabolic and cardiovascular effects that occur 
with obesity in dogs. 
Study 4 
1. Compared to a rice-based diet, a pea-based diet will result in improved glucose 
tolerance and insulin sensitivity, reduced total and visceral body fat, a more favourable 
adipokine profile, and improved cardiovascular health in obese dogs. 
.
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CHAPTER 2 
LITERATURE REVIEW 
2.1 Obesity and Weight Management 
2.1.1 Obesity 
Obesity is defined by excess body fat sufficient to cause or contribute to disease 
(Laflamme, 2011). Increased morbidity and mortality is associated with increasing body fat 
mass (German, 2006). In humans, body mass index, calculated as weight (kg) divided by 
height (m2), is commonly used to assess the degree of excess weight, with overweight and 
obesity defined as a BMI of 25-30 and >30 kg/m2, respectively (Health Canada, 2005). 
Although some diseases and pharmaceutical drugs can cause obesity, most often obesity is 
due to excessive energy intake compared to energy expenditure and results from the complex 
interactions between social, behavioural, physiological, metabolic and genetic factors 
(German, 2006; Kotsis et al., 2010).  
In dogs, the prevalence of obesity in developed countries is estimated to be 25-40% 
(Laflamme, 2006). This high prevalence is concerning given that even moderately overweight 
dogs are at higher risk of earlier morbidity and mortality (Kealy et al., 2002; Laflamme, 2006; 
Larson et al., 2003; Lawler et al., 2005; Lawler et al., 2008; Smith et al., 2006). The impact of 
environmental factors likely plays a large role in the development of canine obesity since a 
significant association has been found between the degree of overweight in dogs and the BMI 
of their owners (Nijland et al., 2010). Dogs are considered to be clinically obese when their 
body weight exceeds 15% of their ideal body weight (Gossellin et al., 2007). Canine obesity 
is ideally identified and monitored using a combination of three techniques: body weight; 
body condition score; and body composition (Gossellin et al., 2007). A 9-point body 
condition score scale has been shown to be reproducible and has good correlation with other 
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methods used to determine body fat, including dual energy x-ray absorptiometry (DEXA) and 
deuterium oxide dilution (Laflamme, 1997; Mawby et al., 2004). As the score increases above 
the ideal score of 5, each unit on the scale is approximately equal to 10-15% greater than ideal 
body weight (Laflamme, 2006). Table 2.1 provides a description of each point on the scale.  
Advantages of using body condition score is that it is simple to perform and does not 
require specialized equipment; however, it does not discern the location of fat (i.e. 
subcutaneous versus visceral fat). DEXA is a common technique used to quantify body fat in 
dogs and is advantageous because of the low within-animal coefficient of variation (<2%) 
(Toll et al., 1994). However, it too lacks the ability to determine the location of body fat. 
Computed tomography (CT) scanning also can be used to determine body composition which 
has the major advantage of being able to evaluate visceral and subcutaneous fat separately 
(Ishioka et al., 2005). Disadvantages of CT scanning in dogs include the need for anesthesia 
to inhibit movement, radiation exposure, cost and the availability of equipment (Ishioka et al., 
2005). 
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Table 2.1 Body condition score system for dogs. 
Score Description 
1 Emaciated Ribs, lumbar vertebrae, pelvic bones and all bony prominences evident 
from a distance. No discernible body fat. Obvious loss of muscle mass. 
2 Very thin Ribs, lumbar vertebrae and pelvic bones easily visible. No palpable fat. 
Some evidence of other bony prominence. Minimal loss of muscle 
mass. 
3 Thin Ribs easily palpated and may be visible with no palpable fat. Tops of 
lumbar vertebrae visible. Pelvic bones becoming prominent. Obvious 
waist and abdominal tuck. 
4 Underweight Ribs easily palpable, with minimal fat covering. Waist easily noted, 
viewed from above. Abdominal tuck evident. 
5 Ideal Ribs palpable without excess fat covering. Waist observed behind ribs 
when viewed from above. Abdomen tucked up when viewed from side. 
6 Overweight Ribs palpable with slight excess fat covering. Waist is discernable 
viewed from above but is not prominent. Abdominal tuck apparent. 
7 Heavy Ribs palpable with difficulty, heavy fat cover. Noticeable fat deposits 
over lumbar area and base of tail. Waist absent or barely visible. 
Abdominal tuck may be absent. 
8 Obese Ribs not palpable under very heavy fat cover, or palpable only with 
significant pressure. Heavy fat deposits over lumbar area and base of 
tail. Waist absent. No abdominal tuck. Obvious abdominal distention 
may be present. 
9 Grossly obese Massive fat deposits over thorax, spine and base of tail. Waist and 
abdominal tuck absent. Fat deposits on neck and limbs. Obvious 
abdominal distention. 
(Laflamme, 1997) 
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2.1.2 Health Effects of Obesity 
The primary mechanisms by which obesity can predispose a human or animal to 
disease are through the mechanical/physical effects and through the subsequent alterations in 
endocrine function (German et al., 2010). Obesity in humans results in numerous hormonal 
and glucose metabolism changes that increase the risk for type 2 diabetes and cardiovascular 
disease (Gayet et al., 2004; Hoenig, 2002; Martin et al., 2006). Obesity affects the heart by 
increasing cardiac output and stroke volume in proportion to the degree of excessive weight 
(Van Vliet et al., 1995). Cardiac hypertrophy and impairment in systolic and diastolic 
function are also common with obesity (Van Vliet et al., 1995). Obesity is recognized as a 
state of chronic, low-grade inflammation and has been shown in humans to result in elevated 
levels of inflammatory markers such as C-reactive protein, interleukin-6 and tumour necrosis 
factor alpha (German et al., 2010). Obesity also has been shown in humans to increase the 
production of reactive oxygen species (ROS) within adipose tissue leading to oxidative stress 
(German et al., 2010).  
Both the amount and distribution of adipose tissue may have a negative impact on 
health. In humans, body fat stored in the central segment of the body (i.e. visceral fat) is more 
strongly associated with obesity-related disorders than subcutaneous fat (Bergman et al., 
2006). This may be due to differences in the metabolic and endocrine functions of the 
different adipose depots (Leray et al., 2008). Visceral fat is a risk factor for insulin resistance 
which may be due to its higher lipolytic activity and anatomic location upstream of the liver 
(Leray et al., 2008). In dogs, visceral body fat also may be particularly damaging. In a canine 
model of obesity, adipocytes from the visceral depot were found to be larger than that of 
subcutaneous adipocytes (Kabir et al., 2011). Visceral adipocytes larger than 75 µm were 
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found to be independent predictors of whole body and hepatic insulin resistance (Kabir et al., 
2011). 
2.1.3 Glucose Tolerance and Insulin Resistance 
Obesity is associated with impaired glucose tolerance, which is defined as blood 
glucose levels that are higher than normal after an oral or intravenous glucose load (Ceriello, 
2004). Post-prandial hyperglycemia (i.e. elevated blood glucose levels after eating) is 
believed to induce oxidative stress (Node & Inoue, 2009). Evidence suggests that post-
prandial hyperglycemia is an independent risk factor for cardiovascular disease and is a better 
predictor of future cardiovascular events than either fasting glucose or glycated hemoglobin 
(Node & Inoue, 2009). Even in the absence of overt diabetes, post-prandial hyperglycemia 
and high-normal blood glucose levels may have deleterious effects on cardiovascular health 
(Thomas et al., 2004; Zhu et al., 2007).  
Post-prandial glucose levels may be a better predictor of vascular dysfunction and 
cardiovascular events than fasting glucose in both diabetic and healthy individuals (Siervo et 
al., 2011). Maintaining good glycemic control is an important factor in preventing long-term 
complications in individuals with impaired glucose tolerance and diabetes. Among humans 
with well-controlled type 2 diabetes, but who follow different insulin regimes, those on a 
more intensive regime that results in lower post-prandial glucose levels show less vascular 
pathology (von Bibra et al., 2009).  
Insulin is released from the pancreatic β-cells for blood glucose regulation (Borai et 
al., 2007). Insulin lowers blood glucose by facilitating uptake by tissues, primarily muscle and 
adipose tissue, and inhibiting endogenous glucose production by the liver (Leray et al., 2008). 
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Thus, insulin sensitivity and the amount of insulin delivered to target tissues affects blood 
glucose regulation (Kaiyala et al., 1999).  
In humans, obesity is associated with insulin resistance, hyperinsulinemia and the 
cardiometabolic syndrome (Govindarajan et al., 2008). Insulin resistance is characterized by 
increased fasting plasma insulin and exaggerated insulin response to a glucose load (Brunetto 
et al., 2011; Gayet et al., 2004). One of the mechanisms by which hyperinsulinemia may 
contribute to cardiovascular disease may be due to increased sodium retention as a result of 
insulin’s action on the renal tubules (Kotsis et al., 2010).  
Lifetime diet restriction in dogs is associated with higher insulin sensitivity and 
reduced morbidity and mortality (Larson et al., 2003). On the contrary, there is evidence that 
obesity and high dietary fat intake in dogs causes impaired glucose tolerance and insulin 
resistance (Kaiyala et al., 1999). In dogs, insulin resistance has been shown to be associated 
with weight gain. A study by Bailhache et al. (2003) used the euglycemic hyperinsulinemic 
clamp technique to assess insulin sensitivity in lean dogs and after the dogs had gained at least 
20% of their initial body weight for at least 5 weeks (Bailhache et al., 2003). Baseline glucose 
concentrations were the same in the normal and obese dogs whereas baseline insulin 
concentrations were significantly higher in the obese dogs. To maintain euglycemia, the 
glucose infusion rate was higher in the normal than obese dogs, indicating reduced insulin 
sensitivity in the obese dogs. In the obese state, the dogs were found to have high plasma 
triglyceride levels and low HDL levels which are also common changes observed in insulin 
resistant humans (Bailhache et al., 2003). 
Obesity does not appear to cause overt type 2 diabetes in dogs as is seen in humans 
and cats (Rand et al., 2004). The physiological reason for dogs being resistant to type 2 
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diabetes is of interest because solving this puzzle may help in the treatment and prevention of 
type 2 diabetes in humans. One mechanism may be related to differences in insulin secretion 
between dogs and humans. A study by Verkest et al. (2011a) found that obese dogs did not 
lose first-phase insulin secretion in response to intravenous glucose administration, one of the 
early markers of the development of type 2 diabetes. It also has been suggested that pancreatic 
β-cells in dogs may not be as sensitive to hyperglycemic toxicity as humans or may lack a 
component in the pathophysiology of β-cell failure (Verkest et al., 2012). Additional research 
is needed to determine why obese dogs are resistant to developing type 2 diabetes. 
2.1.3.1 Assessment of Glucose Tolerance and Insulin Resistance 
Various methods have been investigated to measure glucose tolerance and insulin 
sensitivity. These methods can be classified as dynamic tests (samples are collected serially) 
or single specimen tests (samples collected at one time point) (Borai et al., 2007). Common 
examples of dynamic function tests include the hyperinsulinemic euglycemic clamp, the 
insulin tolerance test, the intravenous glucose tolerance test, and the oral glucose tolerance 
test (Borai et al., 2007). Single specimen tests include homeostasis model assessment 
(HOMA) and the quantitative insulin sensitivity check (QUICKI) (Borai et al., 2007). Each 
test has unique advantages and disadvantages which must be taken into account when 
selecting the appropriate technique for a particular study. The clamp technique, oral glucose 
tolerance test and HOMA technique are commonly used techniques and thus will be briefly 
reviewed here.  
The hyperinsulinemic euglycemic clamp is considered to be the gold standard for 
assessing insulin sensitivity in vivo in humans and animals (Borai et al., 2007; Muniyappa et 
al., 2008). It involves infusing exogenous insulin at a constant rate along with a variable 
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amount of glucose to maintain euglycemia (Borai et al., 2007). Individuals with high insulin 
sensitivity will require considerably more exogenous glucose to maintain euglycemia than 
those who are insulin resistant (Borai et al., 2007). However, disadvantages of this technique 
are that it is technically demanding, laborious, time consuming and expensive (Borai et al., 
2007; Muniyappa et al., 2008). In addition, it is performed under non-physiological conditions 
since glucose is given intravenously and bypasses the effect of the gastrointestinal tract on 
glucose and insulin metabolism (Borai et al., 2007).  
The oral glucose tolerance test reflects the ability of the body to dispose of glucose 
after a glucose load and is a useful method to assess glucose tolerance (Muniyappa et al., 
2008). In humans, it is performed by having fasted subjects consume 75 g of glucose (~1 g 
glucose per kg body weight) dissolved in water. Blood glucose concentrations are then 
measured over the subsequent 2 hours. An index of whole body insulin sensitivity, which has 
been shown to have good correlation with insulin sensitivity measurements performed by the 
hyperinsulinemic euglycemic clamp, can then be calculated as:  
 
Equation 2.1 
10000 
[[fasting glucose (mg/dL) x fasting insulin (µU/mL)] x [mean glucose x mean insulin]] 
 
Limitations of the oral glucose tolerance test are the large intraindividual variation and the 
influence of gastrointestinal emptying (Borai et al., 2007).  
Homeostasis model assessment is based on the principle that a given combination of 
fasting insulin and glucose concentrations will be a reflection of β-cell deficiency and insulin 
resistance. HOMA uses a mathematical model of fasting glucose and insulin interactions to 
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determine insulin resistance and β-cell deficiency (Borai et al., 2007). This method is 
convenient and easy for the study subjects but its precision is poor (Borai et al., 2007). In 
addition, since this model was developed in humans, it cannot be assumed that it can be 
applied to other species and more validation studies are needed for other animals (Muniyappa 
et al., 2008; Verkest et al., 2010).   
2.1.3.2 Advanced Glycation End-Products 
Advanced glycation end products (AGEs) are the products of non-enzymatic 
glycosylation and oxidation of proteins and lipids and are an indicator of glycemic control. 
AGEs bind to receptors in endothelial cells, vascular smooth muscle cells and monocytes to 
trigger multiple signaling pathways and the generation of reactive oxygen species (Rammos et 
al., 2008). AGEs generate ROS in part by the activation of NADPH oxidase, resulting in 
reduced endothelial nitric oxide synthase (eNOS) activity, and directly affecting endothelial 
cells by increasing expression and release of vascular cell adhesion molecule-1 (Rammos et 
al., 2008). An example of a commonly measured AGE is glycated hemoglobin (HbA1c), 
which is a non-enzymatically formed product that is directly related to serum glucose 
concentration over the preceding 2-3 months in both dogs and humans (Jorgensen et al, 2004; 
Loste & Marca, 2001; Siervo et al., 2011). AGEs cause cross-linking of proteins which results 
in proteins that are normally flexible to become rigid (Vasan et al., 2003). AGEs tend to 
accumulate and exert their greatest effects in proteins with very low turnover such as collagen 
and elastin (half-lives of years to decades, respectively). Glycated elastin, in particular, has 
serious cardiovascular consequences since this decreases vascular elasticity (Baydanoff et al., 
1984; Konova et al., 2004). 
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2.1.3.3 Methylglyoxal 
Methylglyoxal is a precursor of advanced glycation end products produced primarily 
during glycolysis and is a highly reactive electrophilic dicarbonyl aldehyde compound (Desai 
et al., 2010). Methylglyoxal reacts with the amino acids arginine and lysine in some proteins 
to produce AGEs (Dhar et al., 2008). Methylglyoxal is considered to be one of the most 
reactive advanced glycation end-product precursors in endothelial cells (Brouwers et al., 
2010). Methylglyoxal is associated with the formation of ROS by mitochondria which could 
be an initial event in the development of vascular complications (Brouwers et al., 2010). The 
accumulation of methylglyoxal may play a vital role in the development of insulin resistance 
(Jia & Wu, 2007). Methylglyoxal has been shown to be a sensitive indicator of glycemic 
fluctuation (Nemet et al., 2005). After a single dose of 75 g glucose, post-prandial plasma 
methylglyoxal significantly increased in healthy men (Masterjohn et al., 2012). 
2.1.4 Dietary Treatment of Obesity 
In both dogs and humans, diet therapy is often used in the treatment and prevention of 
obesity and its associated conditions (Flight & Clifton, 2006; Lee et al., 2008; Livesey et al., 
2008; O'Keefe et al., 2008). In all animal species, in order for weight loss to occur, the 
amount of energy consumed must be less than the amount of energy expended. A successful 
weight loss program results in loss of fat mass with little or no loss of lean body mass, which 
may be achieved in dogs by providing a high quality and adequate level of protein (Diez et al., 
2004). A loss of 1-2% body weight per week is ideal for dogs in order to minimize hunger, 
prevent the loss of lean body mass and to prevent rebound weight gain (Roudebush et al., 
2008).  
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High fat diets are known to contribute to obesity in dogs (Laflamme, 2011). On the 
contrary, protein as well as the amount and type of dietary fibre appear to be key nutrients to 
consider in weight loss diets for dogs (Laflamme, 2011; Weber et al., 2007; Yamka et al., 
2007). Weight loss diets for dogs often contain increased levels of fibre with the intention of 
decreasing caloric intake by increasing the bulk of the diet, reducing the caloric density and 
decreasing digestibility (Sunvold & Murray, 2003). However, adverse effects of a high fibre 
diet include decreased nutrient availability, increased fecal volume, poor skin and coat 
quality, and poor palatability (Sunvold & Murray, 2003). 
2.1.5 Adipokines 
Adipose tissue is no longer viewed as simply a storage organ for excess energy, but as 
an active organ that secretes hormones (i.e., adipokines or adipocytokines) that communicate 
with the brain and peripheral tissues to regulate energy homeostasis, insulin sensitivity, and 
lipid and carbohydrate metabolism (Clarke & Judd, 2008; German et al., 2010). Adipokines 
are secreted from adipocytes as well as the associated cells such as macrophages (Laflamme, 
2011). One of the mechanisms by which diet and lifestyle therapy may induce benefits for 
obese individuals is through reduction in systemic inflammation and improvement in the 
adipokine secretory profile (Klimcakova et al., 2010). Differences in adipokine secretion from 
visceral fat may be one of the reasons why visceral fat is more detrimental to health than fat 
located in other areas of the body, such as intramuscular, perivascular and epicardial adipose 
tissue (Laflamme, 2011). 
Canine adipocytes express key adipocyte hormones and inflammation-related 
adipokines and are a highly active endocrine and secretory organ (Ryan et al., 2010). 
However, adipokine research in dogs is still in its infancy. With the development of enzyme-
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linked immunosorbent assay (ELISA) kits that are specific for canine adipokines, such as 
leptin and adiponectin, more research in this area can now be performed (Radin et al., 2009). 
2.1.5.1 Leptin 
Leptin is a product of the ob gene and leptin concentrations are positively correlated 
with adipose tissue mass (Nishii et al., 2010). Leptin plays a key role in the regulation of 
whole body energy balance and body weight by suppressing appetite and promoting energy 
expenditure through stimulation of sympathetic activity (Ishioka et al., 2007; Kotsis et al., 
2010; Morris & Rui, 2009). Leptin induces oxidative stress and upregulation of adhesion 
molecules in endothelial cells and thus, may play a direct role in the pathogenesis of 
endothelial dysfunction (Fantuzzi, 2005). It also may play an indirect role in vascular 
pathology by stimulating the production of C-reactive protein, an acute phase inflammatory 
protein, in the liver which then increases inflammation in the endothelium (Knudson et al., 
2008). In some obese individuals circulating levels of leptin are high, but this does not lead to 
the expected reduction in food intake and increased energy expenditure, suggesting these 
individuals are leptin resistant (Kotsis et al., 2010). Whether or not leptin resistance also 
occurs in dogs is uncertain (Laflamme, 2011). 
Leptin may be used in assessment of adiposity in dogs since plasma leptin 
concentration is strongly correlated with body weight and body fat content (Sagawa et al., 
2002). Fat mass appears to be the primary factor affecting leptin concentrations in dogs 
(Radin et al., 2009) and hyperleptinemia has been observed in overweight dogs fed a high fat 
diet (Knudson et al., 2005). Leptin levels are affected by meal timing and dogs show a peak in 
leptin levels about 5-8 hours after feeding (Ishioka et al., 2005a). Serum leptin levels in 
healthy dogs have been reported to range from 1.4 to 5.6 ng/ml with a mean of 3.0 ± 0.3 
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ng/ml (Iwase et al., 2000). Obese dogs were found to have plasma leptin concentrations of 
13.1 ± 7.6 ng/ml compared to 1.1 ± 0.3 ng/ml in lean dogs (Nishii et al., 2010). Leptin can be 
measured by ELISA using commercially available, canine-specific kits (Tvarijonaviciute et 
al., 2011). 
2.1.5.2 Adiponectin 
Adiponectin is a 30-kD adipokine and is the most abundantly expressed adipokine in 
adipose tissue (Inadera, 2008). Adiponectin plays a central role in a number of metabolic 
processes such as glucose uptake, fatty acid oxidation and gluconeogenesis (Brand-Herrmann, 
2009). In humans, adiponectin contrasts with leptin in that conditions that are associated with 
high leptin levels, such as obesity, cause adiponectin concentrations to be low (Clarke & Judd, 
2008; Hopkins et al., 2007; Shetty et al., 2009). In humans, average plasma adiponectin levels 
are 5-10 µg/ml (Inadera, 2008). 
Initially it was believed that adiponectin is secreted exclusively by adipose cells, but 
there is also evidence that it is secreted by cardiomyocytes, skeletal muscle and osteoblasts 
(Brand-Herrmann, 2009). Adiponectin has an anti-inflammatory function and may be 
protective against inflammatory processes such as atherosclerosis by inhibiting the expression 
of adhesion molecules, decreasing the proliferation of smooth muscle cells, and preventing 
the conversion of macrophages to foam cells (Brand-Herrmann, 2009; Clarke & Judd, 2008; 
German et al., 2010; Inadera, 2008).  
Adiponectin exerts insulin sensitizing effects, lowers hepatic glucose production and 
increases glucose uptake and fatty acid oxidation in skeletal muscle (Inadera, 2008). In 
humans, low concentrations of adiponectin are associated with insulin resistance, 
hyperinsulinemia, reduced HDL and increased LDL levels (Clarke & Judd, 2008). 
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Hypoadiponectemia is an independent risk factor for future cardiovascular events such as 
myocardial infarction, suggesting that adiponectin has direct effects on vascular health 
(Clarke & Judd, 2008). Visceral fat content, rather than total fat, appears to be the primary 
factor that determines adiponectin concentrations (Clarke & Judd, 2008).  
Canine adiponectin is similar to other species in its nucleotide and amino acid 
sequences (Radin et al., 2009). However, in dogs, there is some controversy about whether or 
not adiponectin is decreased with obesity (Verkest et al., 2011; Verkest et al., 2011b) and 
whether adiponectin increases in response to weight loss as is seen in humans (Wakshlag et 
al., 2011). Adiponectin can be measured in serum or plasma and either EDTA or heparin can 
be used as an anticoagulant when using commercially available, canine-specific ELISA kits 
(Radin et al., 2009; Tvarijonaviciute et al., 2010).  
2.1.6 Weight Loss 
Weight loss is recommended for overweight and obese individuals with the goal of 
reversing the negative health effects associated with obesity. Research suggests that some, but 
not all, metabolic and cardiovascular changes that occur with obesity are reversed with 
subsequent weight loss. In humans, weight loss is associated with decreased pro-inflammatory 
markers and increased anti-inflammatory markers, with the greatest improvements seen 
among those who have lost at least 10% body weight (Forsythe et al., 2008). Weight loss 
using a low calorie diet also has been shown to reduce serum advanced glycation end products 
(Gugliucci et al., 2009).  
Weight loss may also improve cardiovascular health. Obesity in humans is associated 
with increased left ventricular mass which may contribute to increased cardiovascular events 
and mortality (Haufe et al., 2012). However, after six months of caloric restriction, left 
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ventricular mass, heart rate and cardiac output were found to significantly decrease in humans 
regardless of whether they consumed a restricted fat or a restricted carbohydrate diet (Haufe et 
al., 2012). On the contrary, a meta-analysis that examined the effect of weight loss on all-
cause mortality risk found that weight loss among otherwise healthy obese and overweight 
individuals did not prolong life (Harrington et al., 2009). 
In dogs, even after weight loss, obesity-induced changes in metabolic parameters seem 
to persist. A comparison of glucose intolerance and insulin resistance in dogs that were lean, 
then gained weight and subsequently lost weight showed that although glucose and insulin 
levels improved with weight loss, levels remained elevated compared to when the dogs were 
lean (Brunetto et al., 2011). Energy metabolism also seems to be altered by weight gain and 
weight loss. Nagaoka et al. (2009) studied the amount of energy required to induce weight 
gain, weight loss, and subsequent weight re-gain in beagles. The results showed that less time 
and fewer calories were necessary to cause the same degree of weight re-gain compared to the 
first time that obesity was induced. Thus, food efficiency increased during the obesity 
reinduction period (Nagaoka et al., 2009). These results highlight why weight maintenance 
after weight loss can be challenging and emphasizes the importance of preventing initial 
weight gain. 
2.1.7 Dogs as a Model for Humans 
Studying the effect of diet on obesity and cardiovascular disease in dogs could also 
provide valuable information for human applications. Dogs are suitable models for humans 
when studying the effect of diet on chronic disease for several reasons. First, dogs possess a 
gastrointestinal tract similar to humans in that their intestinal to body length ratio is similar 
and they experience similar patterns in motility (Knapp et al., 2008). Second, dogs and 
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humans are both omnivorous and eat a diet that is similar in macronutrient composition 
(Knapp et al., 2008). 
Dogs may be advantageous as a model because dietary manipulation in animals is 
much easier than with humans and complete control of dietary intake can be achieved. For 
example, it is difficult to determine if reduced body weight or adiposity is solely attributed to 
low dietary glycemic index because interventions designed to modify dietary glycemic index 
may also influence other factors affecting body weight such as fibre content, palatability and 
energy density (Pawlak et al., 2004). Since dogs can eat the same diet for long durations, 
isolating the effect of glycemic index on health parameters is simplified. In addition, dogs are 
a superior animal model for humans compared to rodents because of the closer homology 
between canine and human genes (Ryan et al., 2010). 
However, as with all models, there are limitations to using dogs as models for humans. 
High-density lipoprotein transports as much as 90% of the total circulating lipids in dogs, 
whereas in humans low-density lipoproteins are the primary lipoproteins (Bailhache et al., 
2003; Maldonado et al., 2001). Cardiovascular disease also does not manifest in dogs the 
same way it does in humans, with atherosclerosis and ischemic heart disease being 
uncommon in dogs. Despite these differences in the end-stage cardiovascular pathology 
between humans and dogs, the early pathological events are still likely to be similar in both 
species.  
2.2 Cardiovascular Disease 
2.2.1 Association between Obesity and Cardiovascular Disease 
In humans, obesity and cardiovascular disease are known to be strongly linked. 
Obesity results in increased risk of factors associated with obesity, including hypertension, 
dyslipidemia and insulin resistance. Obesity also has been identified as an independent risk 
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factor for ischemic heart disease and heart failure (Lopaschuk et al., 2007). Obesity results in 
changes in cardiac fatty acid metabolism that may play a causal role in the development of 
obesity-related cardiomyopathies due to cardiac lipid accumulation and excessive fatty acid 
utilization (Lopaschuk et al., 2007). Canine cardiovascular function can be impaired with age 
resulting in decreased blood flow, arterial compliance and arterial distensibility (Guglielmini, 
2003). Thus, nutrition and obesity may play roles in the maintenance of cardiovascular health 
in dogs, particularly as they get older; however, this is an area that has not been thoroughly 
studied. 
2.2.2 Diet and the Prevention of Cardiovascular Disease 
In humans, diets rich in fruits, vegetables, legumes, fish, poultry and whole grains are 
associated with protection against cardiovascular disease, whereas diets high in red meat, 
processed meat, refined grains, sweets, deep-fried foods and high fat dairy products increase 
disease risk (Lopez-Garcia et al., 2004). In dogs, the association between diet and 
cardiovascular disease is less clear. Most studies in dogs have investigated the effect of diet 
on treatment, not prevention, of cardiac disease. Nutrients that have been the most thoroughly 
studied in dogs in relation to cardiac disease include taurine, carnitine, omega-3 fatty acids 
and sodium, with diets lower in sodium and higher in taurine, L-carnitine, and omega-3 fatty 
acids showing some benefit for dogs with cardiac disease (Freeman, 1998; Freeman et al., 
2006; Gompf, 2005; Sanderson, 2006). However, the effect of carbohydrates on 
cardiovascular disease risk in dogs is unknown. 
2.2.3 Inflammation and Oxidative Stress 
Body cells and tissues are at continuous risk of damage by free radicals and ROS 
(Garcia-Lafuente et al., 2009). Oxidative stress is an imbalance between the levels of ROS 
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and antioxidants in the body which can result in cellular injury and tissue damage 
(McMichael, 2007). The major source of ROS in cells is electron leakage from electron 
transport chains (McMichael, 2007). In both humans and dogs, obesity is associated with 
increased markers of oxidative stress (Laflamme, 2011). 
Oxidative stress and inflammation are closely linked. ROS can attract inflammatory 
mediators, thereby inducing a generalized inflammatory response and tissue damage (Garcia-
Lafuente et al., 2009). In pathophysiological states, inflammatory cells, such as neutrophils, 
macrophages, and eosinophils, contribute substantially to production of ROS (McMichael, 
2007).  
The nuclear factor kappa-B (NFB) transcriptional system is a major effector pathway 
involved in inflammation (Garcia-Lafuente et al., 2009). NFB promotes the transcription of 
multiple proinflammatory cytokines, including tumour necrosis factor-α (TNFα) and 
interleukin-6 (IL-6) (Garcia-Lafuente et al., 2009). TNFα is the first step in the inflammatory 
cascade and induces the product of IL-6 (Bullo et al., 2007). Both TNFα and IL-6 are elevated 
in obesity and diabetes (Bullo et al., 2007). In turn, IL-6 controls C-reactive protein 
production (Bullo et al., 2007). 
2.2.3.1 C-Reactive Protein 
C-reactive protein (CRP) is a 115-kDa pentamer expressed primarily by hepatocytes in 
response to tissue damage, infection, inflammation and malignant neoplasia (Nilsson, 2005). 
CRP is one of the most important inflammatory markers in humans and is positively 
associated with obesity, fasting glucose and insulin levels, blood pressure and lipid profile 
(Bullo et al., 2007). In humans, elevated levels of CRP are associated with coronary events 
through a possible cause-and-effect relationship that has still not been firmly established 
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(Mathieu et al., 2009). Visceral fat may be particularly harmful because of its high production 
of IL-6 which promotes the secretion of acute phase proteins, such as CRP, by the liver 
(Mathieu et al., 2009).  
In dogs, as in humans, CRP is a useful indicator of inflammation (Otabe et al., 1998). 
A study that examined CRP levels in dogs with a variety of diseases found that the diseases in 
which CRP was most frequently elevated were in neoplastic disease and immune-mediated 
diseases (Nakamura et al., 2008). More recently, CRP has also been shown to be elevated in 
dogs with congestive heart failure (median 4.22, range 0.43-45.44 µg/mL) compared to 
healthy dogs (median 0.88, range 0-19.87 µg/mL; P=0.02) (Cunningham et al., 2012). CRP 
values in normal beagles taken at different times throughout the day over 28 days were found 
to range from 0.8-22.6 µg/ml (mean 3.65 ± 1.40 µg/ml) and did not appear to be affected by 
circadian rhythm (Otabe et al., 1998). CRP can also be measured using commercially 
available, canine-specific ELISA kits. 
2.2.3.2 Nitrotyrosine 
Nitrotyrosine is a marker of oxidative stress. Inactivation of nitric oxide by the 
superoxide radical results in the production of peroxynitrite, a potent oxidant (Ceriello, 2002). 
Peroxynitrite has been implicated in the pathogenesis of many chronic diseases and may play 
a role in atherosclerosis due to its ability to initiate low density lipoprotein oxidation 
(Oldreive & Rice-Evans, 2001). Peroxynitrite nitrates amino acids such as tyrosine to produce 
nitrotyrosine. Thus, the production of peroxynitrite can be indirectly inferred by the presence 
of nitrotyrosine (Ceriello, 2002). Nitrotyrosine also may cause oxidative damage that could 
contribute to atherosclerosis and other inflammatory conditions (Mohiuddin et al., 2006). 
Nitrotyrosine is normally not detectable in the plasma of healthy individuals (Ceriello, 2002). 
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However, elevated nitrotyrosine levels have been found in patients with inflammatory 
conditions and diabetes as well as among smokers (Ceriello, 2002; Mohiuddin et al., 2006; 
Pereira et al., 2008).  
Hyperglyemia has been shown to increase the release of nitric oxide and superoxide, 
with the increase in superoxide production being about double that of nitric oxide (Ceriello, 
2002). This imbalance results in excess generation of peroxynitrite and reduced biological 
effects of nitric oxide (Ceriello, 2002). Thus, hyperglycemica may play a direct role in the 
production of nitrotyrosine and cause impaired endothelial function (Ceriello, 2002). Effects 
in dogs are unknown. 
2.2.4 Endothelial Function 
The single layer of endothelial cells that line the blood vessels play an important 
homeostatic role in the vascular system (Al-Qaisi et al., 2008). Healthy endothelial cells 
inhibit platelet aggregation, white blood cell adhesion and smooth muscle cell proliferation 
(Moens et al., 2005). Nitric oxide is produced by the endothelium, primarily by eNOS, but 
can be scavenged by excess reactive oxygen species (Schiffrin, 2008). Nitric oxide is a critical 
regulatory molecule involved in vasodilation and is anti-atherogenic (Al-Qaisi et al., 2008; 
Puglia et al., 2006). In response to shear stress, calcium entry into endothelial cells increases 
(Corretti et al., 2002). Calcium subsequently activates eNOS which generates nitric oxide and 
results in vasodilation (Corretti et al., 2002). Endothelial dysfunction due to decrease NO 
bioavailability is now believed to be the initial step in the development of atherosclerosis 
(Node & Inoue, 2009).  
There is increasing evidence that hyperglycemia is damaging to the endothelium 
(Kawano et al., 1999; Thomas et al., 2004; Wascher et al., 2005). Even moderate elevations in 
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blood glucose can impair endothelial function as seen not only in patients with overt diabetes, 
but also in healthy individuals and those with impaired glucose tolerance (Kim et al., 2003; 
Node & Inoue, 2009; Title et al., 2000; Williams et al., 1998). Although hyperglycemia 
induces endothelial dysfunction, the mechanism by which this occurs is unclear. Impaired 
flow-mediated dilation (FMD) with hyperglycemia suggests that nitric oxide bioavailability is 
reduced (Mah et al., 2011). This could be due to reduced nitric oxide biosynthesis, elevated 
consumption of nitric oxide by ROS or increased uncoupling of eNOS (Mah et al., 2011). 
Oxidative stress plays a critical role in vascular endothelial dysfunction and there is evidence 
that hyperglycemia results in the overproduction of ROS (Node & Inoue, 2009; Yano et al., 
2004). In addition, it has been shown that nitric oxide bioavailability is reduced among 
individuals with diabetes (Masha et al., 2009). The formation of AGEs as a result of 
hyperglycemia may also contribute to endothelial dysfunction (Brouwers et al., 2010). 
The relative effects of obesity and dysglycemia on impairment of endothelium-
dependent vasodilation were investigated a study by Han et al. (2011). The results found that 
dysglycemia, insulin resistance and obesity independently resulted in impairment of 
endothelium-dependent vasodilation, though multivariate modeling suggested that the relative 
contribution of dysglycemia was less than that of obesity. Effects in dogs may be similar, but 
are unknown. 
2.2.4.1 Flow-Mediated Dilation 
FMD is the most reproducible, non-invasive technique of assessing endothelial 
function (Donald et al., 2006). FMD measures changes in brachial artery diameter in response 
to shear stress induced by increasing the local blood flow (reactive hyperemia) which is 
principally mediated by nitric oxide (Al-Qaisi et al., 2008; Moens et al., 2005). Mediators 
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other than nitric oxide may be involved, but FMD is substantially reduced by inhibition of 
eNOS (Jiang et al., 2011). 
In healthy people, FMD is 7-10%, whereas patients with cardiovascular disease have 
values of 0-5% or sometimes may even be negative (i.e. paradoxical vasoconstriction after 
shear stimulus) (Moens et al., 2005). Impaired FMD indicates impaired endothelial function 
and is associated with increased risk of serious cardiovascular events in humans (Moens et al., 
2005). Studies have shown that FMD is an independent predictor of future cardiac events 
(Green et al., 2011). A meta-analysis reported that in humans, a 13% decrease in future risk of 
cardiovascular events exists for every 1% increase in FMD (Inaba et al., 2010).  
Diet has been shown to affect FMD in humans. Volek et al. (2009) investigated the 
effect of hypocaloric diets that were restricted in either carbohydrate or fat among overweight 
men and women. FMD was assessed pre- and post- ingestion of a high fat meal, before and 12 
weeks after consuming the carbohydrate or fat restricted diets. At 12 weeks, FMD increased 3 
hours after the test meal in the subjects receiving the carbohydrate restricted diet, but was 
decreased in the subjects receiving the fat restricted diet (Volek et al., 2009). 
To perform FMD, ultrasound is used to image the brachial artery before and after 
inflation of a sphygmomanometric cuff to suprasystolic pressure (at least 50 mm Hg above 
systolic pressure) (Corretti et al., 2002). Subsequent deflation of the cuff results in shear stress 
and the release of nitric oxide which causes vasodilation. FMD is the percent change in artery 
diameter from baseline compared to the maximum dilation after cuff release, calculated as 
(Harris et al., 2010): 
 
Equation 2.2 
FMD = 100% x [(maximum diameter after cuff release – baseline diameter )/baseline diameter] 
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The methods used to perform FMD need careful consideration because of the many 
variables that can affect the outcome. Currently, most of the methodological 
recommendations for FMD have been developed from studies using human subjects. 
Longitudinal imaging of the artery is recommended over cross-sectional imaging because of 
inadequate image definition of the lateral wall and the presence of skew artifacts in the cross-
sectional view (Corretti et al., 2002). A longitudinal image also allows for an average derived 
from multiple diameter measurements along the vessel which produces less variability 
(Corretti et al., 2002). The diameter of the brachial artery should be measured at end diastole 
(onset of the R-wave on ECG trace) and the maximum dilation after cuff release should be 
measured rather than the dilation at a specific time point (Al-Qaisi et al., 2008; Corretti et al., 
2002; Puglia et al., 2006). In humans, the recommended occlusion time is 5 minutes. A 
minimum of 10 minutes of rest has been recommended before another baseline FMD image is 
acquired to allow for the reestablishment of baseline conditions (Corretti et al., 2002). 
However, a more recent study found that a second FMD performed 15 minutes after the first 
assessment was significantly decreased so more time between measurements may be 
necessary (Nerla et al., 2011) 
Environmental factors that can affect FMD in humans include room temperature, time 
of day, ingestion of fatty foods or caffeine, concurrent inflammation or infection and stage of 
menstrual cycle (Al-Qaisi et al., 2008). Other factors that may affect FMD include age, 
gender, arterial hypertension, diabetes mellitus, cholesterol, obesity, hyperhomocysteinemia, 
coronary artery disease and smoking (Moens et al., 2005). Factors affecting FMD in dogs 
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have not been characterized. To improve reproducibility, FMD measurements should be 
performed by a single tester (Moens et al., 2005). 
A limited number of studies have reported performing FMD in dogs. FMD has been 
validated in normal dogs (Puglia et al., 2006), but the clinical implications of decreased FMD 
are still unknown for non-humans. The baseline brachial artery diameter in dogs with a 
median body weight of 31.4 kg (range 21.9-34.6 kg) was found to be 0.25-0.30 cm compared 
to values of 0.40-0.50 cm in adult humans (Puglia et al., 2006). In dogs, one study found that 
a 3 minute occlusion time may be as effective as 5 minutes and offers the advantage of 
decreased opportunity for the dog to move (Puglia et al., 2006). In dogs, brachial artery FMD 
has been recommended over femoral artery FMD due to improved repeatability and higher 
values (Jones et al., 2011). 
A study by Jones et al. (2010) evaluated the between- and within-dog repeatability of 
measuring FMD in healthy dogs using techniques recommended in the human literature. FMD 
was found to be significantly greater among dogs ≤15 kg (median 7.7%, range 0-19.3%) than 
dogs >15 kg (median 2.2%, range -2.2-10.6%). Increasing age also was shown to reduce 
FMD. The coefficient of variation for within-dog repeatability for FMD assessments 
performed 24 hours apart by the same sonographer was 62.8%. The between-dog coefficient 
of variation for FMD was 99.7%. Peak arterial dilation usually occurred within 90 seconds 
after release of the blood pressure cuff. Some of the issues that were encountered with 
performing FMD in dogs that are less problematic with humans included maintaining constant 
probe position, obtaining images of a consistent arterial segment, obtaining true longitudinal 
images, and limb movement (Jones et al., 2010). For this thesis, some of the technical 
problems with FMD in dogs were overcome by using a single breed (beagles) that were 
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housed under identical conditions and fed identical diets. The dogs were also well acclimated 
to the FMD procedure which was performed with each dog several times prior to performing 
any experiments. 
2.2.4.2 Relationship between Flow-Mediated Dilation and Cardiac Function 
The left ventricle of the heart pumps oxygenated blood into the aorta for distribution 
throughout the body. An important component in the overall health and function of the 
cardiovascular system is the relationship between the heart, particularly the left ventricle, and 
the systemic vasculature (i.e. ventricular-arterial coupling) (Frenneaux & Williams, 2007). 
Increased vascular stiffness results in reduced FMD, elevated blood pressure and increased 
load on the heart (Frenneaux & Williams, 2007). To compensate, the heart increases systolic 
and diastolic stiffness, which can result in the development of left ventricular hypertrophy 
(Frenneaux & Williams, 2007). Thus, measurement of changes in left ventricular structure 
and function not only provides information about the health of the heart, but also about the 
health of the systemic vasculature. 
2.2.5 Echocardiography 
Echocardiography, or cardiac ultrasound, can be used to determine changes in heart 
structure and function. Echocardiography is non-invasive with little or no stress as dogs only 
require gentle restraint (Hanton et al., 1998). Another advantage of echocardiography is that 
measurements are easily repeatable and echocardiography does not alter the function of the 
tissues being examined (Hanton et al., 1998). Two-dimensional (brightness mode or B-mode) 
echocardiography is used to view anatomical relationships while motion-mode (M-mode) 
echocardiography is used primarily for quantification of cardiac dimension (Brown et al., 
2003).  
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Left ventricular measurements are commonly taken from the right parasternal location 
in the short axis view using two-dimensional guided M-mode echocardiography (Chetboul et 
al., 2004; Schober & Baade, 2000). In the dog, the right parasternal location is located 
between the 3rd and 6th intercostal spaces. A long axis view of the heart is observed when the 
imaging plane transects the left ventricle parallel to the long axis of the heart from apex to 
base, as shown in figure 2.1 (Thomas et al., 1993). To obtain a short axis view, the transducer 
is rotated 90 degrees from the long axis view. A series of short axis views can be obtained 
from the apex to the base of the heart (figure 2.2). The left ventricle is generally circular in the 
short axis view and thus is easy to recognize (Bonagura et al., 1985). When the upper part of 
the left ventricle is visualized at the level of the papillary muscles, a distinct mushroom-
shaped view of the ventricular chamber is observed (figure 2.2B). Once this image is 
obtained, the M-mode guideline is positioned between the papillary muscles and the 
movement is recorded (Hanton et al., 2008).  
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Thomas et al. (1993) 
Figure 2.1 Right parasternal long-axis echocardiographic views 
Reproduced with permission (Appendix E).  
  
Abbreviations: 
AO - Aorta 
CH – Chordae tendineae 
LA – Left atrium 
LC – Left coronary cusp 
LV – Left ventricle 
MV – Mitral valve 
RA – Right atrium 
RPA – Right pulmonary 
artery 
RV – Right ventricle 
TV – Tricuspid valve 
• Transducer index mark 
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Thomas et al. (1993) 
Figure 2.2 Right parasternal short axis echocardiographic views. 
Short axis view at the level of the apex (A), papillary muscles (B), chordae tendineae (C), mitral 
valve (D), aorta (E), and pulmonary arteries (F). Reproduced with permission (Appendix E). 
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From these echocardiographic images, measurements can be made in diastole (d) and 
systole (s) for left ventricular internal dimension (LVID), free-wall thickness and 
interventricular septal thickness (Chetboul et al., 2004). An average of three to five cardiac 
cycles should be used for each measurement (Boon, 1998). From these measurements, 
fractional shortening can then be calculated using the formula (Chetboul et al., 2005; Crippa 
et al., 1992). 
 
Equation 2.3 
FS = [LVIDd – LVIDs]/LVIDd 
 
Fractional shortening provides an index of left ventricle systolic function and values in normal 
dogs are typically between 30-40 percent (Bonagura et al., 1985; Hanton et al., 2008).  
Left ventricular volume (LVV) in diastole and systole can be calculated using the 
modified Simpson’s rule (biplane method of disks) from the two-dimensional apical four-
chamber and two-chamber views (figure 2.3) (Boon, 1998; Hanton et al., 2008). These two 
images provide near-orthogonal views which is preferable to using a single plane (St John 
Sutton et al., 2009). Simpson’s rule involves tracing the inner circumference of the left 
ventricle which is then analyzed as a stack of disks by computer analysis software. The 
volume for each disk is determined and the total volume of the disks is summated to calculate 
left ventricular volume (Boon, 1998). Subsequently, stroke volume (SV) and ejection fraction 
(EF) can be calculated by (Hanton et al., 2008): 
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Equation 2.4 
SV = LVVd – LVVs  
 
Equation 2.5 
EF = SV/LVVd 
 
Ejection fraction is an indicator of ventricular contractile function as it is the fraction of the 
ventricular diastolic volume that is ejected at each heart beat (Hanton et al., 2008). 
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B 
 
Thomas et al. (1993) 
Figure 2.3 Echocardiographic apical views. 
(A) Apical 2-chamber view (B) Apical 4-chamber view. Reproduced with permission  
(Appendix E). 
 
Abbreviations: 
AMV – Anterior mitral valve 
cusp 
AS – Atrial septum 
LA – Left atrium 
LAu – Left auricle 
LV – Left ventricle 
PMV – Posterior mitral valve 
cusp 
RA – Right atrium 
RPA – Right pulmonary artery 
RV – Right ventricle 
TV – Tricuspid valve 
• Transducer index mark 
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During an echocardiography exam, dogs can be in a recumbent or standing position. It 
is recommended that repeat examinations be performed with the dog in the same position and 
that the same observer perform subsequent examinations (Chetboul et al., 2005). 
Simultaneous electrocardiogram recording during an echocardiography examination is 
essential as a timing reference (Bonagura et al., 1985). M-mode diastolic measurements 
should be taken at the beginning of the QRS complex on the electrocardiogram and systolic 
measurement should be taken at the peak downward point of septal motion (Boon, 1998). M-
mode measurements should be made vertically on the image with chamber size, free wall 
thickness and septal thickness measured along the same line (Boon, 1998). For two-
dimensional images, the end diastolic frame is defined as the frame just before the mitral 
valves close or the first frame that shows the QRS complex, whereas end systole is identified 
as the frame just before the mitral valve opens (Boon, 1998). Parameters of chamber size and 
wall thickness in dogs are correlated linearly with weight and body surface area (Boon, 1998). 
Body surface area, in square meters, can be calculated by the formula: body surface area = (K 
x W2/3) x 10-4 where weight (W) is in grams and K is the proportionality constant which is 
equal to 10.1 for dogs (Bonagura, 2000; Cowgill & Drabkin, 1927; O'Grady, 1986). 
2.2.6 Blood Pressure 
Obesity is a risk factor for hypertension in humans (Kotsis et al., 2010). However, 
research is still ongoing to understand the mechanisms by which obesity causes hypertension. 
Activation of the sympathetic nervous system in obese individuals is considered to be a 
primary mechanism by which obesity induces hypertension (Kotsis et al., 2010). High energy 
intake increases norepinephrine turnover in peripheral tissues and high dietary fat and 
carbohydrate intake may stimulate adrenergic receptors leading to elevated sympathetic 
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activity (Kotsis et al., 2010). Increased sympathetic activity in obesity may be due to impaired 
baroreceptor sensitivity and/or increased levels of circulating free fatty acids, angiotensin II, 
insulin and leptin (Kotsis et al., 2010). 
Blood pressure can be measured in non-sedated dogs in an outpatient setting using 
high definition oscillometry (Brown et al., 2007; Henik et al., 2005). This technique detects 
pressure changes produced in an air bladder within the occluding cuff resulting from the 
pressure pulse (Henik et al., 2005). As reported by Brown et al. (2007), several studies have 
used oscillometry to measure arterial blood pressure in normal dogs. These studies found a 
fairly large variation in pressures, with systolic pressure ranging from 131-150 mm Hg and 
diastolic pressure ranging from 71-91 mm Hg. The wide variation in values can be attributed 
to the differences in subject populations, measurement techniques and animal handling 
(Brown et al., 2007). Thus, standardization of the technique is crucial (Brown et al., 2007). 
Interbreed variation can also result in significant differences in blood pressure values. The 
blood pressure in sighthounds is generally 10-20 mm Hg higher than in mongrels and values 
between other breeds can vary by 7-10 mm Hg (Brown et al., 2007). Within-day and between-
day coefficient of variation in systolic blood pressure were reported to be 9.0-10.1% and 12.8-
16.4%, respectively, and 10.3-14.4% and 14.2-24.9% for diastolic blood pressure (Rattez et 
al., 2010). 
The effects of age on blood pressure in dogs is less clear than in humans, but there is 
some evidence to suggest that blood pressure may increase by 1-3 mm Hg/year as dogs age 
(Brown et al., 2007). Obesity in dogs also may produce an increase in blood pressure. One 
study reported an increase in mean arterial pressure from 94.4 ± 2.1 to 105.5 ± 3.7 mm Hg 
after induction of obesity from high fat overfeeding (Truett et al., 1996). An epidemiological 
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study that measured blood pressure using oscillometry found that obese dogs had slightly 
higher (<5 mm Hg) blood pressure that lean dogs (Bodey & Michell, 1996). 
2.2.7 Heart Rate 
Elevated heart rate (i.e. tachycardia) is an independent risk factor for cardiovascular 
morbidity and mortality in healthy humans as well as among those with established cardiac 
disease (Palatini, 2011). Increased heart rate may be even more predictive of mortality than 
cholesterol and blood pressure (Palatini, 2011). Tachycardia may increase cardiac disease risk 
through a number of mechanisms, including increased cardiac work, increased arterial wall 
stress, higher mean blood pressure, decreased large artery compliance, and disruption of 
arterial plaques (Palatini & Julius, 2004). As with hypertension, increased sympathetic 
activation may be responsible for elevated heart rate in obesity (Palatini, 2011). However, 
there is evidence in dogs that obesity may elevate heart rate due to reduced parasympathetic 
control (Truett et al., 1996; Van Vliet et al., 1995). 
2.3 Carbohydrates 
2.3.1 Types of Carbohydrates 
Carbohydrates are classified based on the number of sugar units present (Institute of 
Medicine, 2005). A monosaccharide has one sugar unit, a disaccharide has two sugar units, an 
oligosaccharide consists of 3-10 sugar units and polysaccharides contain more than 10 sugar 
units (Institute of Medicine, 2005). Dietary fibre is carbohydrate that is non-digestible 
(Institute of Medicine, 2005). Monosaccharides and disaccharides are commonly referred to 
as simple sugars whereas oligosaccharides and polysaccharides are considered complex 
carbohydrates. 
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Starch, a polysaccharide, is the main digestible carbohydrate found in plants. It is an 
important and economical energy source in the diet of humans and animals (Bednar et al., 
2001). Starch consists of two types of glucose polymers, amylose and amylopectin. Amylose 
is a linear glucose polymer whereas amylopectin is a branched-chain glucose polymer 
(Biliaderis, 1991). The content of amylose and amylopectin in starch affects properties such 
as pasting, gelatinization and retrogradation which in turn affects product quality and stability 
(Abdel-Aal, 2002).  
Resistant starch is the fraction of starch in foods that remains undigested and 
consequently reaches the colon where it is fermented by colonic bacteria, producing short 
chain fatty acids as by-products (Akerberg, 1998). Some resistant starch occurs naturally, but 
new resistant starch can also be created by the formation of bonds between amylose chains 
(i.e., retrogradation) which results from the heating and cooling of foods (Kendall et al., 
2004). Amylose is more susceptible to retrogradation than amylopectin (Spears & Fahey, 
2004). Extrusion, the process used to make the majority of dry pet foods, usually decreases 
the amount of resistant starch, but retrogradation can result in increased concentrations 
(Spears & Fahey, 2004).  
Resistant starch possesses properties that may provide health benefits. Products high 
in resistant starch tend to have a lower energy density and often produce low glycemic and 
insulinemic responses (Akerberg, 1998; Knapp et al., 2008). In addition, the fermentation of 
resistant starch appears to result in higher amounts of butyric acid compared to fermentation 
of soluble fibre. Butyric acid is the major energy source for colonocytes, thus resistant starch 
is considered to play an important role in colonic health (Akerberg, 1998).  
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Pet foods can contain as much as 50% starch which is commonly derived from cereal 
grains (Spears & Fahey, 2004). In general, starch is highly digestible by companion animals 
and the digestibility is generally increased through extrusion (Spears & Fahey, 2004; Twomey 
et al., 2002). Conversely, as the dietary fibre content in dog food increases, fecal weight also 
increases, whereas digestibility and transit time decrease (Burrows et al., 1982). Fibre may 
help in weight control because it adds bulk to food without adding calories, but the diet may 
also need to be high in protein in order for weight loss to occur (Butterwick & Markwell, 
1997; German et al., 2009a). 
2.3.2 Glycemic Index 
Carbohydrate is the primary dietary component that affects postprandial glycemic and 
insulinemic responses with both the amount and type of carbohydrate affecting the responses 
(Barclay et al., 2008). In humans, there is increasing evidence that the type of carbohydrate 
included in the diet may play a role in weight control, as well as in the prevention or 
management of diabetes and cardiovascular disease (Thomas & Elliott, 2009; Thomas et al., 
2007; Thomas et al., 2004). The glycemic index was developed to rank carbohydrate-
containing foods based on their effect on postprandial glycemic response and was developed 
to assist people with diabetes to control their blood glucose levels (Du et al., 2008; Jenkins et 
al., 1981). Glycemic index is calculated from the area under the blood glucose curve that is 
above the baseline value (Wolever et al., 1991). High glycemic index foods produce a higher 
peak postprandial glycemic response and an overall greater area under the blood glucose 
curve in the two hours after consumption than do foods with a low glycemic index (Foster-
Powell et al., 2002). The glycemic load is defined as the glycemic index of a food multiplied 
by its carbohydrate content (Barclay et al., 2008). 
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2.3.2.1 Glycemic Index Methodology 
Methodology recommendations for performing glycemic index testing come primarily 
from human studies. There are several variables that affect the glycemic index value including 
food portion size, choice of reference food, repeated testing of the standard food, frequency 
and length of time of blood sampling, and the method of calculation of area under the glucose 
curve (Wolever et al., 1991). However, if procedures are standardized for these factors within 
a given series of experiments, all test foods using the same procedure would be affected 
similarly to the reference food. Thus, the use of a reference food minimizes these effects on 
the calculated glycemic index values (Wolever et al., 1991).  
For testing glycemic index in humans without impaired glucose tolerance, it is 
recommended that glucose measurements be performed at 15, 30, 45, 60 and 120 minutes 
after ingestion of the test food. In contrast, for subjects with impaired glucose tolerance, it is 
recommended that testing be done every 30 minutes for 3 hours after ingestion of the test food 
(Wolever et al., 1991). It is not desirable to extend the testing time any longer because this 
can decrease the difference between the glycemic indices of foods. In addition, it is the early 
part of the glucose response curve (i.e. <2 h) that reflects carbohydrate absorption which in 
turn affects insulin and counter-regulatory hormone responses (Wolever et al., 1991). 
However, in dogs, extending the post-prandial sampling period to 3 hours may be more 
appropriate than the 2 hour time frame used in humans because it appears to take longer for 
blood glucose levels to return to baseline in dogs (Watanabe et al., 2004).  
The amount of carbohydrate offered is an important factor in calculating glycemic 
index (Aziz, 2009). In humans, the area under the glucose curve increases almost linearly for 
foods that contain up to 50 g of carbohydrate, but then flattens (Aziz, 2009; Wolever et al., 
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1991). Lower doses can be used as long as the amount of carbohydrate in the test and 
reference foods is the same (Aziz, 2009). For dogs, offering a 50 g portion of carbohydrate 
may result in feeding an intolerable volume of food. One study that examined glycemic 
response in dogs fed diets that provided 5.5-7.3 g of starch in one feeding (Carciofi et al., 
2008). Thus, offering portions of single ingredient reference and test foods that provide 10 g 
of carbohydrate (equivalent to 1 g/kg body weight, approximating the standard human dose) 
may be more reasonable.  
It is also important that the carbohydrate used in calculating the amount fed is the 
available carbohydrate, not the total carbohydrate. Available carbohydrate is the portion of 
carbohydrate that is digestible and absorbable in the small intestine. According to the Food 
and Agriculture Organization of the United Nations, available carbohydrate includes the 
proportion of carbohydrate that can be digested by human enzymes and absorbed (Food and 
Agriculture Organization of the United Nations, 2003). Thus, available carbohydrate includes 
D-glucose, D-fructose, sucrose, maltodextrins, non-resistant starch and the D-glucose 
component of lactose, which can be all measured as D-glucose plus D-fructose following 
enzymatic hydrolysis (McCleary, 2007). Available carbohydrate does not include dietary fibre 
or resistant starch, which only provide a source of energy after being fermented in the large 
intestine (Food and Agriculture Organization of the United Nations, 2003). Available 
carbohydrate can be estimated by difference or analyzed directly (Food and Agriculture 
Organization of the United Nations, 2003). The difference method uses the following formula 
to estimate the weight of available carbohydrate:  
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Equation 2.6 
Available carbohydrate = 100 – [weight in grams [protein + fat + water + ash +alcohol +  
    dietary fibre] in 100 g of food] 
 
Alternatively, direct analysis uses the formula:  
 
Equation 2.7 
Available carbohydrate = weight in grams [monosaccharides + disaccharides +  
    oligosaccharides + polysaccharides, excluding fibre] 
 
Available carbohydrate can be determined by direct analysis using commercially available 
assay kits (McCleary, 2007). 
Venous and capillary blood are both considered acceptable for calculating glycemic 
index, though capillary blood is recommended (Aziz, 2009). Capillary blood glucose 
concentrations are less variable compared to venous and it is less invasive to use capillary 
finger pricks than it is to insert a catheter (Aziz, 2009). However, peripheral pricks are not as 
easy to perform in dogs compared to humans and catheter insertion is necessary if other blood 
parameters (e.g., insulin) are being measured simultaneously. To improve glycemic index 
precision, it is recommended that two tests are performed for each food by each test subject 
(Aziz, 2009) and that the reference food be tested at least three times by each subject 
(Wolever et al., 1991).  
Typically the glycemic index methodology is used to analyze single ingredients. It is 
not useful to determine the glycemic index of meals consumed by humans since each meal 
tends to contain different types and proportions of food. However, dogs do not eat single 
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ingredients and they generally eat the same mixed meal for long periods of time. Thus, it is of 
potential value to the manufacturer and consumer to know the glycemic index of a formulated 
dog food. There is evidence in dogs that the starch content has the most impact on 
postprandial glucose whereas carbohydrate, protein and fat all affect the insulin response 
(Nguyen et al., 1998).  
2.3.2.2 Effects of Glycemic Index on Health 
There is increasing evidence in humans that the glycemic index of a diet influences 
insulin sensitivity, lipid metabolism, inflammation, chronic disease risk, and weight 
management (Barclay et al., 2008; Du et al., 2008; Livesey et al., 2008; Thomas et al., 2007). 
Authors of a systematic review from the Cochrane Library concluded that a diet with a lower 
glycemic load promotes weight loss and improves lipid profiles in humans (Thomas et al., 
2007). In addition, a meta-analysis of 37 prospective observational studies found that in 
humans, diets with a high glycemic index or glycemic load increased the risk of type 2 
diabetes, heart disease, gallbladder disease, breast cancer and all diseases combined (Barclay 
et al., 2008). However, the glycemic index appeared to have more effect than the glycemic 
load. This could be because a low glycemic load diet could consist of low glycemic index, 
high carbohydrate foods or of foods that are low in carbohydrates, but high in other harmful 
dietary components, for example the saturated fat in cheese and meat (Barclay et al., 2008).  
In humans, high glycemic index and high glycemic load diets are associated with 
moderately improved cholesterol profiles and reduced C-reactive protein (Levitan et al., 2008; 
Liu et al., 2002). Consumption of low glycemic index foods offers a similar or higher level of 
protection against chronic disease compared to the consumption of whole grain foods or high 
fibre intake (Barclay et al., 2008).  
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A limited number of studies have investigated the health effects of glycemic index in 
dogs. A study by Mitsuhashi et al. (2010) investigated the effect of a low glycemic index 
starch (high amylose corn starch) and diacylglycerol on metabolic parameters and weight 
management in dogs. The low glycemic index starch diets resulted in greater weight loss than 
the high glycemic index starch diets regardless of the type of fat the diets contained. However, 
the low glycemic index diet had lower digestibility and metabolizable energy than the high 
glycemic index diet. The actual glycemic indices of the diets were not reported. 
A study by Nguyen et al. (1994) examined the effect of four foods differing in 
macronutrient composition on post-prandial glucose and insulin concentrations. The test foods 
were fed in amounts based on each dog’s calculated energy requirement. The incremental area 
under the glucose response curve was not significantly different among the test foods. 
Significant differences were observed between the foods for the area under the insulin 
response curve. This variable was highest for the foods with the greatest carbohydrate content 
(Nguyen et al., 1994).  
2.3.3 Carbohydrate Sources in Dog Food 
Although there is significant evidence in humans that hyperglycemia is detrimental to 
health, the long term consequences of a high glycemic index diet are unknown in dogs. The 
type of carbohydrate included in dog food may have important health effects given that dry 
dog foods typically consist of 30-60% carbohydrate and canned foods include up to 30% 
carbohydrate (Carciofi et al., 2008; Murray et al., 1999). Furthermore, many dog foods 
include a high glycemic index carbohydrate source such as white rice or corn.  
In dogs with insulin-dependent diabetes, the macronutrient (i.e. carbohydrate, fat and 
protein) composition of the diet has been shown to influence glucose metabolism. For 
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example, a canned high fibre diet has been shown to decrease the degree of fluctuation in 
postprandial plasma glucose concentration (Graham et al., 1994). A study by Carciofi et al. 
(2008) examined the effects of several carbohydrate sources on the glycemic and insulinemic 
responses in dogs. The study found that the diets containing sorghum, lentils and peas delayed 
and lengthened the glycemic and insulinemic responses (Carciofi et al., 2008). Another study 
found that a high fibre diet that included pea fibre and guar gum as the fibre sources 
significantly lowered mean 24 hour and postprandial glucose concentrations in addition to 
reducing plasma concentrations of fructosamine, glycated hemoglobin and cholesterol 
(Graham et al., 2002). In dogs, plasma fructosamine concentration provides an indication of 
blood glucose control over the previous one to three weeks, whereas glycated hemoglobin 
concentration is an indicator for glycemic control over the past three to four months (Graham 
et al., 2002). Another study that compared the glycemic responses of corn, wheat, barley, rice 
and sorghum found that rice resulted in the highest postprandial glycemic and insulinemic 
response in dogs (Sunvold & Bouchard, 1998). Many commercial dog foods use corn, rice or 
sorghum as carbohydrate sources. 
Pulses are the edible seeds of legumes and include peas, beans, lentils, chickpeas and 
faba beans. Whole yellow pea flour has been shown to be a beneficial ingredient in human 
food products to create novel low glycemic foods (Marinangeli et al., 2009). Peas also may be 
a potential pet food ingredient that could offer advantages over other carbohydrate sources 
traditionally used in pet foods, such as rice and corn. A potential advantage of peas may be 
related to their low glycemic index due to the high proportion of resistant starch (62 % of total 
starch) and slowly digestible starch (21 % of total starch) compared to the proportion of starch 
that is rapidly digestible (17 % of total starch) (Fouhse, 2011). Peas are also high in dietary 
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fibre (20 % of seed dry matter) and contain both insoluble (10-15 %) and soluble fibre (2-9 
%). Soluble fibre tends to increase the viscosity of gastrointestinal contents and results in 
prolonged gastric emptying and reduced transit time through the small intestine, thus 
producing a lower post-prandial glycemic response (Dikeman et al., 2006). 
In addition to being a carbohydrate source, peas have twice the protein content of most 
cereal grains (Saskatchewan Pulse Growers, 2009). Peas are also are gluten-free. Canada is 
the world’s largest grower of peas (Bond, 2009) and Saskatchewan produces 80% of 
Canada’s pea crop (Saskatchewan Pulse Growers, 2009). Thus, peas are a local ingredient 
which minimizes the environmental impact of shipping if used in locally produced dog foods. 
Furthermore, using local products would contribute to promoting growth in the local 
economy. Another advantage of peas is that they fix their own nitrogen which reduces the 
need for synthetic fertilizer made from fossil fuels (Bond, 2009), further reducing the 
environmental impact.  
2.3.3.1 Effects of Processing 
The majority of commercial dry dog and cat food are manufactured using extrusion 
(Lankhorst et al., 2007). Extrusion is a cooking process where the food mixture is exposed to 
high temperature and pressure for a relatively short period of time (Lankhorst et al., 2007). 
Benefits of extrusion include achieving a desired physical form, inactivation of anti-
nutritional factors, increased product shelf life, improved digestibility and enhanced 
palatability (Lankhorst et al., 2007). Disadvantages of extrusion include micronutrient losses, 
lipid oxidation, and destruction or reduction in bioavailability of amino acids, particularly 
lysine (Lankhorst et al., 2007).  
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In addition to the carbohydrate source in the food, the type of processing may impact 
the glycemic index of dog food (Nguyen et al., 1998). The high temperature and high pressure 
characteristics of extrusion allow starch granules to be completely gelatinized, thereby 
increasing susceptibility to amylase degradation and increased release of glucose (Lankhorst 
et al., 2007; Nguyen et al., 1998). Canning, another common processing method used for 
making dog food, also increases starch availability by using high moisture/high temperature 
conditions which are required for sterilization (Nguyen et al., 1998). The changes in starch 
structure during the manufacturing process affects the functional properties of the food, 
including the rate and extent of starch digestion (Spears & Fahey, 2004). Conditions used for 
both extruding and canning dog foods tend to produce higher glycemic index foods. However, 
optimizing processing conditions to increase starch retrogradation has the potential to enhance 
starch resistance to digestion and produce lower glycemic index foods. 
2.3.3.2 Starch Digestibility 
Apparent digestibility of a food or ingredient is the proportion of nutrients absorbed in 
the gastrointestinal tract (Brambillasca et al., 2010). Digestibility trials are used to determine 
apparent digestibility and protocols described by the Association of American Feed Control 
Officials are commonly used to determine digestibility of pet foods (Association of American 
Feed Control Officials, 2009). 
Starch in dog food tends to be highly digestible though there are a variety of factors 
that influence starch digestibility, including the type of cereal, starch-protein interactions, 
physical granule form, type of starch, digestion inhibitors, and processing (Carciofi et al., 
2008). There is increasing interest in using legumes, such as peas, beans and lentils, as 
carbohydrate sources in pet food. A study by Carciofi et al. (2008) examined the effects of six 
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extruded diets, each with a different carbohydrate source, on dog total tract apparent 
digestibility. Starch digestibility was greater than 98% for all of the diets, though the brewer’s 
rice and cassava flour diets had improved starch digestibility compared to the lentil and pea 
diets (Carciofi et al., 2008). Another study that investigated the digestibility of a diet 
containing navy bean powder found digestibility coefficients of 68.58% for dry matter, 
78.22% for crude protein, 74.91% for organic matter, and 94.49% for acid hydrolyzed fat 
(Forster et al., 2012). Thus, pulses may have somewhat lower digestibility than some other 
starch sources, but appear to be well-tolerated by dogs. Further research is needed to explore 
the potential health benefits of pulses as a carbohydrate source in pet food. 
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CHAPTER 3 
STUDY 1: POST-PRANDIAL IMPAIRMENT OF FLOW-MEDIATED DILATION AND 
ELEVATED METHYLGLYOXAL AFTER SIMPLE, BUT NOT COMPLEX, 
CARBOHYDRATE CONSUMPTION IN DOGS 
This study was performed first in the series of four studies included in this thesis 
because the data that resulted from this study was necessary for the subsequent studies. 
Specifically, this study determined which of four carbohydrate sources (peas, rice, corn and 
barley) had the lowest and highest glycemic index. The carbohydrate sources with the highest 
and lowest glycemic index were then formulated into complete dog diets that were used in 
studies 2 and 4. Thus, the results of this study permitted comparison of the acute health effects 
of unprocessed, individual carbohydrate sources versus the acute and chronic health effects of 
the same carbohydrate sources once processed and incorporated into a dog diet. 
This chapter was published in the journal Nutrition Research and is reproduced with 
permission (Appendix E).  
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3.1 Introduction 
Increasing evidence suggests that the type of carbohydrate included in the diet plays a 
role in chronic disease mitigation. Specifically, post-prandial hyperglycemia is a known risk 
factor for cardiovascular disease among healthy and diabetic patients with low glycemic index 
foods improving markers of cardiovascular disease risk (Brand-Miller et al., 2007; Ceriello, 
2004; Lavi et al., 2009; Levitan et al., 2004; Thomas et al., 2007; von Bibra et al., 2009). 
Modifying the type of dietary carbohydrate is likely more important in reducing chronic 
disease risk than altering the total amount of carbohydrate or fat (Brand-Miller et al., 2009; 
Ghanim et al., 2009; Hung et al., 2003). However, it is not clear whether the benefits of low 
glycemic index foods are related to long-term consumption, or whether acute feedings of high 
glycemic index foods are detrimental to cardiovascular health. 
Hyperglycemia is thought to initiate a cascade of events that may be detrimental to the 
cardiovascular system (Aljada et al., 2006; Crandall et al., 2009; Dhindsa et al., 2004; 
Dickinson & Brand-Miller, 2005). Endothelial dysfunction is considered to be the initial step 
in the development of atherosclerosis as well as hypertension and many cardiovascular 
diseases (Endemann & Schiffrin, 2004). Oxidative stress plays a critical role in vascular 
endothelial dysfunction and there is evidence that hyperglycemia can initiate pro-
inflammatory events such as increases in NFB and TNFα followed by overproduction of 
reactive oxygen species and inhibition of eNOS (Cosentino et al., 1997; Mohanty et al., 2000; 
Node & Inoue, 2009). Reduced vasodilation in response to shear stress is an indicator of 
endothelial dysfunction which can be assessed in vivo using FMD (Harris et al., 2010; 
Thijssen et al., 2010). Nitric oxide, a potent vasodilator, is thought to be largely responsible 
for mediating FMD, but becomes inactivated in the presence of oxidative stress with 
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subsequent formation of peroxynitrite (Joannides et al., 1995; Schiffrin, 2008). Since 
peroxynitrite has a high affinity for reacting with tyrosine residues, nitrotyrosine can be used 
as an indicator of biological inactivation of nitric oxide and increased oxidative stress 
(Ceriello, 2002). 
Another mechanism by which hyperglycemia may contribute to endothelial 
dysfunction is through the formation of AGEs (Brouwers et al., 2010; Dhar et al., 2010). 
Methylglyoxal (MG) is a reactive glucose metabolite and is a precursor of AGE (Desai et al., 
2010). MG has been reported to increase with chronic hyperglycemia resulting from diabetes 
and is considered to be one of the most reactive AGE precursors in endothelial cells (Nemet et 
al., 2005). MG may also indirectly play a role in endothelial cell damage by increasing 
oxidative stress (Desai et al., 2010; Miyazawa et al., 2010). However, post-prandial effects on 
methylglyoxal in normal patients are unknown.  
Based on these observations, we hypothesize that MG levels will cause impaired 
endothelial function via increased oxidative stress after consuming high glycemic index, but 
not low glycemic index, foods in normal animals. Elevated MG levels, impaired endothelial 
function and decreased vasodilation due to hyperglycemia may in turn cause elevated blood 
pressure and increased cardiac load, but this should not change left ventricular size because of 
the acute nature of this post-prandial stress. The objective of this research was to examine the 
acute effects of glucose versus four complex carbohydrate sources (corn, rice, peas and 
barley) on glycemic, insulinemic and cardiovascular responses using a dog model. 
3.2 Methods and Materials 
3.2.1 Animals and Treatments 
Six neutered beagle dogs, three males and three females at ideal body weight and a 
mean age of 2.8 ± 0.75 years were used. The dogs were obtained from Covance Research 
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Products Inc. (Princeton, NJ, USA) and were kept in the Western College of Veterinary 
Medicine at the University of Saskatchewan (Saskatoon, Saskatchewan, Canada). The animals 
were housed individually in 1.1 x 2.7 m kennels and were walked and given play time for at 
least one hour per day. Dogs were fed a commercial adult maintenance dry diet (Purina Dog 
Chow, Ralston Purina Co., St. Louis, MO) in amounts based on the National Research 
Council guidelines (National Research Council, 2006). No anesthetics or sedatives were used 
in this study. This work was approved by the University of Saskatchewan’s Animal Research 
Ethics Board and adhered to the Canadian Council on Animal Care guidelines for humane 
animal use. 
Four complex carbohydrate sources (barley, corn, peas and rice) were tested using a 
20% (w/v) glucose solution (simple carbohydrate) as the control. In addition, 10% and 30 % 
glucose solutions providing 5 and 15 g of glucose, respectively, were tested to examine the 
dose response of glucose on cardiovascular responses. The available carbohydrate content of 
the complex carbohydrate sources (D-glucose, D-fructose, sucrose, maltodextrins, non-
resistant starch and the D-glucose component of lactose, which can be all measured as D-
glucose plus D-fructose following enzymatic hydrolysis) was determined using a 
commercially available assay kit (Megazyme International, Wicklow, Ireland). All 
carbohydrate sources were fed in amounts that provided 10 g available carbohydrate. Prior to 
feeding, the dried complex carbohydrate sources were ground and then hydrated to form a 
paste. Each carbohydrate source was tested twice in each dog, except for the 10 and 30 % 
glucose solutions which were each tested once, and the order of feeding was randomized. All 
foods were consumed by each dog in <5 minutes. 
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3.2.2 Serum Analysis 
Fasted dogs were aseptically catheterized using a peripheral intravenous catheter 
inserted into the cephalic or saphenous vein. Blood samples (3 ml) were taken for serum 
collection at pre-feeding (time 0) and 15, 30, 45, 60, 90, 120, 150 and 180 minutes post-
feeding.  
Serum glucose analysis was performed using a glucose oxidase assay method 
(Association of Official Analytical Chemists, 2005) using reagents from Sigma Aldrich (St. 
Louis, MO). Serum insulin levels were measured by radioimmunoassay using a commercially 
available assay kit (Siemens, Munich, Germany). Serum glucose and insulin concentrations 
were determined at all time points for all treatments. The incremental area under the curve, 
peak concentration, and time to peak concentration for serum glucose and insulin were 
calculated and the glycemic index was determined based on the methods of Wolever et al. 
(Wolever et al., 1991). 
Serum nitrotyrosine was measured using a commercially available ELISA kit (Hycult 
Biotech, Uden, The Netherlands). Nitrotyrosine was determined in one serum sample per dog 
per treatment at 60 minutes post-prandial. Serum MG levels were measured in one serum 
sample per dog per treatment at time 0 and 60 minutes post-prandial according to previously 
published HPLC-based methods (Wang et al., 2006; Wang et al., 2005).  
3.2.3 Ultrasound and Oscillometry 
All ultrasound measurements were performed and analyzed by one individual. FMD 
was measured in conscious, unsedated dogs using a SonoSite M-Turbo ultrasound unit with a 
vascular transducer L38x/10-5 MHz (Sonosite Canada Inc., Markham, ON) before feeding a 
carbohydrate source as well as 60 minutes after feeding based on previously published 
 60 
 
methods from this laboratory and others (Al-Dissi & Weber; Puglia et al., 2006) . Images 
were captured at end diastole and analyzed using Adobe Premiere Elements 2.0 (Adobe Inc., 
San Jose, CA) and Image-Pro Express 6.0 (Media Cybernetics Inc., Bethesda, MD). FMD was 
calculated using the formula: %FMD = 100% x [(maximum diameter post-cuff release) – 
(baseline diameter)]/(baseline diameter). 
Echocardiography techniques were performed using a Sonosite cardiac transducer 
P21x/5-1 MHz (Thomas et al., 1993). Measurements were taken before feeding and 60 
minutes post-prandial. Two-dimensional ultrasonography was used to measure left ventricular 
volume using the left parasternal apical two- and four-chamber views in diastole and systole 
(Lang et al., 2005). The inner wall of the left ventricle was traced and Simpson’s Rule 
(Sonosite Inc., 2007) was used to calculate LVV in diastole (d) and systole (s) from which 
stroke volume, ejection fraction and cardiac output were calculated (Hanton et al., 1998). 
Heart rate was determined using an oscillometric blood pressure cuff (see below).  
Two-dimensional guided M-mode echocardiography was used to obtain a right 
parasternal short axis view of the heart at the level of the papillary muscles (Lang et al., 
2005). Image analysis software (Image-Pro Express 6.0, Media Cybernetics Inc., USA, 2006) 
was used to measure LVID in systole and diastole and fractional shortening was calculated 
(Hanton et al., 1998).  
Blood pressure and heart rate were measured by high definition oscillometry using a 
Vet Memodiagnostic HDO Monitor (S + B medVET, Germany) and MDS Win software 
version 1.4.5.1 (S + B medVET, Germany, 2007) according to a protocol validated in dogs 
(Brown et al., 2007). Measurements were taken before feeding and 60 minutes after feeding. 
The cuff (4.5 x 15 cm) was placed at the tail base. An average of three readings was used to 
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determine diastolic and systolic pressures, mean arterial pressure and heart rate. Total 
peripheral resistance was calculated as TPR = mean arterial pressure/cardiac output. 
3.2.4 Statistical Analyses 
Analyses were performed using SPSS Statistics 18.0 (SPSS Inc., USA). Prior to 
performing all analyses, data were explored for normality and outliers using the Kolmogorov-
Smirnov test, Q-Q plots and boxplots. When datasets failed normality tests, outliers were 
identified using boxplots, then removed if they were greater than 2 SD from the mean and if 
their removal produced a normal dataset. Data were expressed as means ± SEM. One-way 
ANOVA was used to compare glycemic and insulinemic responses, FMD, MG and 
nitrotyrosine between treatments. MG was expressed as a percentage of the pre-feeding value 
(Wang et al., 2004). Repeated measures GLM was used to analyze echocardiographic and 
blood pressure variables with time as the within-subject factor and carbohydrate source as the 
between-subject factor. All post-hoc analyses were performed using the Fisher’s least 
significant difference (LSD) method. Differences were considered significant at P < 0.05. 
3.3 Results 
3.3.1 Serum Glucose and Insulin 
The results of the available carbohydrate assay found that the barley, corn, peas and 
rice contained 73.7 ± 2, 71.4 ± 0.6, 50.8 ± 1, and 88.9 ± 0.8 g of available carbohydrate per 
100g of food, respectively. Thus, the amount of each food that was fed to provide 10 g of 
available carbohydrate was 13.6 g barley, 14.0 g corn, 19.7 g peas, and 11.2 g rice.  
The peak serum glucose concentration was significantly higher and the time to peak 
was significantly shorter for the glucose solution compared to all complex carbohydrate 
sources (rice, barley, corn and peas; Table 3.1 and Figures A.1-A.2 in Appendix A). However, 
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the peak serum glucose concentration and the time to peak did not differ between the complex 
carbohydrate sources. The mean serum glucose concentration before feeding was 4.4 ± 0.04 
mmol/L and no significant differences in pre-feeding serum glucose values were found 
between groups. Figure A.3 in Appendix A shows the serum glucose response to the three 
oral glucose solutions. The area under the curve for serum glucose was significantly greater 
for the 30% glucose solution compared to the 10% glucose solution. The rank order of 
glycemic index for the complex carbohydrate sources, from highest to lowest, was: rice > 
barley > corn > peas, with the glycemic index for peas significantly different from rice and 
barley. 
No significant differences in pre-feeding insulin values were found between groups 
(mean = 4.2 ± 0.7 pmol/L). The peak insulin response and the area under the insulin curve 
were greatest for the glucose solution, which was significantly different from all complex 
carbohydrate sources (Table 3.1 and Appendix A). The time to peak insulin concentration was 
the shortest for the glucose solution. No significant differences were found in the area under 
the insulin response curve among the complex carbohydrate sources. However, the rank order 
for the area under the insulin response curve, from highest to lowest, was: glucose > rice > 
corn > barley > peas. Figure A.3 in Appendix A shows the serum insulin response to the three 
oral glucose solutions. The area under the curve for serum insulin was significantly different 
between the 10, 20 and 30% glucose solutions with area under the curve increasing in 
response to increasing glucose dose. 
3.3.2 Flow-Mediated Dilation 
At 60 min post-prandial, the glucose group had the lowest FMD and was significantly 
lower than the response after corn feeding (P=0.02; Figure 3.1). Compared to glucose, the P-
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values for the FMD response at 60 min after feeding the other carbohydrate sources were rice 
P=0.3, barley P=0.2, and peas P=0.1. Moreover, if the FMD of all the complex carbohydrate 
sources was combined (rice, barley and peas; 3.6 ± 0.4%), then it was significantly higher 
than the FMD response after glucose feeding (1.6 ± 0.51%; p=0.046 in t-test). In contrast, 
FMD did not differ between treatment groups before feeding and an overall mean pre-feeding 
FMD was calculated as 4.3 ± 0.4%. Furthermore, brachial artery diameter before cuff 
inflation during FMD testing did not differ across time points or treatments for all groups. 
Mean baseline brachial artery diameter prior to all FMD tests (n=180 tests in 6 dogs) was 0.20 
± 0.00 cm. Figure A.4 in Appendix A shows the FMD response to the three oral glucose 
solutions 60 min after ingestion. Although no significant differences in FMD were observed 
after ingestion of the glucose solutions, numerically FMD was greatest after feeding the 10% 
glucose solution and FMD was lowest after feeding the 30% glucose solution, suggesting a 
possible dose response. 
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Table 3.1 Glycemic and insulinemic responses to 10 g of available carbohydrate from simple 
(glucose) and complex (rice, barley, corn and peas) sources. 
 Glucose Rice Barley Corn Peas 
Glucose      
Peak (mmol/L) 8.5 ± 0.3a 5.3 ± 0.1b 5.4 ± 0.1b 5.3 ± 0.1b 5.0 ± 0.1b 
Time to peak (min) 34 ± 4a 85 ± 9b 91 ± 10b 111 ± 12b 94 ± 15b 
Area under the curve 
(mmol/L min) 
181 ± 13a 95 ± 7.4b 91 ± 12b 80 ± 15b,c 50 ± 7.6c 
Glycemic index 100 55 ± 6b 51 ± 7b 47 ± 10a,b 29 ± 5a 
Insulin      
Peak (pmol/L) 458 ± 60a 75 ± 12b 62 ± 11b 78 ± 15b 95 ± 14b 
Time to peak (min) 30 ± 4a 106 ± 12b 79 ± 9b,c 99 ± 16b 53 ± 12a,c 
Area under the curve 
(pmol/L min) 
16377 ± 2310a 3698 ± 508b 3164 ± 497b 3635 ± 752b 2993 ± 491b 
Values are mean ± SEM, n=6 in duplicate. Values in a row without a common superscript differ, 
P < 0.05; 1-way ANOVA with LSD post-hoc test.  
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3.3.3 Methylglyoxal and Nitrotyrosine 
MG concentration was significantly higher 60 min after feeding the glucose solution 
compared to all 4 complex carbohydrate groups (Figure 3.1B). However, no significant 
differences were observed in post-prandial MG levels among the complex carbohydrate 
sources. In contrast, neither glucose nor any complex carbohydrates produced any significant 
difference in nitrotyrosine concentrations 60 min after feeding (Figure 3.1C).  
3.3.4 Hemodynamics 
No significant differences were observed in any cardiac function end-points when 
comparisons were made among carbohydrate sources before feeding or 60 minutes post-
prandial (data not shown). Similar to what was found for cardiac function, no significant 
effects of time or carbohydrate source were found for these variables (data not shown). 
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Figure 3.1 Flow-mediated dilation, methylglyoxal and nitrotyrosine 60 min after feeding simple 
(glucose) or complex (rice, barley, corn, peas) carbohydrate sources. 
Cross-over trial in dogs (n=6) at ideal body weight with each carbohydrate source providing 10 g 
of available carbohydrate and tested twice in each dog (A) *Significantly different (P<0.05; 1-
way ANOVA with LSD post-hoc test). (B) Methylglyoxal levels are presented as the percentage 
of the pre-feeding value. *P<0.05 compared to peas, corn, barley and rice. (C) No significant 
differences were found. 
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3.4 Discussion 
The most important finding of this study is that post-prandial MG levels increased 
after a single feeding of simple carbohydrate, which may be associated with acute changes in 
endothelial function. Thus, we accept our hypothesis that MG levels caused impaired 
endothelial function via increased oxidative stress after consuming high glycemic index, but 
not low glycemic index, foods in normal animals. Previous research has shown that chronic 
hyperglycemia is associated with increased levels of MG (Nemet et al., 2005) and individuals 
with greater fluctuations in plasma glucose over 24 hours have higher MG concentrations 
(Nemet et al., 2005). In addition, elevated post-prandial MG levels have been reported, but 
only in individuals with type 1 diabetes (Beisswenger et al., 2001) or in individuals who were 
overweight (Masterjohn et al., 2012). Thus, the results of the present study provide the first 
evidence of increased MG concentrations after a single glucose feeding in healthy, lean 
animals.  
In addition to elevated MG levels, our data showed that FMD was reduced after 
glucose ingestion. Several mechanisms have been proposed to explain why hyperglycemia 
causes endothelial dysfunction and vascular damage (Aljofan & Ding, 2010; Ceriello, 2002, 
2004). The common theme linking these mechanisms is that hyperglycemia produces ROS 
and increases oxidative stress (Mohanty et al., 2000). The results of the present study support 
this mechanism since MG has been shown to increase ROS production (Miyazawa et al., 
2010), which could have contributed to the impaired FMD found for the glucose group. No 
differences in FMD were seen among the complex carbohydrate groups. This suggests that 
post-prandial responses to complex carbohydrates may not have any deleterious effect on 
endothelial function which is consistent with their known benefits for cardiovascular health 
(Howard & Wylie-Rosett, 2002). As predicted, we did not observe changes in 
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echocardiographic and blood pressure parameters as diet-related changes in these variables 
are more likely to occur if high glycemic index foods are consumed over a longer time period 
(Jeckel et al., 2011). 
Although we found an increase in MG, which is known to be associated with an 
increase in ROS production (Brouwers et al., 2010), we did not observe an acute increase in 
post-prandial nitrotyrosine. Other studies have found increased nitrotyrosine in human 
patients with diabetes (Ceriello et al., 2001; Ceriello et al., 2002) or after a glucose challenge 
(Marfella et al., 2001), while others have not (Wang et al., 2004a). A study that measured 
nitrotyrosine at 1, 2 and 3 h after feeding glucose, white bread (high glycemic index) or pasta 
(low glycemic index) in humans found increased nitrotyrosine in the bread and glucose 
groups at 2 h, but not at 1 and 3 h post-prandially (Dickinson et al., 2008). In the present 
study, nitrotyrosine, MG, FMD, echocardiographic and blood pressure measurements were all 
performed at 60 min post-prandial. The 60 minute time point was picked since it fell between 
the times to peak glucose after consumption of simple versus complex carbohydrates. 
Therefore, although MG was elevated at 60 min post-prandial in this study, it seems likely 
that more time was needed to observe a change in nitrotyrosine levels (Dickinson et al., 
2008).  
Peas are an economical and nutrient-rich food and increased pea intake has been 
suggested to improve diet quality (Mitchell et al., 2009). Thus, one of the objectives of this 
research was to examine the effect of peas on glycemic, insulinemic and cardiovascular 
responses. The present study showed that peas had the lowest glycemic index. Peas also 
produced the lowest insulin response compared to the other complex carbohydrate sources, 
though the results were not statistically significant. The glycemic index of dried peas in 
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humans has been reported to be 22 when glucose was used as the control (Foster-Powell et al., 
2002). Thus, a glycemic index of 29 in dogs for the yellow field peas used in this study is 
comparable to that reported in humans. Another study in dogs that fed diets formulated with 
one of six different carbohydrate sources also found that the pea diet resulted in reduced 
glycemic and insulinemic responses (Carciofi et al., 2008).  
The present study was performed in dogs as a model for humans due to the inherent 
confounding factors associated with this type of research in humans, including the wide 
genetic diversity and the lack of control over diet and lifestyle. Dogs are a suitable model for 
humans for studying dietary interventions because they possess a gastrointestinal tract similar 
to humans and they consume an omnivorous diet (Knapp et al., 2008). In addition, the same 
ultrasound and glycemic testing techniques included in this study that are routinely used in 
humans can also be used in dogs because they are adequate size. The present study suggests 
for the first time that a single high glycemic meal may induce negative cardiovascular 
consequences. Thus, this study provides justification for further research about the effects of 
carbohydrates on cardiovascular health in humans.  
A limitation of this study was the small sample size. A power analysis found that a 
sample size of 25 was required to show significant differences in FMD between the five 
treatments (Faul et al., 2007). We could have increased power by decreasing the number of 
treatments. However, the original intent was to examine commonly consumed carbohydrate 
sources in the human diet spanning a wide variety of glycemic index values in humans: high 
(rice), moderate (barley, corn) and low (peas) glycemic index (Foster-Powell et al., 2002). 
FMD is influenced by many factors, including stress and activity in both humans and dogs 
(Al-Qaisi et al., 2008; Moens et al., 2005) and this led to greater variability in this end-point. 
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We were able to control for this variability better than is possible in many humans studies by 
acclimating the dogs to the procedures prior to the study, keeping the diet quality and quantity 
consistent prior to testing, performing the tests at the same time of the day, allowing the dogs 
to re-acclimate to the test room for at least 20 minutes before starting testing, and maintaining 
a constant room temperature. Therefore, although we did not detect any differences among 
FMD responses at 60 min after complex carbohydrate consumption, the sample size was 
clearly sufficient to detect a large impairment in FMD response after feeding a simple 
carbohydrate. 
In conclusion, the present study provides support for the hypothesis that glucose, a 
simple carbohydrate, induces negative cardiovascular consequences by elevating MG and 
reducing FMD. Thus, the results of this study provide further support for the theory that post-
prandial hyperglycemia results in negative cardiovascular consequences. Future studies are 
needed to examine the acute and chronic effects of low and high glycemic index foods on 
overweight animals as low glycemic index foods may be particularly cardioprotective for 
overweight or diabetic individuals (Beulens et al., 2007). 
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CHAPTER 4 
STUDY 2: DIGESTIBILITY AND ACUTE GLYCEMIC, INSULINEMIC AND 
CARDIOVASCULAR EFFECTS OF PEAS AS A CARBOHYDRATE SOURCE IN DOG 
FOOD 
This study used the results from study 1 to create two diets: a diet that contained a 
high glycemic index carbohydrate source (rice); and a diet that contained a low glycemic 
index carbohydrate source (peas). In order to formulate the diets so that the macronutrient and 
energy content were equivalent, the first step in this study was to perform digestibility trials to 
determine the total tract apparent digestibility of the main ingredients that would be used in 
the diets, namely chicken meal, rice and peas. Once the diets were formulated, their acute 
glycemic and cardiovascular effects were tested using the same procedures as in study 1, and 
the apparent digestibility of the diets also were determined. Thus, this study was a logical 
follow-up to study 1 since dogs eat complete diets, not individual carbohydrate sources. This 
study permitted a comparison of the glycemic and insulinemic responses once the 
carbohydrate sources were incorporated into complete diets and processed using extrusion.  
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4.1 Introduction 
Pulses are the edible seeds of leguminous plants and include peas, chickpeas, beans 
and lentils (Anderson and Major, 2002). In humans, pulses have been shown to possess a 
number of health-promoting characteristics, including protection against cardiovascular 
disease, diabetes and obesity (Anderson & Major, 2002; Hermsdorff et al., 2011; Messina, 
1999). Peas (Pisum sativum) are a pulse that are becoming an increasingly common ingredient 
in pet foods (Aldrich, 2010). With the growing problem of obesity and its associated co-
morbidities among the North American pet population (Laflamme, 2006, 2011), low glycemic 
index peas may be a healthy carbohydrate source for pet diets.  
One of the characteristics of pulses to which their health benefits may be attributed is 
their low glycemic index (Jenkins et al., 1980; Sievenpiper et al., 2009). Post-prandial 
hyperglycemia due to the consumption of high glycemic index diets is thought to be 
detrimental to the cardiovascular system by increasing oxidative stress (Crandall et al., 2009; 
Dickinson & Brand-Miller, 2005; Node & Inoue, 2009). Endothelial dysfunction is associated 
with oxidative stress and can be assessed in vivo using flow-mediated dilation (Endemann & 
Schiffrin, 2004; Harris et al., 2010; Thijssen et al., 2010). Thus, pulses may provide 
cardiovascular benefits by preventing post-prandial hyperglycemia and the associated 
oxidative stress. 
We previously reported that single feedings of unprocessed peas had a lower glycemic 
index in dogs than rice or barley (Adolphe et al., 2012). However, there is a lack of 
information about the digestibility and health effects of peas as a carbohydrate source in 
extruded dog food. The purpose of this study was to measure the digestibility of peas and rice 
in dogs as individual ingredients as well as in complete and balanced canine diets, and to 
subsequently test the effects of the diets on acute glycemic, insulinemic and cardiovascular 
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responses in dogs. We hypothesize that a pea-based diet will result in lower glycemic and 
insulinemic responses as well as improved cardiovascular function in dogs compared to a 
rice-based diet. 
4.2 Materials and Methods 
4.2.1 Animals 
Neutered beagle dogs (n=3-8) at ideal body weight and a mean age of 3.1 ± 0.2 years 
were used. The dogs were obtained from Covance Research Products Inc. (Princeton, NJ, 
USA) or the University of Guelph (Guelph, ON, Canada) and were kept in the Western 
College of Veterinary Medicine at the University of Saskatchewan (Saskatoon, SK, Canada). 
The animals were housed during feeding and at night in 1.1 x 2.7 m individual kennels, but 
were housed together during the day with access to outdoor runs and were walked daily. Dogs 
were subject to a 12-hour photoperiod with ad libitum access to water. When dogs were not 
on digestibility trials they were fed a commercial adult maintenance dry diet (Purina Dog 
Chow, Ralston Purina Co., St. Louis, MO) in amounts based on the National Research 
Council guidelines (National Research Council, 2006) and adjusted to maintain a stable, ideal 
body weight in each dog for the study duration. This work was approved by the University of 
Saskatchewan’s Animal Research Ethics Board and adhered to the Canadian Council on 
Animal Care guidelines for humane animal use. 
4.2.2 Digestibility and Diet Formulation 
Apparent digestibility of chicken meal, peas and rice were measured using an indicator 
method (Association of American Feed Control Officials, 2009). A reference diet was 
formulated according to Fahey et al. (1992) that met or exceeded nutrient requirements of 
dogs (National Research Council, 2006). Three experimental diets were formulated using 
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70% (w/w) of the reference diet and 30% (w/w) of the experimental ingredient (chicken meal, 
peas or rice). Celite®, a non-absorbable marker, was added at a 1% inclusion rate to the 
reference and experimental diets. Diet ingredients were ground in a hammer mill with a 3 mm 
screen prior to mixing. The diets were cold extruded using a 5 mm die on a Hobart Pelleter 
(Model 4822; Ohio, USA), dried in a forced air oven (55⁰C, 12 h), chopped and screened to 
obtain the appropriate pellet size.  
A study was performed in which dogs (n=6; 3 neutered males, 3 spayed females) were 
fed the reference or experimental diets for seven days with fecal sample collection 
commencing on day 8. The experiment was repeated with all of the diets until 3 dogs had 
been fed each of the 3 experimental diets and 6 dogs had been fed the reference diet.  
Diets and fecal material for the reference diet and experimental diets were analyzed 
for energy (oxygen bomb calorimetry; Parr Adiabatic Calorimeter, Model 1200), moisture 
(AOAC 934.01), acid ether extract (AOAC 954.02) and acid insoluble ash (AOAC 954.02) 
(Association of Official Analytical Chemists, 1990, 1995). Acid insoluble ash was measured 
to determine the concentration of the non-absorbable marker Celite® in the diets and fecal 
material in order to perform digestibility calculations. Nitrogen content was determined using 
a Kjeldahl analyzer (model 2400, Foss, Denmark), and values were multiplied by 6.25 in 
order to estimate crude protein (AOAC 968.06). Starch was analyzed using an AOAC 996.11 
assay (Megazyme Assay Kit K-TSTA; Megazyme, Bray Co., Wicklow, Ireland). The total 
tract apparent digestibility coefficient (TTADC, %) for the individual diets and test 
ingredients were calculated (Association of American Feed Control Officials, 2009; Bureau & 
Cho, 1999; Cho et al., 1982; Sugiura et al., 1998). Nutrient digestibility was calculated by the 
following formula:  
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Equation 3.1 
Nutrient digestibility (%) = 1 -  % nutrient in feces x % Celite in food       x % nutrient in food 
       % nutrient in food x % Celite in feces  
 
Nutrient digestibility of the test ingredients were calculated as: 
 
Equation 3.2 
Nutrient digestibility of individual ingredient (%) = nutrient digestibility of experimental diet + 
[((0.7 x % nutrient in reference diet)/(0.3 x % nutrient in experimental diet)) x (nutrient 
digestibility of experimental diet – nutrient digestibility of reference diet)] 
 
Digestible energy (DE) was calculated as:  
 
Equation 3.3 
DE (kcal/kg) = 1 –  gross energy of feces x % Celite in food       x gross energy of food 
          gross energy of food x % Celite in feces  
 
Diet and fecal values on a dry matter (DM) basis were used in all calculations. 
Two diets were then formulated to meet nutritional recommendations (Association of 
American Feed Control Officials, 2009) using Concept 5 software (Creative Formulation 
Concepts, LLC, Annapolis, MD, USA) based on the ingredient digestibility values from the 
digestibility experiment described above. Diets were formulated to contain equal amounts of 
metabolizable energy (ME), protein, starch and fat, but each diet contained only one 
carbohydrate source (peas or rice). The composition of the pea and rice diets is shown in 
Table 4.1 and the calculated nutrient analysis of the diets is shown in Table 4.2. Since the 
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starch, protein and fiber composition of peas and rice vary widely, gelatin and isolated pea 
starch were added to the pea diet, and Solka Floc®, a source of isolated fibre, was added to the 
rice diet in order to achieve equivalent macronutrient and energy composition. The diets were 
extruded at the Saskatchewan Food Industry Development Centre Inc. (University of 
Saskatchewan, Saskatoon, SK, Canada) using a Clextral Evolum 32 twin screw extruder 
(Firminy, France) with a 20:1 length:diameter ratio and a 4.88 mm die. Extrusion parameters 
were the same for both diets (cooking temperature 110⁰C and screw speed 550 rpm), except 
that moisture content was 31% and 28% for the rice and pea diets, respectively, in order to 
obtain appropriate product consistency. 
Apparent digestibility of the pea and rice diets was measured in dogs (n=8; 3 neutered 
males, 5 spayed females) using an indicator method as described above (Association of 
American Feed Control Officials, 2009). Proximate analysis of the diets and fecal material 
were performed accordingly: methods AOAC 930.15 for moisture, AOCS Ba6a-05 for crude 
fiber, AOAC 990.03 for crude protein, AOCS Am 5-04 for fat, AOAC 923.03 for ash, and 
modified AOAC 920.08 for acid insoluble ash (Association of Official Analytical Chemists, 
2006; Firestone, 2009). Gross energy (GE) was calculated as GE (kcal) = (5.7 x g protein) + 
(9.4 x g fat) + [4.1 x g nitrogen free extract + g fiber)] (National Research Council, 2006). 
Starch (non-fibre carbohydrate, NFC) was calculated using the formula: % NFC = % DM – 
(% protein + % fat + % fibre + % ash). All tests were performed at a commercial laboratory 
(Central Testing Laboratories Ltd., Winnipeg, MB, Canada). The TTADC (% DM) for the 
diets were calculated as described above.  
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Table 4.1 Ingredient composition of pea and rice diets. 
Ingredient Pea Diet, g/kg Rice Diet, g/kg 
Chicken meal 206 346 
Pea starch 314 - 
Rice - 288 
Peas 150 - 
Chicken fat 136 120 
Solka Floc® - 100 
Fish meal 66 50 
Gelatin 57 - 
Dicalcium phosphate 18 47 
Salmon oil 10 10 
Vitamin/mineral premix1 10 10 
Celite® 10 10 
Potassium chloride 7 7 
Sodium chloride 5 5 
Calcium carbonate 6 2 
Choline chloride 4 4 
DL-methionine 1 1 
1Wheat, magnesium oxide, zinc, methionine, vitamin C, Alltech Bio-Mos, vitamin E, zinc sulphate, ferrous sulphate, 
iron proteinate, vitamin D3, Alltech deodorase, mineral oil, copper proteinate, copper sulphate, niacin, selenium 
enriched yeast, calcium iodate, vitamin A, manganese proteinate, calcium pantothenate, biotin, vitamin B12, 
riboflavin, manganese oxide, thiamine, sodium selenite, pyridoxine, folic acid. 
  
 78 
 
Table 4.2 Calculated nutrient analysis of pea and rice diets. 
Nutrient Amount in Pea Diet Amount in Rice Diet 
DM (%) 92.7 93.9 
ME (kcal/kg) 3200 3200 
Crude Protein (%) 25.0 25.0 
Crude Fat (%) 16.1 16.1 
Ash (%) 2.8 4.2 
Calcium (%) 0.6 1.0 
Phosphorus (%) 0.5 1.0 
Starch (%) 25.0 25.0 
Methionine (%) 0.43 0.43 
Lysine (%) 0.96 0.88 
DM, dry matter; ME, metabolizable energy. Values reported on as fed basis except for DM. 
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4.2.3 Serum Glucose and Insulin Analysis 
Single feedings of the pea and rice diets were tested by laboratory beagles (n=7; 4 
neutered males, 3 spayed females) using a 20% (w/v) glucose solution as the control. The 
available carbohydrate content of the diets was determined using a commercially available 
assay kit (Megazyme International, Wicklow, Ireland). The diets and glucose solution were 
fed in amounts that provided 10 g available carbohydrate. Each treatment was tested twice in 
each dog and the order of feeding was randomized. The individual who performed all of the 
testing and data analyses was blinded to the treatment order. Dogs were fasted overnight, then 
aseptically catheterized using a peripheral intravenous catheter inserted into the cephalic or 
saphenous vein. Blood samples (3 ml) were taken for serum collection at pre-feeding (time 0) 
and 15, 30, 45, 60, 90, 120, 150 and 180 minutes post-feeding. All foods were consumed by 
each dog in <5 minutes. 
Serum glucose and insulin concentrations were determined at all time points for all 
treatments. Serum glucose analysis was performed using a glucose oxidase assay method 
using reagents from Sigma Aldrich (St. Louis, MO). Serum insulin levels were measured by 
radioimmunoassay using a commercially available assay kit (Siemens, Munich, Germany). 
The incremental area under the curve, peak concentration, and time to peak concentration for 
serum glucose and insulin were calculated and the glycemic index of the diets was determined 
based on the methods of Wolever et al. (1991). 
4.2.4 Ultrasound and Oscillometry 
All ultrasound measurements were performed and analyzed by one individual who 
was blinded to the treatments. FMD was measured in conscious, unsedated dogs using a 
SonoSite M-Turbo ultrasound unit with a vascular transducer L38x/10-5 MHz (Sonosite 
 80 
 
Canada Inc., Markham, ON) before feeding (time 0) as well as 60 minutes after feeding (time 
60) based on previously published methods from this laboratory and others (Al-Dissi & 
Weber, 2011; Puglia et al., 2006). Images were captured at end diastole and analyzed using 
Adobe Premiere Elements 2.0 (Adobe Inc., San Jose, CA) and Image-Pro Express 6.0 (Media 
Cybernetics Inc., Bethesda, MD). FMD was calculated using the formula: %FMD = 100% x 
[(maximum diameter post-cuff release) – (baseline diameter)]/(baseline diameter). 
Echocardiography techniques were performed to assess acute post-prandial changes in 
cardiac structure and function. Measurements were taken using a Sonosite cardiac transducer 
P21x/5-1 MHz (Thomas et al., 1993). Measurements were taken before feeding and 60 
minutes post-prandial. Two-dimensional ultrasonography was used to measure left ventricular 
volume using the left parasternal apical two- and four-chamber views in diastole and systole 
(Lang et al., 2005). The inner wall of the left ventricle was traced and Simpson’s Rule 
(Sonosite Inc., 2007) was used to calculate left ventricular volume in diastole and systole 
from which stroke volume and ejection fraction were calculated (Hanton et al., 1998). Heart 
rate was determined using an oscillometric blood pressure cuff (see below).  
Two-dimensional guided M-mode echocardiography was used to obtain a right 
parasternal short axis view of the heart at the level of the papillary muscles (Lang et al., 
2005). Image analysis software (Image-Pro Express 6.0, Media Cybernetics Inc., USA, 2006) 
was used to measure left ventricle internal dimension and left ventricle free wall thickness in 
systole and diastole, and fractional shortening was calculated (Hanton et al., 1998).  
Blood pressure and heart rate were measured by high definition oscillometry using a 
Vet Memodiagnostic HDO Monitor (S + B medVET, Germany) and MDS Win software 
version 1.4.5.1 (S + B medVET, Germany, 2007) according to a protocol validated in dogs 
 81 
 
(Brown et al., 2007). Measurements were taken before feeding and 60 minutes after feeding. 
The cuff (4.5 x 15 cm) was placed at the tail base. An average of three readings was used to 
determine diastolic and systolic pressures and heart rate.  
4.2.5 Statistical Analyses 
Data were expressed as mean ± SEM. Prior to performing all analyses, data were 
explored for normality and outliers using the Kolmogorov-Smirnov test, Q-Q plots and 
boxplots. Independent-sample t-tests or one-way ANOVA were used to compare apparent 
digestibility values, glycemic and insulinemic responses between treatments. Repeated 
measures GLM was used to analyze FMD, echocardiographic and blood pressure variables 
with time as the within-subject factor and treatment as the between-subject factor. All post-
hoc analyses were performed using the Fisher’s least significant difference (LSD) method. 
Differences were considered significant at P < 0.05. Analyses were performed using IBM 
SPSS Statistics version 20 (International Business Machines Corp., USA). 
4.3 Results 
4.3.1 Digestibility and Diet Formulation 
The proximate analysis and apparent digestibility values for protein, fat and starch are 
reported on a DM basis in Table 4.3. TTADC for chicken meal were 84 ± 4 % for protein and 
78 ± 4 % for fat (no starch was present in the chicken meal). For peas, TTADC was 62 ± 6 % 
for protein, 51 ± 7 % for fat, and 81 ± 3 % for starch. TTADC for rice was 74 ± 3 % for 
protein, 84 ± 20 % for fat, and 100 ± 1 % for starch. DE for the chicken meal, peas and rice 
were 2781 ± 118, 2388 ± 276 and 3992 ± 49 kcal DE/kg, respectively. The DE (P=0.005) and 
apparent digestibility of starch (P=0.005) were significantly lower for peas than for rice.  
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Table 4.3 Proximate analysis and total tract apparent digestibility of ingredients and diets. 
Proximate Analysis of Ingredients 
Ingredient GE, kcal/kg Protein, % DM Fat, % DM Starch, % DM 
Chicken meal 3295 67.5 14.4 - 
Peas 4370 24.4 2.2 45.7 
Rice 4233 9.2 2.0 93.5 
Total Tract Apparent Digestibility of Ingredients 
Ingredient DE, kcal/kg Protein, % DM Fat, % DM Starch, % DM 
Chicken meal 2781 ± 118 84 ± 4 78 ± 4 - 
Peas 2388 ± 2761 62 ± 6 51 ± 7 81 ± 31 
Rice 3992 ± 49 74 ± 3 84 ± 20 100 ± 1 
Proximate Analysis of Diets 
Diet GE, kcal/kg Protein, % DM Fat, % DM Starch, % DM 
Pea diet 5030 33.6 14.0 39.9 
Rice diet 4942 32.4 14.8 36.1 
Total Tract Apparent Digestibility of Diets 
Diet DE, kcal/kg Protein, % DM Fat, % DM Starch, % DM 
Pea diet 4764 ± 221 93 ± 0.7 98 ± 0.2 97 ± 0.21 
Rice diet 4500 ± 14 92 ± 0.3 98 ± 0.4 92 ± 0.5 
1Significantly different than rice/rice diet (P<0.05; independent sample t-test).  
Protein, fat and starch reported on dry matter basis. Digestibility of ingredients n=3, digestibility of diets n=8. 
GE, gross energy; DE, digestible energy 
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The pea and rice diets had similar composition as shown by proximate analysis (Table 
4.3). Gross energy was 4769 and 4736 kcal/kg, protein was 33.6 and 32.4 %, fat was 14.0 and 
14.8 %, and starch was 39.9 and 36.1 % for the pea and rice diets, respectively. TTADC and 
DE content for the pea and rice diets, respectively, were 93 ± 0.7 and 92 ± 0.3 % for protein, 
98 ± 0.2 and 98 ± 0.4 % for fat, 97 ± 0.2 and 92 ± 0.5 % for starch, and 4764 ± 22 and 4500 ± 
14 kcal/kg DE. DE (P<0.005) and apparent digestibility for starch (P<0.005) was significantly 
higher for the pea diet than the rice diet.  
4.3.2 Serum glucose and insulin analysis 
The pea and rice diets contained 28.0 and 19.1 g available carbohydrate per 100 g of 
food, respectively. Thus, 35.7 g of the pea diet and 52.4 g of the rice diet were fed to provide 
10 g of available carbohydrate.  
The serum glucose and insulin responses to the oral glucose solution, pea diet and rice diet 
are shown in Table 4.4. Supplemental serum glucose and insulin data shown in Figure B.2 in 
Appendix B. No significant differences in pre-feeding serum glucose values were found 
between groups and thus, an overall baseline serum glucose concentration was calculated (4.9 
± 0.07 mmol/L). No significant differences were observed for serum glucose responses 
between the pea and rice diets. The glycemic index was 56 ± 12 for the pea diet and 63 ± 9 for 
the rice diet (P=0.7). The oral glucose solution resulted in higher peak glucose and area under 
the glucose response curve, as well as faster time to peak glucose compared to both the pea 
and rice diets.  
No significant differences in pre-feeding insulin values were found between groups 
(9.1 ± 2.8 pmol/L). The peak insulin response and area under the insulin response curve was 
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significantly greater after feeding glucose than after feeding either the pea or rice diet. No 
significant differences in insulin responses were observed between the pea and rice diets. 
Our laboratory previously reported the glycemic index in dogs of peas (29 ± 5) and 
rice (55 ± 6) as individual, unprocessed ingredients (Adolphe et al., 2012). The glycemic 
index of the pea diet in the present study was 56 ± 12, which showed a trend toward being 
higher than the glycemic index of unprocessed peas (P=0.06). The glycemic index of the rice 
was not significantly different from that of the rice-based diet (P=0.5). 
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Table 4.4 Glycemic and insulinemic responses to pea and rice diets. 
Measurement Glucose Pea Diet Rice Diet 
Serum Glucose    
Peak, mmol/L 8.8 ± 0.4a  5.7 ± 0.1b  6.1 ± 0.1b  
Time to peak, min 38 ± 3a  136 ± 11b  125 ± 11b  
AUC, mmol/L•min 167 ± 21a  75 ± 10b  97 ± 13b 
Glycemic index 100 56 ± 12a  63 ± 9a  
Serum Insulin    
Peak, pmol/L 440 ± 40a  140 ± 25b  173 ± 23b  
Time to peak, min 35 ± 3a  57 ± 9a,b 62 ± 11b  
AUC, pmol/L•min 17620 ± 2064a  6016 ± 781b  9882 ± 1153b  
AUC, area under the curve. Values are mean ± SEM, n=7 in duplicate. Within a row, means without a common 
superscript differ (P<0.05; one-way ANOVA with LSD posteriori test). 
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4.3.3 Ultrasound and Oscillometry 
No significant effect of time was found for FMD values before compared to after 
feeding. FMD did not differ between treatment groups before feeding and an overall mean 
pre-feeding FMD was calculated as 4.7 ± 0.4%. FMD values at 60 min post-prandial were 4.1 
± 0.7 % for glucose, 6.7 ± 0.7 % for the pea diet, and 6.2 ± 0.9 % for the rice diet (Figure 
4.1A). Thus, glucose resulted in the lowest post-prandial FMD which was significantly lower 
than the response after feeding both the pea diet (P=0.01) and rice diet (P=0.04). No 
significant difference in FMD was found between the pea and rice diets (P=0.5). Brachial 
artery diameter before cuff inflation during FMD testing did not differ across treatments 
before or after feeding. However, time had a significant effect on baseline artery diameter 
(diameter at pre-feeding = 0.20 ± 0.005, post-prandial diameter at time 60 = 0.19 ± 0.005; 
P=0.004), indicating a significant post-prandial brachial artery vasoconstriction (Figure 4.1B). 
No significant effect of time or treatment was observed for cardiac size and volume 
measurements or blood pressure. Thus, overall values were calculated (n=84 tests in 7 dogs): 
left ventricle internal dimension systole 2.0 ± 0.03 cm; left ventricle internal dimension 
diastole 3.0 ± 0.03 cm; left ventricle free wall systole 1.01 ± 0.01 cm; left ventricle free wall 
diastole 0.77 ± 0.01 cm; fractional shortening 32.2 ± 0.5 %; ejection fraction 49.4 ± 1.2 %; 
stroke volume 12.3 ± 0.5 ml; diastolic blood pressure 127 ± 1.2 mm Hg; and systolic blood 
pressure 66 ± 0.7 mm Hg. The one cardiac parameter that did change was heart rate which 
significantly increased after feeding compared to pre-feeding (P=0.01), but no significant 
effect among treatments was found (Figure 4.1C). Pre- and post-feeding heart rate for each 
treatment group, respectively, were: glucose 74 ± 3, 76 ± 4 bpm; pea diet 76 ± 3, 79 ± 2 bpm; 
and rice diet 76 ± 2, 82 ± 2 bpm. Supplemental cardiac and hemodynamic data are provided in 
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Table B.1 in Appendix B. No significant changes were observed between the glucose, pea diet 
and rice diet for systolic and diastolic LVID and LVFW, fractional shortening, ejection 
fraction, stroke volume, and systolic and diastolic blood pressure. 
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Figure 4.1 Cardiovascular effects of feeding glucose, pea diet or rice diet. 
Measurements were performed in dogs (n=7) fasted overnight. Treatments were randomized in a 
cross-over study design with each treatment tested twice per dog. (A) Flow-mediated dilation 
was performed to assess endothelial function 60 min post-prandial. (B) Artery diameter was 
measured using ultrasonography to assess degree of vasoconstriction before and 60 min post-
prandial. (C) Heart rate was measured using high definition oscillometry before and 60 min post-
prandial. *Significantly different from pea diet and rice diet (P<0.05; repeated measures GLM 
with LSD posteriori test). †Significant effect of time (P<0.05; repeated measures GLM with LSD 
posteriori test). 
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4.4 Discussion 
The present study examined the digestibility and acute health effects of peas as a 
carbohydrate source in dog food. Peas may provide a higher quality source of protein and 
fiber as well as deliver phytochemicals with health-promoting properties (Champ, 2002). Peas 
also may be beneficial due to their low glycemic index. However, a key finding of this study 
was that extrusion processing, which is used to produce most dry pet foods, negatively 
impacts the glycemic index of peas. As we previously reported, unprocessed peas had a 
glycemic index of 29 ± 5 (Adolphe et al., 2012). However, the results reported herein found 
that peas in an extruded dog diet had a glycemic index of 56 ± 12. Although this difference 
was not statistically significant, the biological impact is likely substantial. In addition, the 
serum glucose and insulin measurements performed in the present study were not 
significantly different between diets containing rice versus peas. Thus, in order to realize the 
potential health benefits of low glycemic index peas as an ingredient in dog food, further 
research is needed to determine how to maintain the low glycemic index of peas after 
extrusion. 
Another important finding of the present study was that an extruded dog diet 
containing 15% whole peas and 31% purified pea starch is a highly digestible source of 
carbohydrates, protein and fat for adult dogs. These results are supported by a study by 
Carciofi et al. (2008) which also found that a diet containing peas as the carbohydrate source 
was highly digestible. Interestingly, in the present study, starch digestibility of the peas as an 
individual ingredient was substantially lower than the starch component of the pea diet. This 
may be due to the inclusion of purified pea starch in the pea diet or a result of the difference 
in the processing methods used in the ingredient and diet digestibility trials. Increased 
temperature during extrusion has been found to increase starch gelatinization degree and also 
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resulted in increased glucose absorption in an in vitro model of digestion (Lankhorst et al., 
2007). For our ingredient digestibility study, diets were processed using a low temperature 
pelleter, not a high temperature extruder, in order to permit small batch diet production. The 
high temperature and pressure used in extrusion appears to play an important role in 
improving the digestibility of the carbohydrates in peas. In addition, the improved 
carbohydrate digestibility of the pea diet compared to the digestibility of whole peas as a 
single ingredient could be due to the use of purified pea starch in the pea diet. Purified pea 
starch was required in order for the pea and rice diets to contain similar macronutrient 
compositions. It is possible that the purified pea starch has a much higher starch digestibility 
than the starch in whole peas, which also helps to explain why the digestibility of the 
carbohydrates in the pea diet was higher than that of the rice diet. 
There are a limited number of published studies that have examined the acute health 
effects of different carbohydrate sources in dogs. One study investigated the glycemic and 
insulinemic responses in dogs (n=6 per group) to diets with similar macronutrient contents but 
with different carbohydrate sources (sorghum, lentils, peas, corn, brewer’s rice or cassava 
flour) (Carciofi et al., 2008). Area under the glucose and insulin response curves, which were 
measured over 300 min, did not differ between the pea diet and the other five diets. These 
results support our finding that the glycemic index of extruded diets containing either peas or 
rice does not differ.  
In another acute feeding study, Nguyen et al. (1994) examined the effect of foods on 
post-prandial glucose and insulin concentrations, but the carbohydrate sources in the foods 
were not reported and foods differed in macronutrient composition. However, the results were 
interesting and found that the time to glucose peak was correlated to protein, fat and nitrogen-
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free extract content of the foods, whereas time to insulin peak and area under the insulin curve 
were correlated to protein and nitrogen-free extract (Nguyen et al., 1994). Thus, the results of 
the study by Nguyen et al. suggest that factors other than the carbohydrate content affect 
glucose and insulin responses. This emphasizes the importance of formulating diets with 
equivalent macronutrient levels in order to make it possible to unambiguously determine the 
effect of different carbohydrate sources on health parameters.  
To our knowledge, this is the first study to examine the acute effects of diets 
containing different carbohydrate sources on cardiovascular health in dogs. The effect of the 
pea diet on FMD did not differ from that of the rice diet, though both diets resulted in a higher 
FMD compared to feeding glucose. These findings support our previous work which showed 
that FMD was decreased 60 min after feeding glucose while feeding complex carbohydrate 
sources preserved healthy endothelial function (Adolphe et al., 2012). In the present study, 
echocardiographic and blood pressure parameters did not differ between diet groups nor was 
there an effect after feeding. However, an increase in heart rate and brachial artery 
vasoconstriction after feeding was observed, though no difference was apparent between diet 
groups. In our previous study (Adolphe et al., 2012), we did not find an effect of feeding or 
diet treatment on heart rate or vasoconstriction. It is possible that the increase observed in the 
present study was due to the effect of a larger meal or to the higher dietary fat or protein in the 
diets compared to that of the individual ingredients. Other studies have suggested that meals 
with higher fat lead to a generalized stimulation of the sympathetic nervous system 
(Straznicky et al., 1993), though it should be noted that meal composition appears to have less 
affect on heart rate than meal size (Hlebowicz et al., 2011).  
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In conclusion, canine diets containing peas are highly digestible and are a viable 
alternative carbohydrate source for dog food formulations. After extrusion, a dog diet 
containing peas resulted in similar glycemic, insulinemic and cardiovascular responses to a 
dog diet containing rice. Thus, future studies are necessary to determine the extrusion 
processing conditions that will maintain the low glycemic index properties of peas in order to 
maximize the potential cardiovascular health benefits of peas as an ingredient in dog food. 
Longer-term feeding trials also are needed to determine the safety and health effects of peas in 
dogs.
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CHAPTER 5 
STUDY 3: SHORT-TERM OBESITY RESULTS IN DETRIMENTAL METABOLIC AND 
CARDIOVASCULAR CHANGES THAT MAY NOT BE REVERSED WITH WEIGHT LOSS 
Once the acute effects of the pea and rice diets were tested in study 2, the next step 
was to study the longer term health effects of the diets which led to the design of study 3. 
Since all of the dogs were at ideal body weight (i.e. lean) for studies 1 and 2, and we wanted 
to examine the effects of the pea and rice diets in obese dogs (study 4), the first step was to 
allow the dogs to become obese. Allowing the dogs to become obese resulted in the creation 
of study 3, which compared metabolic and cardiovascular health parameters in the dogs when 
they were lean, obese, and after weight loss.  
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5.1 Introduction 
Obesity results in numerous detrimental alterations that affect endocrine function, 
glucose metabolism and cardiovascular health (German et al., 2010). Post-prandial 
hyperglycemia, which is associated with obesity, is an independent risk factor for 
cardiovascular disease (Kawano et al., 1999; Node & Inoue, 2009; Wascher et al., 2005). In 
addition, obesity impacts the cardiovascular system by increasing heart rate and cardiac 
output, promoting cardiac hypertrophy, impairing systolic and diastolic function, and 
elevating blood pressure (Kotsis et al., 2010; Van Vliet et al., 1995). 
Adipose tissue is an active endocrine organ that secretes adipokines, including leptin 
and adiponectin, which regulate energy homeostasis, insulin sensitivity, and lipid and 
carbohydrate metabolism (Clarke & Judd, 2008; German et al., 2010). Both the amount and 
distribution of adipose tissue may have a negative impact on health. Body fat stored in the 
central region of the body (i.e. visceral fat) is more strongly associated with obesity-related 
disorders than subcutaneous fat, which may be due to differences in the metabolic and 
endocrine functions of the different adipose depots (Bergman et al., 2006; Leray et al., 2008). 
Weight loss is recommended for overweight and obese individuals with the goal of 
reversing the negative health effects associated with obesity. However, there is some evidence 
that certain metabolic alterations seem to persist even after weight loss that increase the 
possibility of weight regain and have lasting health consequences (Harrington et al., 2009; 
Makoundou et al., 2011; Nagaoka et al., 2009; Singh et al., 2012). The time course of changes 
in metabolic and cardiovascular function with weight gain and subsequent weight loss is not 
fully understood and is difficult to determine in humans due to the limitations associated with 
manipulating body weight among the same individuals. Thus, the present study used a dog 
model of obesity to examine the effect of weight gain, weight loss and body fat distribution on 
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metabolic and cardiovascular changes. We hypothesized that obesity would result in 
detrimental changes in metabolic and cardiovascular parameters after short term obesity (12 
weeks), which would worsen with prolonged obesity (32 weeks), but would be improved with 
weight loss.  
5.2 Materials and Methods 
5.2.1 Animals 
Eight beagle dogs, three neutered males and five spayed females with a mean age of 
3.3 ± 0.4 y were used. The dogs were obtained from Covance Research Products Inc. 
(Princeton, NJ, USA) or the University of Guelph (Guelph, ON, Canada) and were kept in the 
Western College of Veterinary Medicine at the University of Saskatchewan (Saskatoon, SK, 
Canada). The animals were housed in 1.1 x 2.7 m kennels at night, but were housed together 
during the day with access to outdoor runs, and all dogs were walked daily. This work was 
approved by the University of Saskatchewan’s Animal Research Ethics Board and adhered to 
the Canadian Council on Animal Care guidelines for humane animal use. 
Dogs were fed a commercial adult maintenance dry diet (Purina® Dog Chow®, Ralston 
Purina Co., St. Louis, MO). At baseline, the dogs were fed the commercial diet in amounts 
based on the National Research Council guidelines(National Research Council, 2006) which 
was adjusted to maintain an ideal lean body weight (body condition score 4-5 on 9-point 
scale) (Laflamme, 1997). During the obesity phase dogs were given unlimited access to the 
commercial diet for 24 hours per day. Dogs were considered obese when they were 15 % 
above their lean baseline body weight. To achieve weight loss, food was restricted to 74 ± 2.2 
% of lean body weight maintenance energy requirements and adjusted to promote a moderate 
rate of weight loss of 1-2% of body weight per week. Activity levels were kept constant 
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throughout all phases of the study so body weight changes were achieved solely through 
adjusting the amount of food the dogs received. Metabolic and cardiovascular variables were 
measured at four time points: when the dogs were lean (baseline); after 12 weeks of 
overfeeding; after 32 weeks of overfeeding; and after weight loss when dogs returned to 
baseline body weight (17 ± 1 week weight loss period).  
5.2.2 Body Fat Analysis 
Abdominal body fat was analyzed using CT scans. Scans were performed at 12 and 32 
weeks of obesity as well as after weight loss. A single slice helical scanner (Tomoscan M, 
Philips Medical Systems North America, Bothell, WA) was used for the scans when the dogs 
had been obese for 12 weeks and a 16-slice scanner (Acquilon, Toshiba America Medical 
Systems, Inc., Tustin, CA) was used for all subsequent scans. Dogs were fasted overnight and 
sedated using dexmedetomidine hydrochloride (Dexdomitor®, Orion Pharma, 5µg/kg). When 
anaesthesia was required for longer duration with the helical CT, dogs were induced with 
propofol (Propofol, Novopharm, 4 mg/kg), intubated, and anaesthetized with isoflurane 
(IsoFlo®, Abbott Animal Health, inhalation maintained at 0.5-3%). Dogs were placed in 
dorsal recumbency for all scans. After scanning, sedation was reversed with atipamezole 
hydrochloride (Antisedan®, Orion Pharma, 5 µg/kg). 
Transverse digital images were obtained through the thorax and abdomen of each dog 
for analysis of abdominal body fat area. The abdomen was delineated from the thorax at the 
level of the diaphragm and 5 mm slices were analyzed using General Electric Advantage 
Windows Server version 2.0-5.0 with Volume Viewer version 10.3.67 (General Electric 
Company, Fairfield, CT). Thresholds of -105/-135 Hounsfield units, as previously determined 
in beagles, were used to identify fat (Ishioka et al., 2005). Abdominal fat was partitioned into 
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visceral and subcutaneous fat by drawing a region of interest surrounding the visceral cavity 
using the clearly visible border of the peritoneal wall (Zhao et al., 2006). Visceral and 
subcutaneous fat were measured at the level of each vertebra by quantifying the volume of fat 
in two slices in the middle of the vertebra. Total fat was calculated as the sum of visceral and 
subcutaneous fat. Total, visceral and subcutaneous fat for the entire abdomen was calculated 
as the sum of the fat values from the sum of the two vertebral slices from cranial thoracic 
vertebra 13 to caudal lumbar vertebra 7 (i.e. T13-L7).  
5.2.3 Blood Collection and Analyses 
After an overnight fast, dogs were fed a 20% glucose solution providing 10 g glucose. 
The solution was consumed by each dog in <5 minutes. Dogs were aseptically catheterized 
using a peripheral intravenous catheter inserted into the cephalic or saphenous vein. Blood 
samples (3 ml) were taken for serum collection at pre-feeding (time 0) and 15, 30, 45, 60, 90, 
120, 150 and 180 minutes post-feeding. Serum glucose analysis was performed using a 
glucose oxidase assay method using reagents from Sigma Aldrich (St. Louis, MO). Serum 
insulin levels were measured by radioimmunoassay using a commercially available assay kit 
(Coat-A-Count Insulin, Siemens, Munich, Germany) previously validated for dogs 
(Wolfsheimer et al., 1986). Serum glucose and insulin concentrations were determined at all 
time points. The trapezoidal method was used to determine the incremental area under the 
curve (AUC) for glucose and insulin (Wolever et al., 1991). Peak concentration and time to 
peak concentration for serum glucose and insulin were calculated. 
Additional fasting blood samples (10 ml) were taken using collection tubes with 
EDTA. Analysis of plasma leptin, adiponectin and C-reactive protein (CRP) were measured 
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using canine-specific commercial ELISA kits according to the manufacturer’s instructions 
(Millipore, St. Charles, MO, USA).  
5.2.4 Ultrasound and Oscillometry 
All ultrasound measurements were performed and analyzed by one individual. As a 
measure of endothelial function, FMD was measured in conscious, unsedated dogs using a 
SonoSite M-Turbo ultrasound unit with a vascular transducer L38x/10-5 MHz (Sonosite 
Canada Inc., Markham, ON) before feeding the glucose solution as well as 60 minutes after 
feeding based on previously published methods from this laboratory and others (Al-Dissi & 
Weber; Puglia et al., 2006). Images were captured at end diastole and analyzed using Adobe 
Premiere Elements 2.0 (Adobe Inc., San Jose, CA) and Image-Pro Express 6.0 (Media 
Cybernetics Inc., Bethesda, MD). FMD was calculated using the formula: %FMD = 100% x 
[(maximum diameter post-cuff release) – (baseline diameter)]/(baseline diameter). Change in 
FMD was calculated as: ΔFMD = FMD at time 60 – FMD at time 0. 
Echocardiography techniques were performed to assess cardiac structure and function 
using a Sonosite cardiac transducer P21x/5-1 MHz (Thomas et al., 1993). Measurements were 
taken after an overnight fast. Two-dimensional ultrasonography was used to measure left 
ventricular volume using the left parasternal apical two- and four-chamber views in diastole 
and systole (Lang et al., 2005). The inner wall of the left ventricle was traced and Simpson’s 
Rule (Sonosite Inc., 2007) was used to calculate left ventricular volume in diastole and systole 
from which stroke volume, ejection fraction and cardiac output were calculated (Hanton et al., 
1998).  
Two-dimensional guided M-mode echocardiography was used to obtain a right 
parasternal short axis view of the heart at the level of the papillary muscles (Lang et al., 
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2005). Image analysis software (Image-Pro Express 6.0, Media Cybernetics Inc., USA, 2006) 
was used to measure left ventricle internal dimension and left ventricle free wall (LVFW) 
thickness in systole and diastole, and fractional shortening was calculated (Hanton et al., 
1998).  
Blood pressure and heart rate were measured in fasted dogs by high definition 
oscillometry using a Vet Memodiagnostic HDO Monitor (S + B medVET, Germany) and 
MDS Win software version 1.4.5.1 (S + B medVET, Germany, 2007) according to a protocol 
validated in dogs (Brown et al., 2007). The cuff (4.5 x 15 cm) was placed at the tail base. An 
average of three readings was used to determine diastolic and systolic pressures and heart rate. 
5.2.5 Statistical Analyses 
Data were expressed as mean ± SEM. Prior to performing all analyses, data were 
explored for normality and outliers using the Kolmogorov-Smirnov test, Q-Q plots and 
boxplots. Repeated measures GLM with LSD posteriori comparisons were used to compare 
variables between multiple time points (lean, obese for 12 weeks, obese for 32 weeks, and 
after weight loss). Pearson correlation coefficients using combined data from the obese and 
weight loss time points were determined between body fat measurements and metabolic and 
cardiovascular variables that changed with body weight. Differences were considered 
statistically significant at P < 0.05. Analyses were performed using IBM SPSS Statistics 
version 20 (International Business Machines Corp., USA). 
5.3 Results 
Body weight was 9.8 ± 0.6 kg at baseline, 12.1 ± 0.7 kg after 12 weeks of ad libitum 
feeding, 12.8 ± 0.8 kg after 32 weeks of ad libitum feeding, and 10.2 ± 0.7 kg after weight 
loss. Thus, dogs were 23 ± 3, 30 ± 5 and 5 ± 2 % above baseline body weight at 12 weeks of 
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obesity, 32 weeks of obesity, and after weight loss, respectively. Weight was significantly 
different between all time points except between baseline and after weight loss. Weight loss 
was achieved over a period of 17 ± 1 weeks with an average loss of 0.9 ± 0.1 % per week. 
Abdominal total fat, visceral fat and subcutaneous fat were measured using CT of the 
entire abdomen from cranial thoracic vertebra 13 to caudal lumbar vertebra 7. Figure 5.1 
shows representative CT scans at the level of lumbar vertebra 5 in the same dog when that 
dog was obese for 12 weeks (Figure 5.1A, left panel) and after weight loss (Figure 5.1A, right 
panel). These same CT scans are shown in Figure 5.1B with thresholds of -105/-135 
Hounsfield units applied to identify fat, with the dashed lines illustrating how the region of 
interest surrounding the visceral cavity was selected to permit partitioning of visceral and 
subcutaneous fat. After 12 weeks of obesity, total, visceral and subcutaneous fat, respectively, 
were 736 ± 106, 186 ± 30, and 550 ± 94 cm3, which increased to 1016 ± 167, 303 ± 52, and 
713 ± 135 cm3 after 32 weeks of obesity (Figure 5.1C). After weight loss, body fat values 
were 248 ± 89 for total fat, 74 ± 27 for visceral fat, and 174 ± 64 cm3 for subcutaneous fat 
(Figure 5.1C). All body fat types were significantly different between all three time points.  
The serum glucose and insulin responses to the oral glucose tolerance tests are shown 
in Table 5.1 and supplemental serum glucose and insulin data are provided in Figure C.1 in 
Appendix C. Fasting glucose was significantly higher when the dogs were obese for 12 
(P=0.001) and 32 weeks (P=0.02) than when they were lean, and values returned to lean 
concentration after weight loss (P=0.8). The AUC for glucose also increased after 12 weeks 
(P=0.008) and 32 weeks (P=0.005) of obesity. However, after weight loss, mean glucose 
AUC was between the values at baseline and obesity and was not significantly different from 
when the dogs were the lean (P=0.2) or obese for 12 weeks (P=0.1) or 32 weeks (P=0.1). 
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Fasting insulin was significantly higher after the dogs were obese for 32 weeks compared to 
baseline (P=0.01). After weight loss, mean fasting insulin was between the values at baseline 
and obesity and was not significantly different than the lean (P=0.5) or obese values at 12 
weeks (P=0.6) and 32 weeks (P=0.7). AUC for insulin was lower after weight loss than when 
the dogs were lean (P=0.02) and obese for 12 weeks (P=0.005), but not after they were obese 
for 32 weeks (P=0.1).  
 102 
 
 
Figure 5.1 Assessment of abdominal total, visceral and subcutaneous body fat. 
Representative CT scans at lumbar vertebra 5 of the same dog after 12 weeks of obesity and after 
weight loss (A) without thresholds applied and (B) with thresholds of -105/-135 Hounsfield units 
applied. Dashed line shows partitioning of subcutaneous and visceral body fat regions. (C) 
Abdominal total, visceral and subcutaneous body fat at 12 and 32 weeks of obesity and after 
weight loss (n=8). Bars within the same group without a common letter differ, P<0.05; repeated 
measures GLM with LSD posteriori test. 
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Table 5.1 Serum glucose and insulin responses to oral glucose tolerance test in dogs that were 
lean, have been obese for 12 or 32 weeks or have undergone weight loss. 
 Lean Obese 
12 weeks 
Obese 
32 weeks 
Weight Loss 
Glucose     
Fasting (mmol/L) 4.8 ± 0.1a 5.5 ± 0.2b 5.3 ± 0.1b 4.8 ± 0.1a 
Peak (mmol/L) 8.3 ± 0.7a,c 10.1 ± 0.5b 9.6 ± 0.5a,b 8.8 ± 0.4c,d 
Time to peak (min) 50 ± 14a,b 48 ± 4a 35 ± 3b 45 ± 9a,b 
Area under the curve 
(mmol/L•min) 
154 ± 28a 241 ± 28b 234 ± 25b 206 ± 17a,b 
Insulin     
Fasting (mmol/L) 5.4 ± 1.6a 17.4 ± 5.9a,b 15.7 ± 4.2b 12.6 ± 10.4a,b 
Peak (pmol/L) 324 ± 60a,b 340 ± 49a 310 ± 92a,b 209 ± 28b 
Time to peak (min) 40 ± 5a 45 ± 6a 35 ± 6a 47 ± 7a 
Area under the curve 
(pmol/L•min) 
13318 ± 2265a 14114 ± 2561a 14670 ± 4384a,b 8345 ± 1479b 
Values are mean ± SEM (n=8). AUC, area under the curve; LVFWs, left ventricle free wall 
systole. 
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Changes in cardiovascular function were observed with changes in body weight 
(Figure 5.2). FMD was measured before and 60 min after an oral glucose challenge. Since 
hyperglycemia is associated with endothelial dysfunction, ΔFMD was calculated when the 
dogs were lean, obese for 12 and 32 weeks, and after weight loss to determine the effect of 
body fat and glucose tolerance on FMD response. ΔFMD was positive when the dogs were 
lean, but negative when the dogs were obese for 12 and 32 weeks as well as after weight loss 
(Figure 5.2A). In addition, ΔFMD was significantly lower when the dogs were obese 
compared to when they were lean (Figure 5.2A). Heart rate and cardiac output were 71 ± 3 
bpm and 806 ± 69 ml/min, respectively, when the dogs were lean. Heart rate increased to 93 ± 
5 bpm (P=0.003; Figure 5.2B) and cardiac output also increased to 1256 ± 93 ml/min 
(P<0.005; Table 5.2) after the dogs had been obese for 12 weeks. However, heart rate and 
cardiac output were not different between baseline, obesity after 32 weeks, or after weight 
loss. 
Systolic free wall thickness increased after the dogs had been obese for 12 weeks 
(P=0.002; Figure 5.2C) and was significantly decreased after weight loss compared to when 
the dogs were lean (P=0.03). No significant changes were observed for diastolic LVFW 
thickness, fractional shortening, ejection fraction, or stroke volume (Table 5.2). Thus, overall 
mean values were calculated as 0.75 ± 0.02 cm, 33 ± 1 %, 50 ± 1 %, and 12 ± 0.8 ml, 
respectively. No changes in diastolic blood pressure were observed in response to weight 
change (Table 5.2). However, systolic blood pressure increased from 126 ± 2 mm Hg when 
the dogs were lean to 129 ± 3 mm Hg after weight loss (P=0.02), with no changes observed 
between the lean and obese states (Table 5.2). 
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Figure 5.2 Cardiovascular changes in dogs with different body conditions. 
Measurements were taken when dogs (n=8) were lean, have been obese for 12 or 32 weeks, or 
have undergone weight loss. (A) FMD was measured in dogs before and 60 min after feeding 
glucose (ΔFMD = FMD at time 60 – FMD at time 0). (B) Heart rate was measured in dogs using 
high definition oscillometry. (C) Left ventricular free wall thickness was measured in dogs using 
two-dimensional guided M-mode ultrasonography. Bars without a common letter differ, P < 
0.05; repeated measures GLM with LSD posteriori test. 
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Table 5.2 Cardiac and hemodynamic variables when dogs were lean, obese for 12 wk, obese for 
32 wk or after weight loss. 
 Lean Obese 12 
wk 
Obese 32 
wk 
Weight loss 
LVID systole (cm) 2.0 ± 0.08a 1.9 ± 0.09a 1.9 ± 0.1a 2.1 ± 0.08a 
LVID diastole (cm) 3.0 ± 0.09a 2.9 ± 0.09a 3.0 ± 0.1a 2.9 ± 0.07a 
Fractional shortening 
(%) 
33 ± 1a 35 ± 2a 34 ± 2a 30 ± 2a 
Ejection fraction (%) 50 ± 3a 55 ± 2a 50 ± 5a 46 ± 3a 
Stroke volume (ml) 12 ± 1a 14 ± 0.7a 11 ± 2a 12 ± 2a 
Cardiac output 
(ml/min) 
806 ± 69a 1256 ± 93b 937 ± 153a,b 1024 ± 
299a,b 
Diastolic blood 
pressure (mm Hg) 
64 ± 2a 66 ± 2a 65 ± 1a 69 ± 2a 
Systolic blood 
pressure (mm Hg) 
126 ± 2a 124 ± 3a,b 124 ± 3a,b 129 ± 3b 
Values are mean±  SEM (n=8). Means within a row without a common superscript differ 
(P<0.05; repeated measures GLM with LSD posteriori test). 
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Plasma leptin concentrations were 1.1 ± 0.7 ng/ml when the dogs were lean, 4.2 ± 1.2 
ng/ml after 12 weeks of obesity, 4.0 ± 1.4 ng/ml after 32 weeks of obesity, and 2.3 ± 1.1 
ng/ml after weight loss (Figure 5.3A). Leptin was significantly lower when the dogs were lean 
compared to when they had been obese for 12 weeks (P=0.01) and 32 weeks (P=0.03). Plasma 
adiponectin concentrations when the dogs were lean, obese for 12 weeks, obese for 32 weeks, 
and after weight loss were 21.3 ± 4.5, 13.9 ± 2.6, 12.8 ± 2.9, and 10.1 ± 2.2 µg/ml, 
respectively. Plasma adiponectin significantly decreased after weight gain and decreased 
further after weight loss (Figure 5.3B). Plasma CRP concentrations did not differ between any 
of the time points (Figure 5.3C) and an overall mean concentration was calculated as 413 ± 49 
µg/ml.  
Correlations were performed between total, subcutaneous and visceral body fat and 
metabolic and cardiovascular variables using data from when the dogs were obese for 12 and 
32 weeks and after weight loss (Table 5.3). Fasting glucose was positively correlated with 
total fat (r=0.5, P=0.02) and subcutaneous fat (r=0.5; P=0.02). Peak glucose was associated 
with visceral fat (r=0.4; P=0.03), but no associations were found between glucose AUC and 
total, visceral or subcutaneous fat. Insulin AUC (r=0.7, P<0.001; Figure 5.4A) and peak 
insulin (r=0.6. P=0.001) were positively correlated with visceral fat, but not total or 
subcutaneous fat. Significant correlations were found between heart rate and total fat (r=0.5, 
P=0.01), visceral fat (r=0.5, P=0.01; Figure 5.4B) and subcutaneous fat (r=0.5, P=0.02). 
Systolic LVFW thickness was more strongly correlated with visceral fat (r=0.6, P=0.001; 
Figure 5.4C) than total fat (r=0.4, P=0.03), and was not correlated with subcutaneous fat 
(r=0.3, P=0.1). No significant correlations were found between total, visceral or subcutaneous 
fat and plasma leptin or adiponectin concentrations. 
 108 
 
 
Figure 5.3 Plasma adipokine and C-reactive protein concentrations in dogs with different body 
conditions. 
Plasma (A) leptin, (B) adiponectin, and (C) C-reactive protein were measured when dogs (n=8) 
were lean, have been obese for 12 or 32 weeks, or have undergone weight loss. Bars without a 
common letter differ, P < 0.05; repeated measures GLM with LSD posteriori test. 
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Table 5.3 Correlations between total, subcutaneous and visceral body fat with metabolic and 
cardiovascular variables using combined data when dogs were obese for 12 and 32 weeks, and 
after weight loss. 
 Total fat  
(cm3) 
Subcutaneous fat 
(cm3) 
Visceral fat  
(cm3) 
r P-value r P-value r P-value 
Fasting glucose (mmol/L) 0.45 0.03 0.44 0.03 0.33 0.1 
Peak glucose (mmol/L) 0.31 0.1 0.24 0.3 0.44 0.03 
Glucose AUC (mmol/L•min) 0.064 0.8 -0.003 1.0 0.23 0.3 
Fasting insulin (pmol/L) -0.028 0.9 0.012 1.0 0.048 0.8 
Peak insulin (pmol/L) 0.30 0.2 0.10 0.7 0.73 <0.001 
Insulin AUC (pmol/L•min) 0.38 0.1 0.16 0.5 0.78 <0.001 
Heart rate (bpm) 0.46 0.01 0.4 0.05 0.51 0.01 
ΔFMD (%) 0.21 0.3 0.20 0.3 0.14 0.5 
LVFWs (cm) 0.46 0.02 0.32 0.1 0.67 <0.001 
Leptin (ng/ml) 0.27 0.2 0.27 0.2 0.24 0.3 
Adiponectin (µg/ml) -0.10 0.6 -0.035 0.9 -0.30 0.2 
AUC, area under the curve; LVFWs, left ventricle free wall systole 
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Figure 5.4 Association between visceral body fat, metabolic and cardiovascular parameters. 
Pearson correlations between visceral fat and (A) area under the insulin response curve after an 
oral glucose tolerance test (B) heart rate and (C) systolic left ventricle free wall thickness. 
Measurements were taken when dogs were obese for 12 weeks, 32 weeks, and after weight loss. 
Visceral body fat was determined by CT scan. AUC, area under the curve; LVFWs, left ventricle 
free wall systole. 
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5.4 Discussion 
The major finding of this study was that after only 12 weeks of obesity significant 
alterations were observed in glucose, cardiovascular and adipokine parameters in a dog model 
of obesity. These metabolic and cardiovascular alterations persisted after 32 weeks of obesity, 
and weight loss reversed some, but not all, of these alterations. These results suggest that 
detrimental metabolic and cardiovascular changes occur very quickly with weight gain and 
because weight loss may not completely reverse these changes, obesity prevention is vital for 
promoting long term health.  
In addition, we have shown for the first time in an obese dog model that metabolic and 
cardiovascular changes were most closely correlated to visceral, not subcutaneous fat, as has 
been shown in humans (Bergman et al., 2006; Gastaldelli & Basta, 2010). One of the 
strengths of the present study was the ability to use the same dogs as their own control. 
Inherent challenges exist in performing the same study in humans because of the inability to 
use the same individuals as their own control. Thus, the obese dog model is uniquely powerful 
because it is possible to track the same dogs under all of the body condition states, while 
having strict control over diet and activity levels. Dogs are also advantageous as a model 
because they are large enough to permit the same ultrasound and glycemic testing techniques 
as are routinely used in humans. 
Weight gain increased fasting glucose as well as the AUC for glucose while after 
weight loss, fasting glucose returned to baseline levels and AUC was not significantly 
different than lean or obese levels. Both obesity and hyperglycemia are risk factors for the 
development of endothelial dysfunction (Kawano et al., 1999; Williams et al., 2005) and 
weight loss may improve post-prandial endothelial dysfunction (Haspicova et al., 2011; Kerr 
et al., 2011). Hyperglycemia may induce endothelial dysfunction by initiating pro-
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inflammatory events such as increases in nuclear factor kappa B and tumor necrosis factor 
alpha followed by overproduction of reactive oxygen species and inhibition of endothelial 
dependent nitric oxide synthase (Cosentino et al., 1997; Mohanty et al., 2000; Node & Inoue, 
2009). Another mechanism by which hyperglycemia may contribute to endothelial 
dysfunction is through the formation of advanced glycation end-products (Brouwers et al., 
2010; Dhar et al., 2010). Methylglyoxal is a reactive glucose metabolite and is a precursor of 
AGE (Desai et al., 2010). We previously demonstrated that hyperglycemia was associated 
with increased methylglyoxal and reduced FMD in dogs (Adolphe et al., 2012). In the present 
study, impaired glucose tolerance occurred with obesity and concomitantly ΔFMD was 
significantly lower with obesity compared to the lean state, suggesting that elevated blood 
glucose levels may have a greater impact on endothelial function in obese versus lean 
individuals.  
Even though only moderate improvements were observed in glucose AUC after 
weight loss, AUC for insulin was significantly reduced after weight loss compared to 
baseline. This finding supports results from other studies that have shown that calorie 
restriction improves pancreatic beta cell function and insulin sensitivity (Huffman et al., 2012; 
Larson-Meyer et al., 2006; Leray et al., 2008). In the present study, dogs were receiving about 
25% fewer calories than lean maintenance energy requirements when the oral glucose 
tolerance test was administered after weight loss. Thus, it is possible that caloric restriction in 
addition to the weight loss resulted in the improved insulin response to a glucose challenge. 
Obesity, even after weight loss, appears to have lasting effects on energy homeostasis. 
A study in dogs showed that re-induction of obesity after weight loss occurred more quickly 
and with a lower energy intake (Nagaoka et al., 2009). Another study showed that post-weight 
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loss maintenance energy requirements were lower than requirements prior to weight gain 
(German et al., 2011). The reason for this increased efficiency in energy metabolism after 
weight loss is unknown, but our study suggests that metabolic alterations are present after 
weight loss. Notably, adiponectin was significantly lower after weight loss than during 
obesity and leptin remained higher than pre-obesity levels, both of which could have a 
prolonged effect on energy balance by potentially promoting weight re-gain. Studies by 
German et al. (2009) and Wakshlag et al. (2011) also found that plasma adiponectin did not 
change in obese dogs undergoing weight loss, though Tvarijonaviciute et al. (2012) found that 
adiponectin concentrations did increase in dogs following a weight loss period. The time 
frame over which weight loss is achieved and how long after weight loss adiponectin 
concentrations are measured are possible explanations for the different observed effects of 
weight loss on adiponectin concentrations.  
Obesity has been associated with enhanced sympathetic nervous system activity which 
has been implicated in the negative effects of obesity on cardiovascular health (Govindarajan 
et al., 2008). Elevated heart rate is an independent risk factor for cardiovascular morbidity and 
mortality in healthy humans as well as among those with established cardiac disease (Palatini 
& Julius, 2004). Increased sympathetic activation and/or reduced parasympathetic control 
may be responsible for elevated heart rate in obesity (Palatini, 2011). The sympathetic 
nervous system is strongly influenced by dietary intake. Fasting or caloric deprivation 
reduces, whereas overfeeding stimulates, sympathetic activity. Thus, increased sympathetic or 
decreased parasympathetic stimulation may explain the increased systolic LVFW thickness 
and heart rate observed in the present study. In addition, the present study found that after 
weight loss, systolic LVFW thickness was reduced compared to the lean state. This change 
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may be due to the calorie restriction during the weight loss period (Gruber et al., 2012). The 
health consequences of this change in systolic LVFW are uncertain, though cardiac atrophy is 
generally associated with undesirable conditions such as cachexia and malnutrition.(Gruber et 
al., 2012) However, compared to other studies examining weight loss in dogs (Blanchard et 
al., 2004; Borne et al., 1996; Brunetto et al., 2011; Butterwick & Markwell, 1997), the energy 
restriction used in the present study (74% of maintenance energy requirements) was moderate. 
In conclusion, this study provides evidence that detrimental metabolic and 
cardiovascular consequences occur within 12 weeks after the onset of obesity in an obese dog 
model and that these changes correlate most strongly with visceral, not subcutaneous fat. In 
addition, after an average weight loss period of 17 weeks, most of these changes showed 
improvement, but some had not quite returned to baseline lean values. Thus, the results of this 
study emphasize the importance of obesity prevention since after weight loss, not all 
metabolic indicators had returned to normal and systolic cardiac muscle thickness was 
reduced compared to pre-obesity levels, suggesting possible adverse cardiovascular effects of 
short term weight loss. These data, along with evidence from other studies that show lasting 
changes in energy homeostasis after repeated weight gain/weight loss cycles, further 
emphasize the importance of obesity prevention. 
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CHAPTER 6 
STUDY 4: EFFECT OF A PEA- OR RICE-BASED DIET ON POST-PRANDIAL INSULIN 
RESPONSE, BODY FAT DISTRIBUTION AND CARDIOVASCULAR HEALTH IN OBESE 
DOGS 
Once the dogs were obese for study 3, study 4 commenced and the obese dogs were 
entered into a cross-over study using the pea and rice diets formulated in study 2. Study 4 
expanded on the results from study 2, which looked at the acute health effects of the pea and 
rice diets, by examining the longer term health effects of the diets in obese dogs. Thus, study 
4 was the final study in the series to complement the results of studies 1 and 2 which allowed 
this research to provide a broad perspective on the acute and chronic effects in dogs of diets 
containing either a low or high glycemic index carbohydrate source. 
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6.1 Introduction 
Obesity is a prevalent nutritional disorder among pet dogs and results in higher risk of 
earlier morbidity and mortality (Kealy et al., 2002; Laflamme, 2006; Lawler et al., 2008). In 
comparison, in humans a subset of obese individuals has been described that are considered to 
be metabolically healthy but obese (Karelis et al., 2004; Sims, 2001). This population seems 
to be protected against metabolic complications that are normally associated with obesity and 
have favorable metabolic profiles, including high insulin sensitivity and normal inflammation, 
lipid and hormonal profiles (low triglycerides and CRP, and high HDL cholesterol and 
adiponectin) (Karelis, 2008). However, it is not known why these individuals remain 
metabolically healthier. One possibility is that these metabolically-normal but obese people 
are consuming a healthier diet. The question we asked is whether dogs can be metabolically 
healthy but obese and if diet plays a role. 
A combination of energy restriction and exercise is often recommended for weight 
loss in obese pets. However, this approach often increases metabolic and behavioural stress in 
the animal which results in a loss of compliance, and weight loss is either not achieved or not 
maintained (Mitsuhashi et al., 2010). Dietary treatments that either promote weight loss or 
improve metabolic health in spite of obesity could have an enormous impact on the health of 
both pets and their owners. 
The glycemic index was developed to rank carbohydrate-containing foods based on 
their effect on postprandial glycemic response (Jenkins et al., 1981). Chronic consumption of 
a low glycemic index diet may reduce hunger, prevent fat deposition, and place the pancreatic 
beta cells under decreased stress (Pawlak et al., 2004). Research suggests that in humans, low 
glycemic index diets promote lower bodyweight and decreased risk of chronic disease 
compared with consuming a high glycemic index diet (Barclay et al., 2008; Ma et al., 2012; 
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Thomas et al., 2007). However, there is a lack of information about the health effects of 
glycemic index in companion animals. It also remains unclear as to whether glycemic index is 
the only factor contributing to weight loss based on results from human clinical trials. A 
major deficiency in human studies is that interventions that modify glycemic index 
unavoidably cause changes in other dietary factors that may affect body weight (e.g. fibre 
content, palatability, energy density) (Pawlak et al., 2004). However, animal studies allow for 
these factors to be more easily controlled since a constant, pre-formulated diet can be fed 
long-term. 
We previously reported that in dogs, unprocessed peas have a lower glycemic index 
than rice (Adolphe et al., 2012). Since most dogs in North America consume complete and 
balanced extruded dry diets, we tested the glycemic index of extruded diets with equivalent 
amounts of macronutrients, but that contained either peas or rice as their only carbohydrate 
source. We found that once extruded, the glycemic index of a pea-based diet increased and 
was closer to the glycemic index of a rice-based diet (see Chapter 4). Despite a closer 
glycemic index for the pea-based diet once extruded as a complete and balanced food, we 
asked the question of whether feeding the extruded pea diet could still have beneficial 
biological effects with long term feeding compared to a rice-based diet.  
The purpose of this study was to examine the effects of two diets with identical 
macronutrient profiles, but containing different carbohydrate sources (peas or rice), on 
adiposity, metabolic and cardiovascular outcomes in obese dogs. We hypothesized that 
extruded diets containing peas would demonstrate health benefits, regardless of weight loss, 
in obese dogs compared to a rice-based diet.  
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6.2 Materials and Methods 
6.2.1 Study Design 
A randomized, blinded cross-over study was performed to assess the effects of a pea-
based or rice-based diet on adiposity, metabolic and cardiovascular parameters in obese dogs. 
Laboratory beagle dogs (n=9; 4 neutered males, 5 spayed females) with a mean age of 3.6 ± 
0.4 y were used. The dogs were obtained from Covance Research Products Inc. (Princeton, 
NJ, USA) or the University of Guelph (Guelph, ON, Canada) and were kept in the Western 
College of Veterinary Medicine at the University of Saskatchewan (Saskatoon, SK, Canada). 
The animals were housed in 1.1 x 2.7 m kennels at night, but were housed together during the 
day with access to outdoor runs, and all dogs were walked daily. This work was approved by 
the University of Saskatchewan’s Animal Research Ethics Board and adhered to the Canadian 
Council on Animal Care guidelines for humane animal use. 
For 12 weeks prior to the start of the trial dogs were fed a commercial adult 
maintenance dry diet (Purina Dog Chow, Ralston Purina Co., St. Louis, MO) ad libitum (i.e. 
unlimited access to food 24 hours per day) to promote obesity. Obesity was defined as body 
weight 15% above ideal weight. At the end of the 12 week period, average body weight was 
23% above ideal. The dogs were then randomly assigned to receive ad libitum amounts of a 
pea-based or rice-based diet for 12 weeks (period 1), followed by an 8 week washout period 
before the dogs were crossed-over to the pea or rice diet for another 12 weeks (period 2). 
When the dogs were receiving the pea-based or rice-based diets, they were housed in 
individual runs and had unlimited access to their assigned diet overnight from 4:00 pm to 8:00 
am. During the washout period, dogs received the same commercial diet ad libitum that they 
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received prior to the start of period 1 in order to maintain obese status. Metabolic, 
cardiovascular and body fat analyses were performed before and after periods 1 and 2. 
The pea and rice diets were formulated to meet nutritional recommendations 
(Association of American Feed Control Officials, 2009) using Concept 5 software (Creative 
Formulation Concepts, LLC, Annapolis, MD, USA). Diets were formulated to contain equal 
amounts of ME, protein, carbohydrate and fat, using either peas or rice as the sole 
carbohydrate source. The diets were extruded at Horizon Pet Nutrition (Rosthern, SK). The 
ingredient composition of the pea and rice diets were reported previously (see Chapter 4). 
6.2.2 Body Fat Analysis 
Abdominal body fat was analyzed using CT scans. A single slice helical scanner 
(Tomoscan M, Philips Medical Systems North America, Bothell, WA) was used for the scans 
prior to period 1 and a 16-slice scanner (Acquilon, Toshiba America Medical Systems, Inc., 
Tustin, CA) was used for all subsequent scans. Dogs were fasted overnight and sedated using 
dexmedetomidine hydrochloride (Dexdomitor®, Orion Pharma, 5µg/kg). When anaesthesia 
was required for longer duration with the helical CT, dogs were induced with propofol 
(Propofol, Novopharm, 4 mg/kg), intubated, and anaesthetized with isoflurane (IsoFlo®, 
Abbott Animal Health, inhalation maintained at 0.5-3%). Dogs were placed in dorsal 
recumbency for all scans. After scanning, dogs were removed from anesthetic or sedation was 
reversed with atipamezole hydrochloride (Antisedan®, Orion Pharma, 5 µg/kg). 
Transverse digital images were obtained through the thorax and abdomen of each dog 
for analysis of abdominal body fat area. The abdomen was delineated from the thorax at the 
level of the diaphragm and 5 mm slices were analyzed using General Electric Advantage 
Windows Server version 2.0-5.0 with Volume Viewer version 10.3.67 (General Electric 
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Company, Fairfield, CT). Thresholds of -105/-135 Hounsfield units, as previously determined 
in beagles, were used to identify fat (Ishioka et al., 2005). Abdominal fat was partitioned into 
visceral and subcutaneous fat by drawing a region of interest surrounding the visceral cavity 
using the clearly visible border of the peritoneal wall (Zhao et al., 2006). Visceral and 
subcutaneous fat were measured at the level of each vertebra by quantifying the volume of fat 
in two slices in the middle of the vertebra. Total fat was calculated as the sum of visceral and 
subcutaneous fat. Total, visceral and subcutaneous fat for the entire abdomen was calculated 
as the sum of the fat values from the sum of the two vertebral slices from cranial thoracic 
vertebra 13 to caudal lumbar vertebra 7 (i.e. T13-L7).  
6.2.3 Blood Collection and Analyses 
After an overnight fast, dogs were fed a 20% glucose solution providing 10 g glucose. 
The solution was consumed by each dog in <5 minutes. Dogs were aseptically catheterized 
using a peripheral intravenous catheter inserted into the cephalic or saphenous vein. Blood 
samples (3 ml) were taken for serum collection at pre-feeding (time 0) and 15, 30, 45, 60, 90, 
120, 150 and 180 minutes post-feeding. Serum glucose analysis was performed using a 
glucose oxidase assay method (Association of Official Analytical Chemists, 2005) using 
reagents from Sigma Aldrich (St. Louis, MO). Serum insulin levels were measured by 
radioimmunoassay using a commercially available assay kit (Coat-A-Count Insulin, Siemens, 
Munich, Germany) previously validated in dogs (Wolfsheimer et al., 1986). Serum glucose 
and insulin concentrations were determined at all time points. The trapezoidal method was 
used to determine the incremental AUC for glucose and insulin (Wolever et al., 1991). Peak 
concentration and time to peak concentration for serum glucose and insulin were calculated. 
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To assess the overall health effects of the diets, additional fasting blood samples (2 ml) 
were collected for biochemistry panel and complete blood count (CBC) analyses which were 
performed at Prairie Diagnostic Services Inc. at the University of Saskatchewan (Saskatoon, 
SK) at the end of each feeding trial period. Fasting blood samples (10 ml) were also taken 
using collection tubes with EDTA for analysis of plasma leptin, adiponectin and CRP which 
were measured using canine-specific commercial ELISA kits according to the manufacturer’s 
instructions (Millipore, St. Charles, MO, USA).  
6.2.4 Ultrasound and Oscillometry 
All ultrasound measurements were performed and analyzed by one individual who 
was blinded to the treatment. As a measure of endothelial function, FMD was measured in 
conscious, unsedated dogs using a SonoSite M-Turbo ultrasound unit with a vascular 
transducer L38x/10-5 MHz (Sonosite Canada Inc., Markham, ON) before feeding the glucose 
solution as well as 60 minutes after feeding based on previously published methods from this 
laboratory and others (Al-Dissi & Weber; Puglia et al., 2006). Images were captured at end 
diastole and analyzed using Adobe Premiere Elements 2.0 (Adobe Inc., San Jose, CA) and 
Image-Pro Express 6.0 (Media Cybernetics Inc., Bethesda, MD). FMD was calculated using 
the formula: %FMD = 100% x [(maximum diameter post-cuff release) – (baseline 
diameter)]/(baseline diameter).  
Echocardiography techniques were performed to assess cardiac structure and function 
using a Sonosite cardiac transducer P21x/5-1 MHz (Thomas et al., 1993). Measurements were 
taken after an overnight fast. Two-dimensional ultrasonography was used to measure left 
ventricular volume using the left parasternal apical two- and four-chamber views in diastole 
and systole (Lang et al., 2005). The inner wall of the left ventricle was traced and Simpson’s 
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Rule (Sonosite Inc., 2007) was used to calculate left ventricular volume in diastole and systole 
from which stroke volume, ejection fraction and cardiac output were calculated (Hanton et al., 
1998).  
Two-dimensional guided M-mode echocardiography was used to obtain a right 
parasternal short axis view of the heart at the level of the papillary muscles (Lang et al., 
2005). Image analysis software (Image-Pro Express 6.0, Media Cybernetics Inc., USA, 2006) 
was used to measure left ventricle internal dimension and LVFW thickness in systole and 
diastole, and fractional shortening was calculated (Hanton et al., 1998).  
Blood pressure and heart rate were measured in fasted dogs by high definition 
oscillometry using a Vet Memodiagnostic HDO Monitor (S + B medVET, Germany) and 
MDS Win software version 1.4.5.1 (S + B medVET, Germany, 2007) according to a protocol 
validated in dogs (Brown et al., 2007). The cuff (4.5 x 15 cm) was placed at the tail base. An 
average of three readings was used to determine diastolic and systolic pressures and heart rate. 
6.2.5 Statistical Analyses 
Data were expressed as mean ± SEM. One male dog was withdrawn from the study 
during period 2 due to the development of intervertebral disc disease unrelated to the study. 
Thus, 9 dogs completed testing for the rice diet and 8 dogs tested the pea diet. Prior to 
performing all analyses, data were explored for normality and outliers using the Kolmogorov-
Smirnov test, Q-Q plots and boxplots. Independent sample t-tests were used to compare diet 
intake and energy consumption. Univariate general linear model with diet as a fixed factor 
and corresponding baseline measurement as a covariate was used to assess metabolic, 
cardiovascular and body fat variables. Pearson correlation coefficients were calculated to 
examine the association between body fat and cardiovascular and metabolic variables using 
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combined data from measurements taken before and after periods 1 and 2. Differences were 
considered statistically significant at P ≤ 0.05. Analyses were performed using IBM SPSS 
Statistics version 20 (International Business Machines Corp., USA). 
6.3 Results 
Ad libitum consumption of the diets was similar, being 210 ± 13 g/d for the pea diet 
and 213 ± 14 g/d for the rice diet (P=0.9). Thus, dogs consumed 1000 ± 62 and 959 ± 63 kcal 
DE per day on the pea and rice diets (P=0.6), respectively, based on previously determined 
DE values of 4764 kcal DE/kg for the pea diet and 4500 kcal DE/kg for the rice diet (see 
Chapter 4). Weight loss was negligible and did not significantly differ between the two diets 
after 12 weeks of feeding, with dogs losing 0.1 ± 0.2 kg with the pea diet versus 0.3 ± 0.1 kg 
with the rice diet (P=0.4). Total (P=0.4), visceral (P=0.4), and subcutaneous (P=0.4) body fat 
measured by CT did not differ between diets (Figure 6.1). 
The results of the blood biochemistry and CBC tests are shown in Table 6.1. The 
results indicated that there were no differences between values after feeding the pea or rice 
diet for 12 weeks, except for phosphorus and magnesium which were lower after feeding the 
rice diet, but still within normal limits. Values for all other parameters were within normal 
limits except for globulin which was slightly below the reference range for all time points. 
Since globulin was low after feeding the commercial diet, pea diet and rice diet, a low value 
was likely a unique characteristic of this cohort of dogs and not diet related. 
Fasting glucose, peak glucose and glucose AUC after an oral glucose tolerance test 
were not significantly different between the pea and rice diets (Table 6.2). In contrast, both 
peak insulin (P=0.05) and insulin AUC after an oral glucose tolerance test (P=0.05) were 
lower for the pea-based diet than the rice-based diet (Table 6.2). No significant difference was 
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found between the diets for fasting insulin. Supplemental serum glucose and insulin data are 
provided in Figure D.1 in Appendix D.  
The effects of the pea and rice diets on cardiovascular parameters are shown in Table 
6.3. Diet did not result in any significant changes in FMD, diastolic or systolic LVFW, 
fractional shortening, stroke volume, ejection fraction, cardiac output, systolic or diastolic 
blood pressure, or heart rate (P>0.05).  
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Figure 6.1 Body fat distribution before and after consumption of pea-based or rice-based diet. 
Cross-over study with obese dogs consuming pea-based (n=8) or rice-based (n=9) diet for 12 
weeks separated by 8 week washout period during which the dogs were fed a commercial dog 
food ad libitum to maintain obesity. Total, subcutaneous and visceral body fat measured in 
sedated dogs by computed tomography before and after each diet period. No significant 
differences were found between diets. 
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Table 6.1 Blood chemistry characteristics of adult dogs before and 12 weeks after receiving a pea-
based or rice-based diet. 
Item Reference 
Range1 
Pea Diet2 
Baseline 
Pea Diet2 
12 weeks 
Rice Diet3 
Baseline 
Rice Diet3 
12 weeks 
P-
value4 
Glucose, mmol/L 3.1-6.3 5.0 ± 0.1 5.3 ± 0.2 5.0 ± 0.2 5.1 ± 0.1 0.6 
Sodium, mmol/L 145-158 146 ± 0.7 146 ± 0.5 146 ± 0.6 146 ± 0.5 0.8 
Potassium, mmol/L 3.8-5.6 4.6 ± 0.04 4.6 ± 0.06 4.6 ± 0.06 4.5 ± 0.03 0.2 
Chloride, mmol/L 103-118 112 ± 0.7 112 ± 0.7 112 ± 0.6 113 ± 0.4 0.3 
Bicarbonate, mmol/L 15-25 20 ± 0.7 20 ± 0.7 20 ± 0.5 20 ± 0.4 1.0 
Anion Gap, mmol/L 16-30 19 ± 0.8 18 ± 0.8 19 ± 0.6 17 ± 0.6 0.3 
Calcium, mmol/L 1.91-3.03 2.48 ± 0.04 2.53 ± 0.05 2.52 ± 0.05 2.53 ± 0.04 1.0 
Phosphorus, mmol/L 0.63-2.41 1.27 ± 0.03 1.34 ± 0.04 1.26 ± 0.04 1.14 ± 0.06 0.01 
Magnesium, mmol/L 0.70-1.16 0.81 ± 0.02 0.80 ± 0.01 0.81 ± 0.02 0.76 ± 0.01 0.04 
Urea, mmol/L 3.5-11.4 4.4 ± 0.2 4.7 ± 0.3 5.2 ± 0.3 5.2 ± 0.2 0.6 
Creatinine, mmol/L 41-121 48 ± 2 54 ± 4 53 ± 3 53 ± 3 0.3 
Cholesterol, mmol/L 2.70-5.94 4.51 ± 0.4 4.44 ± 0.4 4.61 ± 0.3 4.62 ± 0.4 0.8 
Total Bilirubin, µmol/L 1.0-4.0 1.6 ± 0.2 1.4 ± 0.1 1.2 ± 0.1 1.3 ± 0.1 0.7 
ALP, U/L 9.0-90 38 ± 4 35 ± 5 37 ± 3 30 ± 2 0.3 
ALT, U/L 19-59 33 ± 3 27 ± 2 31 ± 2 31 ± 3 0.1 
GGT, U/L 0-8 2 ± 0.6 1 ± 0.5 1 ± 0.7 1 ± 0.6 0.5 
GLDH, U/L 0-7 4 ± 0.5 3 ± 0.5 4 ± 0.5 5 ± 0.9 0.06 
CK, U/L 51-418 139 ± 22 131 ± 10 171 ± 24 145 ± 16 0.7 
Albumin, g/L 28-38 34 ± 0.5 35 ± 0.7 35 ± 1.2 35 ± 0.7 0.7 
Globulin, g/L 23-37 21 ± 0.9 19 ± 0.9 21 ± 1.2 21 ± 0.9 0.1 
Total Protein, g/L 55-71 55 ± 1.2 53 ± 1 56 ± 1.0 56 ± 1 0.2 
Hgb, g/L 128-196 150 ± 4 149 ± 3 148 ± 2 153 ± 3 0.2 
Hct, % 36.5-57.3 43.3 ± 1.1 44.0 ± 0.9 42.9 ± 0.7 45.1 ± 0.8 0.3 
Values are mean ± SEM. Hgb, hemoglobin; Hct, hematocrit; ALP, alkaline phosphatase; ALT, alanine 
aminotransferase; GGT, gamma-glutamyl transferase; GLDH, glutamate dehydrogenase; CK, creatine kinase. 
1Reference ranges used at Prairie Diagnostic Services, University of Saskatchewan (Saskatoon, SK). 
2n=8 
3n=9 
4Pea diet vs. rice diet at 12 weeks (univariate GLM with baseline as covariate).  
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 Table 6.2 Serum glucose and insulin response to oral glucose tolerance test in dogs before and 
after receiving pea-based or rice-based diet. 
 Pea Diet1 
Baseline 
Pea Diet1 
12 weeks 
Rice Diet2 
Baseline 
Rice Diet2 
12 weeks 
P-Value3 
Serum Glucose      
Fasting glucose 
(mmol/L) 
5.4 ± 0.2 5.6 ± 0.2 5.4 ± 0.1 5.6 ± 0.4 0.9 
Peak glucose 
(mmol/L) 
9.7 ± 0.6 8.9 ± 0.2 9.9 ± 0.5 9.4 ± 0.6 0.4 
AUC 
(mmol/L•min) 
236 ± 30 202 ± 21 239 ± 23 224 ± 36 0.5 
Serum Insulin      
Fasting insulin 
(pmol/L) 
18.7 ± 6.6 16.0 ± 4.6 14.5 ± 2.9 9.8 ± 4.9 0.2 
Peak 
insulin(pmol/L) 
288 ± 57 185 ± 57 362 ± 86 351 ± 51 0.05 
AUC 
(pmol/L•min) 
13151 ± 2830 8546 ± 3270 15633 ± 4171 16384 ± 3120 0.05 
Values are mean ± SEM. AUC, area under the curve.  
1n=8 
2n=9 
3Pea diet vs. rice diet at 12 weeks (univariate GLM with baseline as covariate). 
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Table 6.3 Cardiovascular parameters in dogs before and after receiving pea-based or rice-based 
diet. 
 Pea Diet1 
Baseline 
Pea Diet1 
12 weeks 
Rice Diet2 
Baseline 
Rice Diet2 
12 weeks 
P-Value3 
FMD (%)4 2.7 ± 0.9 5.3 ± 1.2 3.6 ± 1.2 3.8 ± 1.2 0.4 
LVFW diastole (cm) 0.83 ± 0.03 0.83 ± 0.03 0.76 ± 0.04 0.80 ± 0.04 0.3 
LVFW systole (cm) 1.2 ± 0.2 1.1 ± 0.05 1.1 ± 0.06 1.1 ± 0.05 0.3 
Fractional shortening 34 ± 2 34 ± 2 36 ± 2 38 ± 1 0.08 
Stroke volume 12.4 ± 0.8 11.8 ± 1.0 12.7 ± 1.5 9.7 ± 0.9 0.2 
Ejection fraction 55 ± 2 45 ± 3 52 ± 4 38 ± 3 0.2 
Cardiac output (ml/min) 1120 ± 116 929 ± 82 1069 ± 130 797 ± 99 0.3 
Systolic blood pressure 
(mm Hg) 
129 ± 3 132 ± 3 123 ± 4 130 ± 4 0.9 
Diastolic blood pressure 
(mm Hg) 
67 ± 2 68 ± 2 66 ± 2 68 ± 2 1.0 
Heart rate (bpm) 88 ± 5 79 ± 4 86 ± 4 81 ± 4 0.5 
Values are mean ± SEM. FMD, flow-mediated dilation; LVFW, left ventricle free wall; bpm, beats per minute.  
1n=8 
2n=9 
3Pea diet vs. rice diet at 12 weeks (univariate GLM with baseline as covariate).  
4Measured 60 minutes post-oral glucose challenge. 
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No significant differences in plasma leptin (Figure 6.2A), adiponectin (Figure 6.2B) or 
CRP (Figure 6.2C) were found between the pea and rice diets after 12 weeks on the diet. 
Thus, overall mean values using measurements from before and after periods 1 and 2 (n=34) 
were calculated: leptin 2.8 ± 0.5 ng/ml; adiponectin 10.1 ± 1.3 µg/ml; and CRP 337 ± 45 
µg/ml. In addition, leptin, adiponectin and CRP values were observed to be lower on the test 
diets versus the commercial diet that was used prior to the start of the trial and during the 
washout period. To further explore this observation, leptin, adiponectin and CRP data for the 
pea and rice diets were combined and compared to these parameters for the commercial diet. 
Leptin (Figure 6.2D; P=0.02) and adiponectin (Figure 6.2E, P<0.001) were significantly 
lower on the test diets compared to the commercial diet, but no significant effect of diet was 
observed for CRP (Figure 6.2F). 
To determine the effect of both the amount and distribution of body fat on metabolic 
and cardiovascular parameters in obese dogs, correlation analysis was performed (Table 6.4 
and Figure 6.3). Insulin AUC (r=0.52, P=0.002; Figure 6.3A, right panel) and peak insulin 
(r=0.49, P=0.003, Table 6.4) were positively associated with visceral fat, but not with total 
(Figure 6.3A, left panel) or subcutaneous fat (Table 6.4). Systolic LVFW thickness was 
significantly correlated with visceral fat (r=0.64, P<0.001; Figure 6.3B, right panel), but not 
with total (r=0.3, P=0.08; Figure 6.3 B, left panel) or subcutaneous fat (r=0.13, P=0.5; Table 
6.4). Also, plasma leptin showed a better association with visceral fat (r=0.38, P=0.03; Figure 
6.3C, right panel) and total fat (r=0.37, P=0.03; Figure 6.3C, left panel), while the relationship 
with subcutaneous fat was not significant (r=0.31, P=0.07, Table 6.4). A negative association 
was found between plasma adiponectin and visceral fat (r=-0.41, P=0.02; Figure 6.3D, right 
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panel), but no association was found between adiponectin and total fat (r=-0.28, P=0.1; Figure 
6.3D, left panel) or subcutaneous fat (r=-0.19, P=0.3, Table 6.4).  
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Figure 6.2 Plasma leptin, adiponectin and C-reactive protein concentrations on commercial diet, 
pea-based diet or rice-based diet. 
Cross-over study with dogs consuming pea-based (n=8) or rice-based (n=9) diet for 12 weeks 
with commercial diet fed prior to trial and during 8 week washout period. (A,B, C) Plasma 
leptin, adiponectin and C-reactive protein concentrations before and after receiving pea or rice 
diets. No significant differences. (D, E, F) Plasma leptin, adiponectin and C-reactive protein 
concentrations with pea/rice diet data combined and compared to the commercial 
diet.*Significantly different from commercial diet (P<0.05, paired t-test) 
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Table 6.4 Correlations between total, subcutaneous and visceral body fat with metabolic and 
cardiovascular variables using combined data before and after feeding a pea-based or rice-based 
diet to dogs 
 Total fat  
(cm3) 
Subcutaneous fat 
(cm3) 
Visceral fat  
(cm3) 
r P-value r P-value r P-value 
Peak insulin (pmol/L) 0.063 0.7 -0.12 0.5 0.49 0.003 
Insulin AUC (pmol/L•min) 0.035 0.8 -0.16 0.4 0.52 0.002 
LVFWs (cm) 0.30 0.08 0.13 0.5 0.64 <0.001 
Leptin (ng/ml) 0.37 0.03 0.31 0.07 0.38 0.03 
Adiponectin (µg/ml) -0.28 0.1 -0.19 0.3 -0.41 0.02 
AUC, area under the curve; LVFWs, left ventricle free wall systole 
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Figure 6.3 Effect of body fat distribution on area under the insulin response curve, systolic left 
ventricle free wall thickness, leptin and adiponectin. 
Pearson correlations were performed between total fat or visceral fat and (A) insulin AUC, (B) 
LVFWs, (C) plasma leptin, and (D) plasma adiponectin in n=8-9 dogs before and after receiving 
a pea-based or rice-based diet. AUC, area under the curve; LVFWs, left ventricle free wall 
thickness at systole.  
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6.4 Discussion 
To our knowledge, this study demonstrates for the first time that a diet containing peas 
provides health benefits for obese dogs. Specifically, the results of this study found that 
compared to a rice-based diet, a pea-based diet reduced the post-prandial insulin response in 
obese dogs after exclusive feeding of the diet for only 12 weeks. Although the dogs in this 
study did not lose weight on either diet, they were more metabolically healthy on the pea diet 
due to the reduced post-prandial insulin response. Hyperinsulinemia has been suggested to be 
a risk factor for many diseases, including cardiovascular disease, cancer, kidney disease and 
liver disease (German et al., 2010; Laflamme, 2011). Thus, a diet that significantly reduces 
the post-prandial insulin response, even without weight loss, has tremendous potential to 
improve the metabolic profile of dogs and decrease the risk of chronic disease.  
A previous study also demonstrated that the source of dietary carbohydrate impacts 
insulin levels in dogs (Holste et al., 1989). Dogs were fed either a dry food, a soft moist food 
or a canned food for 5 days. It was found that fasting insulin levels were significantly higher 
among the dogs fed the soft moist food compared to the other two groups. After ingestion of 
the diets, peak insulin and insulin AUC was highest among the dogs that received the soft 
moist food. The major carbohydrate source in the soft moist food was primarily sucrose, a 
disaccharide (i.e. simple carbohydrate), in the form of corn syrup, whereas the other diets 
contained mostly complex carbohydrate sources, namely wheat, barley and whole ground 
corn (Holste et al., 1989). In comparison, the present study found that peak and AUC insulin 
levels in dogs differed in response to an oral glucose challenge after they received a pea-based 
or rice-based diet for 12 weeks, though no difference was found in fasting insulin 
concentrations between diets. The study by Holste et al. (1989) did not perform a standardized 
oral glucose tolerance test as was done in our study. Thus, Holste et al. (1989) demonstrated 
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that the type of carbohydrate (simple vs. complex) affects insulin levels in dogs, and the study 
reported herein expands on this concept and suggests that the source of the complex 
carbohydrate also affects post-prandial insulin levels. We also previously found that simple 
vs. complex carbohydrates have differential effects on vascular responses which may relate to 
the levels of reactive glucose metabolites produced post-prandially (Adolphe et al., 2012).  
A major advantage of the study described herein was that CT was used to measure 
body fat which permits the evaluation of visceral and subcutaneous fat separately (Ishioka et 
al., 2005). Other commonly used techniques to assess body fat, such as dual energy x-ray 
absorptiometry, deuterium oxide dilution and body condition score, only allow for total body 
fat measurement (Laflamme, 1997; German et al., 2010a; Mawby et al., 2004; Toll et al., 
1994). The ability to measure body fat distribution resulted in another novel finding of this 
study which was that detrimental changes in insulin metabolism, cardiac function and 
adipokine concentrations were more strongly correlated with visceral fat than with total or 
subcutaneous fat in dogs. It is known in humans that body fat stored in the central segment of 
the body (i.e. visceral fat) is more strongly associated with obesity-related disorders than 
subcutaneous fat (Bergman et al., 2006). However, this association has not previously been 
clearly demonstrated in dogs. It has been found that adipocytes in dogs differ depending on 
their location with visceral adipocytes being larger than subcutaneous adipocytes, and large 
adipocytes may predict insulin resistance (Kabir et al., 2011). The results of the present study 
provide further evidence of an association between visceral obesity and negative health 
effects in dogs as is seen with humans. 
Obesity and insulin resistance are associated with poor cardiovascular health in both 
dogs and humans (Govindarajan et al., 2008; Kil & Swanson, 2010). After 12 weeks we did 
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not observe any changes in cardiovascular parameters between the rice and pea diets in spite 
of lower post-prandial insulin responses with the pea diet. However, the positive effects on 
insulin sensitivity would be predicted to have positive cardiovascular effects over a longer 
time frame if dogs behave similarly to humans. We also observed a significant effect of the 
test diets compared to the commercial diet on adipokine profiles with the pea and rice diets 
reducing both plasma leptin and adiponectin concentrations. An ideal diet would reduce leptin 
while maintaining or increasing adiponectin and the consequences of these changes are 
unknown at this time. Thus, this observation along with the positive effects of the pea diet on 
insulin responses in this study warrant further research in this area.  
Peas are becoming an increasingly common protein, carbohydrate and fiber source in 
pet foods (Aldrich, 2010) and the results of this study provide support for both the safety and 
acceptability of peas as a carbohydrate source in dog diets. The pea diet in the present study 
contained 31% pea starch and 15% whole peas and did not result in any observed negative 
health effects after feeding for 12 weeks. In addition, the dogs in this study consumed 
equivalent amounts of both diets, suggesting that the diets were equally palatable. More 
importantly, peas may offer additional nutritional benefits in dog food. They provide nearly 
twice as much protein and higher quality protein than cereal grains and also provide unique 
bioactive compounds (Rochfort & Panozzo, 2007). It is not clear if other low glycemic index 
carbohydrate sources would provide similar health benefits as peas or whether the unique 
bioactive compounds from peas are responsible for the benefits observed in the current study. 
Further research is needed into the long-term health effects of peas and low glycemic index 
carbohydrates for dogs. 
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In conclusion, the results of this study demonstrate that peas are a healthy alternative 
carbohydrate source in dog diets and result in improved metabolic health, specifically reduced 
post-prandial insulin responses, in obese dogs. In addition, this study provides evidence that 
visceral fat in dogs, as in humans, is more strongly associated with detrimental metabolic and 
cardiovascular changes than subcutaneous fat. The results of this study also suggest that it 
may be possible to use dietary treatment to improve the metabolic health of obese individuals, 
even without weight loss, which could have a significant impact on the health of dogs. 
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CHAPTER 7 
DISCUSSION 
7.1 Conclusions 
In summary, the studies described herein examined the acute and longer term effects 
of peas as a single ingredient as well as incorporated into a complete and balanced dog diet. 
The overall objective of these studies, to develop a low glycemic index canine diet with 
proven health benefits for dogs, was achieved. Together, the results of these studies found that 
peas were well tolerated by dogs and provided health benefits compared to rice. Thus, the 
overall hypothesis for these studies, that a low glycemic index carbohydrate source, such as 
peas, will have metabolic and cardiovascular benefits compared to high glycemic index 
carbohydrate sources in lean and obese dogs, was accepted. 
These studies resulted in a number of important findings that have not been previously 
reported in the literature. A summary of the most significant findings of these studies follows: 
1. Study 1 demonstrated that post-prandial MG levels increased after a single feeding of 
simple carbohydrate in healthy, lean animals, which may be associated with acute changes 
in endothelial function. This finding provides further support for the theory that post-
prandial hyperglycemia results in negative cardiovascular consequences.  
2. Study 1 found that compared to rice and barley, peas had a significantly lower glycemic 
index. 
3. Studies 1 and 2 showed that FMD is affected by dietary treatment and post-prandial 
hyperglyecmia in dogs. 
4. Extrusion processing increases the glycemic index of peas, as shown in study 2. 
 139 
 
5. Study 2 showed that an extruded dog diet containing 15% whole peas and 31% purified 
pea starch is a highly digestible source of carbohydrates and protein for adult dogs. 
6. Study 3 demonstrated for the first time that alterations in glucose, cardiovascular and 
adipokine parameters were observed in dogs after only 12 weeks of obesity. These 
changes persisted after 32 weeks of obesity, and weight loss reversed some, but not all, of 
these changes. Thus, obesity prevention is vital to promote health in dogs. 
7. As has been shown in humans, metabolic and cardiovascular changes that occur with 
obesity were more closely associated with visceral, not subcutaneous fat, as reported in 
study 3. 
8. Study 4 demonstrated that longer term consumption of a pea-based diet resulted in health 
benefits compared to a rice-based diet. After 12 weeks, the pea-based diet reduced the 
post-prandial insulin response in obese dogs suggesting that the dogs were more 
metabolically healthy in spite of continued obesity. 
 
A summary of the interactions between the metabolic and cardiovascular health 
parameters examined in this thesis are presented in figure 7.1. The possible mechanisms for 
the observed dietary treatment effects are hyperglycemia and oxidative stress, which may be 
further exacerbated by obesity. Previous research provides evidence for post-prandial 
hyperglycemia inducing oxidative stress (Node & Inoue, 2009). The results of study 1 provide 
further support for this theory as we found that compared to feeding complex carbohydrate 
sources, feeding a glucose solution resulted elevated serum methylglyoxal, which is 
associated with increased oxidative stress (Brouwers et al., 2010). New evidence suggests that 
oxidative stress may induce hyperinsulinemia/insulin resistance (Pillon et al., 2012), which 
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may explain the results from studies 2 and 4. In study 2, we did not find a statistical difference 
in glycemic index between the pea and rice diets. However, in study 4, we found that the pea 
diet lowered insulin response to an oral glucose challenge. Although the studies herein 
focused on the carbohydrate fraction of the peas, it is possible that the effect of the peas on 
post-prandial insulin may be due to other bioactive components in peas that provide health 
benefits by reducing oxidative stress, as discussed below. 
Increased oxidative stress due to diet-induced hyperglycemia is likely further 
exacerbated by obesity (figure 7.1). Obesity is considered a state of chronic low-grade 
inflammation and results in increased oxidative stress (German et al., 2010). As shown in 
study 3, obesity resulted in increased leptin and reduced adiponectin concentrations. Since 
leptin is pro-inflammatory and adiponectin is anti-inflammatory, both adipokines impact 
oxidative stress status (Clarke & Judd, 2008; Knudson et al., 2008). Oxidative stress due to 
hyperglycemia and obesity subsequently impacts the cardiovascular system. Oxidative stress 
decreases nitric oxide availability, as demonstrated by reduced endothelial dysfunction after 
ingestion of a glucose load (Kim et al., 2003; Mah et al., 2011; Title et al., 2000), and 
supported by the FMD results from studies 1, 2 and 3. Obesity has further negative 
consequences on the cardiovascular system by increasing sympathetic tone and/or decreasing 
parasympathetic tone (Kotsis et al., 2010; Palatini, 2011; Truett et al., 1996; Van Vliet et al., 
1995), which is a likely explanation for the observed increase in heart rate and systolic left 
ventricle free wall thickness in study 3. Taken together, the results from this thesis research in 
dogs are consistent with and extend the findings from human studies. More importantly, this 
research highlights the central role that hyperglycemia, oxidative stress and obesity play in 
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acute and chronic health and provides further evidence that diet plays an important role in 
chronic disease mitigation.  
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Figure 7.1 Interrelationships between metabolic and cardiovascular health parameters affected 
by hyperglycemia, oxidative stress and obesity. 
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7.2 Implications for the Pet Food Industry and Veterinary Practice 
Overall, this research supports the usefulness of peas as an ingredient in canine diets. 
An examination of the pet foods in the market today reveals that peas and pea fractions (i.e. 
pea protein, starch and fibre) are becoming an increasingly common ingredient. Thus, the 
research reported herein provides valuable data for the pet food and pulse industries, as well 
as for veterinarians and pet owners.  
The findings of the studies reported herein will make important contributions to the 
pet food industry. The pet food industry is constantly striving to develop new and innovative 
products that are desirable to consumers. We have demonstrated that peas have acute and 
longer term health benefits for dogs, which the pet food industry can use to their advantage to 
formulate dog diets that include peas and pea starch. Many pet foods already make marketing 
claims regarding the carbohydrate source in their diets and claims about glycemic index. 
However, many of these claims are not substantiated. Our research will provide evidence for 
pet food companies regarding the health benefits of peas as a carbohydrate source in dog 
diets. 
In addition, the results of our research will have positive implications for the pulse and 
agricultural industries in Canada. In Canada alone, the dog food industry is worth $967 
million (Euromonitor International, 2011). Peas are a major export commodity in Canada. By 
demonstrating the benefits of peas as a carbohydrate source in dog food, this research may 
help to increase the number of dog diets that include peas and thus, increase the local and 
international demand for peas and other pulses. This research could result in significant local 
and national economic benefits for the pulse and agriculture industries. 
The results of study 2 demonstrated that peas are a highly digestible carbohydrate and 
protein source for dogs and study 4 demonstrated that a pea-based diet appeared to be well 
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tolerated by laboratory beagles over a 12 week feeding period. One of the advantages of peas 
over other more traditional carbohydrate sources used in pet foods, such as wheat, corn and 
rice, is that peas are a significantly greater source of protein (approximately 25 % w/w protein 
in peas versus 10 % w/w protein in corn) (Carciofi et al., 2008). The protein in peas is a good 
source of most essential amino acids, particularly lysine (Dahl et al., 2012). Methionine and 
cysteine are the first limiting amino acids in peas, followed closely by tryptophan (Aldrich, 
2010). Peas as a protein source are advantageous for the pet food industry because plant 
protein sources are typically cheaper than animal sources. Compared to lower protein grains, 
peas would allow for easier formulation of higher protein diets which are currently popular 
among consumers. 
The research described herein also has important implications from a clinical 
veterinary perspective. The prevalence of obesity in dogs is estimated to be between 22 and 
44% (German, 2006). The results of study 3 provide further evidence about the negative 
effects of obesity on canine health. Specifically, we demonstrated for the first time that after 
only 12 weeks of obesity, dogs had increased fasting, peak and AUC serum glucose 
concentrations, elevated heart rate, and increased systolic left ventricle free wall thickness. 
These detrimental changes after a very short time period provide veterinary practitioners 
valuable information when counseling their clients about the importance of preventing weight 
gain and encouraging weight loss. In addition, the results of study 4 provide evidence that 
veterinarians should consider the carbohydrate source when recommending diets for obese 
canine patients since diets containing peas may help improve metabolic health by reducing 
post-prandial insulin concentrations. 
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7.3 Strengths and Limitations 
One of the major strengths of the studies performed herein was the ability to use the 
same dogs as their own control by using a cross-over design in all four studies. A primary 
advantage of this study design is that fewer subjects are necessary. A cross-over design 
permitted all dietary treatments to be tested by all animals which helps to reduce inter-
individual variability. However, a limitation of a cross-over design is the possibility that a 
previous treatment had an effect on a later treatment, though this was minimized in these 
studies by randomizing treatments and including washout periods.  
An additional strength of this research was the applicability of the research to both 
canine and human health. All four studies in this thesis were designed to investigate the 
treatment effects on canine health, but were also designed to act as a model for human health 
research. Using a dog model in these studies allowed for study designs that would have been 
very challenging, if not impossible, to perform in a human population, particularly the obesity 
study (study 3) and long-term diet study (study 4). In addition, dogs as a model for humans 
permit strict control over diet, lifestyle and body weight status. 
The dog model has advantages over other animal models for nutrition and obesity 
research. Rodents are a popular animal model in many situations due to their size, cost, 
availability, short life span, and ease of being genetically manipulated (Swanson & Schook, 
2006). Rodents are a valuable model in a basic research environment, but anatomical and 
physiological shortcomings make them not always suitable as a model for humans (Swanson 
& Schook, 2006). For example, the gastrointestinal tract of rats differs significantly from that 
of humans. In humans, the primary organ where bacterial fermentation occurs is the proximal 
half of the colon, whereas rats are primarily cecal fermenters (Swanson & Schook, 2006). The 
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cecum in humans and dogs is small and has little physiological importance. Thus, rodents are 
not an ideal model for studies involving digestive physiology. 
The pig model is another important animal model of human disease and nutrition 
(Merrifield et al., 2011). Pigs are a beneficial biomedical model because they have similar 
characteristics to humans, including an omnivorous diet, propensity to sedentary lifestyle and 
obesity, and comparable metabolic and cardiovascular features (Torres-Rovira et al., 2012). 
However, pigs create a challenge when performing techniques that require the animal to be 
motionless, such as echocardiography and FMD. Pigs require sedation to perform these 
techniques (Al-Dissi & Weber, 2011) and sedatives have cardiovascular effects that could 
interfere with the outcome measurement (Gregory & Wilkins, 1986; van Woerkens et al., 
1990). In addition, pigs are a production animal and studying the health of pigs for their own 
sake is generally not of interest. Conversely, millions of dog owners have a vested interest in 
improving the health of their pets, so using dogs as a model for humans in nutrition research 
serves a dual purpose by benefiting both dogs and humans. 
A benefit of using dogs as a model for human obesity is that there is a large amount of 
literature on the physiology of the dog and the dog genome has already been mapped 
(Speakman et al., 2008). We demonstrated in study 3 that dogs may be a particularly good 
obesity model as the dogs in this study became obese after only a short period of time on a 
regular, ad libitum diet, and cardiovascular and metabolic changes were already evident after 
12 weeks of obesity. In addition, due to the obesity epidemic among the canine population, 
there is a large population of pet dogs with naturally-occurring obesity as well as dogs that 
have been obese for many years, which permit investigation into aspects of obesity that 
cannot be readily achieved with obesity-induced, genetically modified lab animals. An 
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additional benefit of using dogs as a model in the studies herein was that dogs are an adequate 
size to perform the same ultrasound and glycemic testing as is commonly performed in 
humans, which would be much more challenging in smaller animal species such as mice or 
rats. 
One of the limitations of these studies was the small sample size. Some variables of 
interest had relatively high intra- and inter-individual variation, such as FMD. For study 1, a 
power analysis found that a sample size of 25 was required to show significant differences in 
FMD between the complex carbohydrate treatments. In spite of this, significant effects of 
treatment on FMD were observed between simple versus complex carbohydrates. A study by 
Welsch et al. (2002) reported that to detect a difference in vasoreactivity of 60% (2-tailed), for 
example 5% vasodilation versus 8% vasodilation, at 90% power, 23 and 10 subjects would be 
required for cross-sectional and pre-post designs, respectively, in humans (Welsch et al., 
2002). We did not observe such a large difference in vasoreactivity between most of the 
treatment groups. The small effect on FMD after feeding complex carbohydrates could be due 
to the intrinsic beneficial effects of consuming complex carbohydrates or could be due to a 
species difference (i.e. dogs versus humans). However, to our knowledge, the post-prandial 
effect of different complex carbohydrate sources on FMD in humans or any other species has 
not been previously examined and requires further investigation. In study 1, the greatest 
difference in vasoreactivity was between the corn (FMD = 1.6 %) and glucose (FMD = 4.5 %) 
groups, which represented a 64% difference in reactivity. Thus, a larger sample size would 
have been necessary to observe differences between the other treatment groups which had 
smaller changes in vasoreactivity. However, since we did observe a treatment effect between 
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the glucose and complex carbohydrate groups, we demonstrated for the first time that FMD in 
dogs is affected by post-prandial hyperglycemia. 
7.4 Future Research 
Although there is a tremendous amount of literature on glycemic index and glycemic 
load in humans, there is a lack of information about their health effects in dogs. Thus, the 
present research provides important information about the role of different carbohydrate 
sources on metabolic and cardiovascular health in dogs, but much more research is needed. 
For example, this research was performed using laboratory beagles, so additional research is 
needed in free-living pet dogs of different breeds. The effect of glycemic index and different 
carbohydrate sources also needs to be examined in diabetic dogs, for which glycemic index 
may play an even more important role than it does in healthy or obese dogs. In addition, there 
is currently debate among veterinarians and animal scientists as to the health effect of 
carbohydrates in cats, which are obligate carnivores (Buffington, 2008; Laflamme, 2008; 
Stuart, 2005). Although cats are able to tolerate dietary carbohydrates (Laflamme, 2008), the 
long term health effects of a high carbohydrate diet for cats is unknown. Some evidence 
suggests that cats are more prone to obesity and insulin resistance when fed a low protein, 
high carbohydrate diet (Hoenig et al., 2007). However, dry extruded pet foods, the most 
common form of pet food, require carbohydrate to bind the pellets and make a suitable 
extruded product. Thus, research into the effect of different dietary carbohydrate sources on 
feline health is vital. If it is determined that in fact cats are healthier when they consume less 
carbohydrate or avoid certain types of carbohydrate, research would also be necessary to 
determine how to extrude cat food using different carbohydrate sources or with the lowest 
carbohydrate content possible. 
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In study 4, the mechanism by which the pea-based diet resulted in reduced insulin 
response to an oral glucose challenge is unknown and requires further exploration. The 
research in this thesis has focused on the carbohydrate fraction of peas, but the glycemic 
effect of peas may not have been responsible for the improved insulin profile since study 2 
found that the glycemic index of the peas and rice did not differ after formulation into a 
complete, extruded dog diet. Thus, it is possible that other bioactive components in peas may 
be exerting health effects. Peas are higher in protein than rice, and it is possible that the 
protein component of peas could have an effect on health parameters. Emerging research in 
obese rat models suggest that different protein sources have varying effects on insulin 
resistance, inflammatory status, and oxidative stress (Madani et al., 2012; Pilon et al., 2011). 
Another component of peas that may indirectly improve insulin sensitivity is the significant 
concentration of oligosaccharides that may have a prebiotic effect in the large intestine (Dahl 
et al., 2012). Evidence is accumulating that the gut microbiome plays a key role in health 
status and modulation of gut microbiota in obesity has been shown to improve insulin 
signaling and glucose tolerance in an obese mouse model (Carvalho et al., 2012). Lastly, 
antioxidant phytochemicals in peas, such as phenolic compounds, may reduce oxidative stress 
which could consequently improve insulin sensitivity (see above; figure 7.1) (Pillon et al., 
2012). However, current research on the antioxidant activity of peas is limited to in vitro 
studies and intervention studies are still needed to investigate the efficacy of pea antioxidant 
activity in vivo (Dahl et al., 2012).  
Further research is necessary in order to standardize the oral glucose tolerance test and 
glycemic index procedures in dogs. Orally administered glucose was used in this research as 
the control food for determining glycemic index in studies 1 and 2, and as a measure of 
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glucose tolerance in studies 3 and 4. Oral glucose administration was chosen over intravenous 
glucose administration in order to be consistent with methods used in humans and because 
oral glucose is considered to be a more physiologically relevant measure (Borai et al., 2007). 
In addition, oral administration of glucose was chosen so that the glucose and complex 
carbohydrate sources were administered the same way, since it is not possible to administer 
the complex carbohydrate sources intravenously. However, the primary limitation with oral 
administration is the influence of gastrointestinal emptying (Borai et al., 2007). Nevertheless, 
oral glucose tolerance testing is a commonly used research technique and standardization of 
the procedure in dogs is needed.  
The amount of glucose administered as well as the time intervals and duration of post-
prandial testing can vary significantly between studies that employ oral glucose tolerance 
testing. For example, studies in dogs have reported using from 0.9 g/kg glucose to as much as 
4 g/kg (Irvine et al., 2002; Moore et al., 2011; Watanabe et al., 2004). The amount of glucose 
administered can have a significant effect on the results as demonstrated by a study that 
performed oral glucose tolerance tests in non-obese Laborador Retriever dogs and used an 
oral glucose bolus of 4 g/kg body weight given as a 50% w/v solution (Irvine et al., 2002). In 
this study, plasma glucose levels peaked by 30 min and had not returned to baseline after 2 h, 
whereas plasma insulin peaked after only 15 min. The investigators reported that the glucose 
profiles in this study did not follow typical oral glucose tolerance test profiles, which exhibit a 
peak glucose concentration between 30 and 60 min and return to baseline by 120 min with 
mild hypoglycemia by 180 min. The abnormal glucose profile in the study by Irvine et al. 
(2002) may have been due to the large dose of glucose used, which was approximately 4 
times greater than that typically used in humans on a per weight basis, or due to the high 
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osmolarity of the 50% w/v glucose solution, which could have affected gut motility (Irvine et 
al., 2002). In contrast, we used a glucose solution that provided a defined amount of glucose 
(10 g glucose, or approximately 1 mg/kg body weight) in a 20% w/v solution as this is closer 
to the glucose dosage used in human clinical glucose tolerance testing. The methodology we 
employed resulted in significant differences between dietary treatments for both serum 
glucose and insulin responses and thus, the methods seemed to be appropriate for this research 
design and for use in dogs. 
In humans, glycemic index testing in healthy individuals is performed for two hours 
post-prandially. However, we performed three hour post-prandial glucose and insulin 
response tests in the dogs because we found, particularly with the complex carbohydrate 
sources, that serum glucose levels had not returned to baseline after only two hours. This 
finding is in agreement with a study by Watanabe et al. (2004) which found that glucose 
values converged on the level of the pre-load value 180 min after the glucose overload. 
Watanabe et al. (2004) reported that carrying out the testing to 180 min was crucial in 
assessing glucose intolerance under their experimental conditions and our data support their 
conclusion. 
In study 3 we observed significant changes in metabolic and cardiovascular 
parameters after dogs were obese for only 12 weeks. After an average weight loss period of 
17 weeks, not all of these parameters returned to pre-weight gain levels. Additional research 
is necessary to determine whether these alterations will return to lean levels after a longer 
period of time, or if the changes are permanent. Of particular interest is whether plasma leptin 
and adiponectin will eventually return to pre-weight gain concentrations, as alterations in 
these adipokines could have lasting effects on energy homeostasis and propensity for weight 
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re-gain. A study by Jeusette et al. (2005) found that leptin concentrations in a group of dogs 
that had undergone weight loss was not significantly different than that of control lean dogs. 
However, the length of the weight loss period was not reported in this study. Another study 
that measured leptin and adiponectin concentrations before and after weight loss in dogs 
found that leptin decreased after a 26 week weight loss period, but adiponectin, which was 
expected to increase with weight loss, was actually found to decrease (Wakshlag et al. 2011). 
Our results are in agreement with these findings. Study 3 found that after weight loss, leptin 
concentrations had decreased compared to obese concentrations, but were still higher than 
pre-weight gain values, whereas adiponectin was lower after weight loss than when the dogs 
were obese. Adiponectin seems to be less affected by weight loss than leptin, which is a 
finding that has also been reported in humans (Arvidsson et al., 2004). Further research is 
needed to elucidate the role dietary therapy plays in normalizing adipokine profiles after 
weight loss.  
Flow-mediated dilation is a commonly used research technique in human clinical trials 
and is considered to be an independent predictor of future cardiovascular events (Green et al., 
2011). However, there are few trials that have used FMD in dogs (Jones et al., 2011; Puglia et 
al., 2006) and to our knowledge, there are no studies that have examined the clinical 
significance of FMD in dogs or the effect of different dietary treatments on FMD. The studies 
herein demonstrate that FMD is responsive to different dietary treatments in lean and obese 
dogs and, as in humans (Mah et al., 2011), hyperglycemia impaired FMD. Although dogs do 
not develop atherosclerotic heart disease like humans, cardiac disease is one of the top five 
most commonly reported diseases in dogs (Freeman et al., 2006) and thus, makes a significant 
contribution to canine morbidity and mortality. More than 10% of dogs have some form of 
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cardiac disease (Slupe et al., 2008) and approximately 10% of deaths among dogs are due to 
cardiovascular disease (Fleming et al., 2011). Thus, further examination into the significance 
of impaired FMD in dogs is warranted and future studies are needed to examine whether 
FMD is reduced in dogs with various types of cardiac disease. 
The research reported in this thesis suggests that peas are a healthy alternative 
carbohydrate source for inclusion in dog diets. Other pulses, such as lentils and chickpeas, 
which have a similar macronutrient and micronutrient composition as peas may also be 
suitable for use in canine diets, but additional research is necessary. Since the studies reported 
in this thesis were performed in laboratory dogs of only one breed (beagles), it is also 
important to examine the effect of peas in pet dogs of a variety of different breeds. Although 
the pea diet appeared to be well tolerated by the laboratory beagles used in these studies, we 
did not specifically evaluate characteristics of the pea diet that would be important to pet 
owners, such as flatulence and fecal quality. It would be important to study these 
characteristics in pet dogs using diets with different inclusion rates of peas to determine if 
there is an inclusion threshold for peas and/or pea starch above which stool quality is 
compromised or flatulence occurs. 
In study 1 we found that ground, unprocessed peas as a single ingredient had a lower 
glycemic index than rice or barley. However, study 2 found that an extruded pea-based diet 
did not have a lower glycemic index than a rice-based diet, suggesting that extrusion or the 
presence of other ingredients affected the glycemic index of the peas. In spite of the increased 
glycemic index of the pea-based diet, this diet still resulted in lower serum insulin 
concentrations after an oral glucose tolerance test after 12 weeks on the diet in obese dogs 
(study 4). Thus, peas seem to have an inherent benefit on insulin metabolism that, as 
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discussed above, may be due to other bioactive components in peas, though it is possible that 
this benefit would be even greater if the low glycemic index of raw peas were maintained 
after extrusion processing. Thus, further research is needed to determine how to minimize the 
impact of extrusion on the glycemic index of peas. Nonetheless, the research herein suggests 
that peas are a healthy carbohydrate source for inclusion in extruded diets for dogs. 
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APPENDIX A:  SUPPLEMENTAL DATA FOR STUDY 1 
 
       
Figure A.1 Serum glucose and insulin responses after feeding simple (glucose) or complex (rice, 
barley, corn, peas) carbohydrate sources. 
Serum (A) glucose and (B) insulin were measured in a cross-over trial in dogs (n=6) at ideal 
body weight. Each carbohydrate source provided 10 g of available carbohydrate and was tested 
twice in each dog. Carbohydrate sources with different superscripts had significantly different 
area under the curve responses, P<0.05 univariate GLM with LSD posteriori test. 
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Figure A.2 Serum glucose and insulin responses after feeding complex carbohydrate sources. 
Serum (A) glucose and (B) insulin were measured in a cross-over trial in dogs (n=6) at ideal 
body weight. Each carbohydrate source provided 10 g of available carbohydrate and was tested 
twice in each dog. Carbohydrate sources with different superscripts had significantly different 
area under the curve responses, P<0.05 univariate GLM with LSD posteriori test. 
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Figure A.3 Serum glucose and insulin responses after feeding three dosages of glucose. 
Serum (A) glucose and (B) insulin were measured in a cross-over trial in dogs (n=6) at 
ideal body weight. 10, 20 and 30% glucose solutions provided 5, 10, and 15 g glucose, 
respectively. Glucose dosages with different superscripts had significantly different area 
under the curve and peak responses, P<0.05 univariate GLM with LSD posteriori test.
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Figure A.4 Flow-mediated dilation dose response to glucose 60 min after ingestion. 
Cross-over trial in dogs (n=6) at ideal body weight. 10, 20 and 30% glucose solutions provided 
5, 10, and 15 g glucose, respectively. No significant differences. 
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APPENDIX B: SUPPLEMENTAL DATA FOR STUDY 2 
 
          
Figure B.1 Serum glucose and insulin responses after feeding glucose, rice kibble or pea kibble. 
Serum (A) glucose and (B) insulin were measured in a cross-over trial in dogs (n=7) at ideal 
body weight. Each treatment provided 10g of available carbohydrate and was tested twice in 
each dog. Treatments with different superscripts had significantly different area under the curve 
and peak responses, P<0.05 univariate GLM with LSD posteriori test. 
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Figure B.2 Serum glucose and insulin responses after feeding rice or pea kibble. 
Serum (A) glucose and (B) insulin were measured in a cross-over trial in dogs (n=7) at ideal 
body weight. Each treatment provided 10g of available carbohydrate and was tested twice in 
each dog. No significant differences. 
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Table B.1 Cardiac and hemodynamic variables before and after feeding the pea diet, rice diet or 
glucose. 
 Glucose Pea Diet Rice Diet 
 Time 0 Time 60 Time 0 Time 60 Time 0 Time 60 
LVID 
systole(cm) 
2.0 ± 0.07 2.1 ± 0.06 2.1 ± 0.06 2.0 ± 0.06 2.1 ± 0.06 2.0 ± 0.08 
LVID diastole 
(cm) 
3.0 ± 0.08 3.1 ± 0.05 3.0 ± 0.07 2.9 ± 0.10 3.1 ± 0.08 3.0 ± 0.10 
LV free wall 
systole (cm) 
1.02 ± 0.03 1.03 ± 0.03 1.0 ± 0.03 1.0 ± 0.04 1.0 ± 0.03 1.01 ± 0.02 
LV free wall 
diastole (cm) 
0.78 ± 0.03 0.79 ± 0.03 0.79 ± 0.03 0.75 ± 0.02 0.75 ± 0.02 0.75 ± 0.02 
Fractional 
shortening (%) 
33.4 ± 1.3 32.3 ± 1.1 31.1 ± 0.9 32.2 ± 1.4 31.7 ± 1.2 32.4 ± 1.3 
Ejection fraction 
(%) 
47.1 ± 2.9 52.2 ± 1.7 46.2 ± 2.9 48.9 ± 3.4 50.0 ± 3.7 52.1 ± 2.3 
Stroke volume 
(ml) 
11.3 ± 0.9 12.5 ± 0.6 12.7 ± 1.6 10.9 ± 0.7 13.2 ± 1.5 13.3 ± 1.5 
Diastolic blood 
pressure (mm Hg)
66 ± 2 67 ± 3 66 ± 1 64 ± 2 67 ± 2 66 ± 1 
Systolic blood 
pressure (mm Hg)
128 ± 3 126 ± 2 130 ± 3 128 ± 3 125 ± 4 127 ± 3 
Heart rate1 74 ± 3 76 ± 4 76 ± 3 79 ± 2 76 ± 2 82 ± 2 
Values are mean ± SEM. 1Significant effect of time. No significant effect of treatment observed for any variables..
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APPENDIX C: SUPPLEMENTAL DATA FOR STUDY 3 
 
  
Figure C.1 Serum glucose and insulin responses to oral glucose tolerance test in dogs that were 
lean, have been obese for 12 or 32 weeks or have undergone weight loss. 
Serum (A) glucose and (B) insulin were measured in dogs (n=8) that were fed a commercial diet 
in controlled portions to maintain a lean body condition, followed by ad libitum feeding of the 
diet to promote obesity, and subsequently food was restricted for weight loss. Body conditions in 
legend without a common superscript differ in area under the curve response, P<0.05; repeated 
measures GLM with LSD posteriori test. 
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APPENDIX D: SUPPLEMENTAL DATA FOR STUDY 4 
      
Figure D.1 Serum glucose and insulin responses to oral glucose tolerance test after 
consuming pea-based or rice-based diet for 12 weeks. 
Dogs (n=8-9) were fed ad libitum amounts of a pea-based or rice based diet for 12 weeks, 
followed by an 8 week washout period before the dogs were crossed-over to the pea or 
rice diet for another 12 weeks. (A) No significant differences. (B) *Area under the insulin 
response curve and peak insulin significantly different between pea and rice diets, 
P≤0.05; univariate GLM with baseline as covariate.  
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APPENDIX E: PERMISSIONS 
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